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ABSTRACT 
“A Systems Biology Approach to the Human Hair Cycle”. A thesis submitted to 
The University of Manchester for the degree of Doctor of Philosophy by Yusur 
Mamoon Al-Nuaimi, 2011.  
 
The hair cycle represents a dynamic process during which a complex mini-
organ, the hair follicle, rhythmically regresses and regenerates. The control 
mechanism that governs the hair cycle (“hair cycle clock”) is thought to be an 
autonomous oscillator system, however, its exact nature is not known. This 
thesis aims to understand the human hair cycle as a systems biology problem 
using theoretical and experimental techniques in three distinct study 
approaches.  
Using mathematical modelling, a simple two-compartment model of the 
human hair cycle was developed. The model concentrates on the growth control 
of matrix keratinocytes, a key cell population responsible for hair growth, and 
bi-directional communication between these cells and the inductive fibroblasts 
of the dermal papilla. A bistable switch and feedback inhibition produces key 
characteristics of human hair cycle dynamics. This study represents the first 
mathematically formulated theory of the “hair cycle clock”. 
A second chronobiological approach was adopted to explore the 
molecular control of the human hair follicle by a peripheral clock mechanism. 
The hypothesis was tested that selected circadian clock genes regulate the 
human hair cycle, namely the clinically crucial follicle transformation from 
organ growth (anagen) to organ regression (catagen). This revealed that intra-
follicular expression of core clock and clock-controlled genes display a circadian 
rhythm and is hair cycle-dependent. Knock-down of Period1 and Clock promotes 
anagen maintenance, hair matrix keratinocyte proliferation and stimulates hair 
follicle pigmentation. This provides the first evidence that peripheral Period1 
and Clock gene activity is a component of the human “hair cycle clock” 
mechanism. 
Lastly, an unbiased gene expression profiling approach was adopted to 
establish important genes and signalling pathways that regulate the human hair 
cycle. This revealed that similar genes and pathways previously shown to 
control the murine hair cycle in vivo, such as Sgk3, Msx2 and the BMP pathway, 
are also differentially regulated during the anagen-catagen transformation of 
human hair follicles. 
In summary, by using a three-pronged systems biology approach, the 
thesis has shed new light on the control of human hair follicle cycling and has 
generated clinically relevant information: a) The hair cycle model may predict 
how hair cycle modulatory agents alter human hair growth.  b) Period1 and 
Clock are new therapeutic targets for human hair growth manipulation. c) Gene 
expression profiling points to additional key players in human hair cycle control 
with potential for future therapeutic targets. 
15 
 
Declaration 
The author declares that no portion of the work referred to in the thesis has 
been submitted in support of an application for another degree or qualification 
of this or any other university or other institute of learning. 
16 
 
COPYRIGHT STATEMENT 
i. The author of this thesis (including any appendices and/or schedules to 
this thesis) owns certain copyright or related rights in it (the 
“Copyright”) and s/he has given The University of Manchester certain 
rights to use such Copyright, including for administrative purposes.  
ii. Copies of this thesis, either in full or in extracts and whether in hard or 
electronic copy, may be made only in accordance with the Copyright, 
Designs and Patents Act 1988 (as amended) and regulations issued 
under it or, where appropriate, in accordance with licensing agreements 
which the University has from time to time. This page must form part of 
any such copies made.  
iii. The ownership of certain Copyright, patents, designs, trade marks and 
other intellectual property (the “Intellectual Property”) and any 
reproductions of copyright works in the thesis, for example graphs and 
tables (“Reproductions”), which may be described in this thesis, may not 
be owned by the author and may be owned by third parties. Such 
Intellectual Property and Reproductions cannot and must not be made 
available for use without the prior written permission of the owner(s) of 
the relevant Intellectual Property and/or Reproductions.  
iv. Further information on the conditions under which disclosure, 
publication and commercialisation of this thesis, the Copyright and any 
Intellectual Property and/or Reproductions described in it may take 
place is available in the University IP Policy (see 
http://www.campus.manchester.ac.uk/medialibrary/policies/intellectu
al-property.pdf), in any relevant Thesis restriction declarations 
deposited in the University Library, The University Library’s regulations 
(see http://www.manchester.ac.uk/library/aboutus/regulations) and in 
The University’s policy on presentation of Theses. 
17 
 
ACKNOWLEDGEMENTS 
I would like to acknowledge and thank Professor Ralf Paus, Dr Rachel Watson 
and Dr Gerold Baier for their supervision, support and guidance through my 
PhD. You have all taught me a great deal and each provided me with inspiration 
in my work and for the future. I would like to acknowledge the DTC in 
Integrative Systems biology, in particular, Professor Westerhoff for providing 
the environment to develop as a novice Systems Biologist. Professor Griffiths, 
thank you for acting as my PhD advisor, for all your support and for inspiring 
me in my career goal as an academic dermatologist. I would like to thank the 
Paus group in Germany, particularly Dr Jennifer Kloepper for their support, 
guidance and hospitality during my stay at the University of Luebeck and the lab 
technician Nadine Doerwald for experimental support. Thanks to the Watson 
group (especially Dr Abigail Langton) and the Paus UK group (Drs David 
Pattwell, Iain Haslam and Craig Portsmouth) for lab support and advice. I 
acknowledge and thank Marc Goodfellow (Baier Research Group), fellow DTC 
student, for dynamical systems tutorials (MATLAB advice and explanations) 
used for the dynamic introduction section Chapter 4 and the mathematical 
model presented in Chapter 5 in the thesis. I am grateful for the collaborations 
with Professor Mike Philpott, London, and Dr Tamas Biro, Hungary and for their 
contributions to the clock work and qPCR experiments, respectively. I 
acknowledge and thank Dr Qing-Jun Meng for his advice and suggestions on the 
circadian clock work (The University of Manchester). In addition, I acknowledge 
the University of Manchester Genomic Technologies Core Facility for 
performing the microarray experiment (Leanne Wardleworth) and initial 
analyses (Dr. Leo Zeef) that is presented in this thesis. Thank you, my best 
friend M, for always encouraging and believing in me. Finally, thank you Mama, 
Baba and Dania for your endless support. 
18 
 
LIST OF ABBREVIATIONS 
ACTB  actin, beta 
AKR1C1  aldo-keto reductase (AKR) superfamily 
APM  arrector pili muscle 
BAMBI BMP and activin membrane-bound inhibitor homolog  
BDNF   brain-derived neurotrophic factor 
BM  basement membrane 
BMAL1 aryl hydrocarbon receptor nuclear translocator-like 
BMP   bone morphogenetic protein 
BMPR1A  bone morphogenetic protein receptor 1A 
CCG  clock controlled gene 
CDKN1A cyclin-dependent kinase inhibitor 1A (p21, Cip1) 
cDNA  complementary deoxyribonucleic acid  
CLOCK clock homolog (mouse) 
c-MYC  v-myc myelocytomatosis viral oncogene homolog (avian) 
CRY  cryptochrome  
CTS  connective tissue sheath 
ΔCT  delta Ct 
DAPI  4', 6-diamidino-2-phenylindole 
DLX  distal less homeobox 
DNA  deoxyribonucleic acid  
DP  dermal papilla 
DSG4  desmoglein 4 
EGF  epidermal growth factor 
EMI  endogenous mitotic inhibitor 
EP  epithelium 
FAM  follicular automaton model 
FITC  fluorescein isothiocyanate 
FKBPL  FK506 binding like protein 
19 
 
FGF-5  fibroblast growth factor 5  
FGF5S  fibroblast growth factor 5 splice variant 
FZD10  frizzled 10 
GAPDH  glyceraldehyde 3-phosphate dehydrogenase 
GO  gene ontology 
HCC  hair cycle clock  
HFPU  hair follicle pigmentary unit 
HF  hair follicle 
HGF  hepatocyte growth factor  
HS  hair shaft 
IF  immunofluorescence 
IGF-1  insulin-like growth factor 1 
IGF-R  insulin-like growth factor receptor  
IHC  immunohistochemistry 
ISH  in situ hybridisation 
IRS  inner root sheath 
K  keratin 
KAP  keratin-associated protein 
Ki-67  proliferation-related Ki-67 antigen 
ODE  ordinary differential equation 
ORS  outer root sheath 
M  matrix 
MAPK   mitogen-activated protein (MAP) kinases 
MF  masson-fontana 
mRNA  messenger ribonucleic acid 
MSX2  msh homeobox 2 
MK  matrix keratinocyte 
NOG  noggin 
NR1D1 nuclear receptor subfamily 1, group D, member 1 
NT  neurotrophin 
20 
 
NT-3  neurotrophin 3 
P13K  phosphatidylinositol-3-kinase 
P21  cyclin-dependent kinase inhibitor 1A (p21, Cip1) 
PBS  phosphate buffered saline  
PERIOD1 period homolog (mouse) 
PFA  paraformaldehyde 
PM  papilla morphogen 
PPIA  peptidylprolyl isomerase A 
qPCR  quantitative polymerase chain reaction 
RNA  ribonucleic acid 
RNase  ribonuclease 
SC  stem cell 
siRNA  small interfering RNA 
SG  sebaceous gland 
SGK3  serum glucocorticoid regulated kinase 3 
SPP1  secreted phosphoprotein 1 (osteopontin) 
TAC  transient amplifying cell 
TBS  tris buffered saline 
TGF-β1 transforming growth factor β1/ β2 
TRH  thyrotropin hormone 
TUNEL terminal deoxynucleotidyl transferase dUTP nick end labelling 
VEGF  vascular endothelial growth factor 
WNT  wingless-type MMTV integration site 
 
 
 
  
21 
 
 
1 CHAPTER 1: INTRODUCTION 
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This chapter provides an overview of the aims of the thesis and an explanation 
of the thesis structure. A short background describing the motivation of the 
project is provided with the specific aims of the thesis detailed. Following this, 
the format of the thesis is outlined. 
1.1 MOTIVATION AND AIMS 
The hair follicle (HF) undergoes continuous cyclical organ transformations 
involving co-ordinated regeneration (proliferation) and apoptotic regression of 
the HF in its own unique biorhythm (the hair cycle). This dynamic process relies 
on the co-ordinated spatio-temporal interactions of various cell compartments 
that exhibit both molecular and population changes in expression patterns. 
Understanding how the hair cycle mechanism occurs is of clinical 
importance as disruption of normal hair cycling is responsible for most hair 
disorders. In addition the current treatment options available are 
disappointingly ineffective. Although multiple molecules have been identified 
that alter hair cycling, the research relies heavily on other mammalian species 
such as mice. There remains neither an existing mechanistic explanation of how 
the human hair cycle rhythm may come about nor confirmation that synergy 
exists between established research findings in other mammalian species with 
the human HF. 
Systems biology aims to understand the complex interactions within a 
biological system that result in its normal function or dysfunction. The 
discipline involves interdisciplinary approaches and often mathematical 
modelling to elucidate the systems properties of the biological system of 
interest.  
The goal of this thesis is to apply a systems biology approach to 
understand the human hair cycle mechanism as a complex dynamic process. 
Within this work there is a particular focus on elucidating the controls of the 
transition from the growth stage of the hair cycle (anagen) to the regressive 
state (catagen). 
In order to address the problem from a systems biology perspective, 
three specific approaches will be taken for the thesis. Firstly, a theoretical 
23 
 
approach is applied via the use of mathematical modelling. Secondly, a directed 
experimental investigation elucidating the role of circadian clock genes and 
proteins as novel candidates in the human anagen-to-catagen transition is 
adopted. Finally, these two hypothesis-driven approaches are complemented by 
a gene expression profiling strategy to identify key genes and signalling 
pathways that control the transformation of human HFs from the anagen to 
catagen hair cycle stages.  
This three-pronged systems biology investigation aims to shed new light 
on the controls of human HF cycling and to generate clinically relevant 
information for the future management of human hair growth disorders. 
 
1.2 STRUCTURE OF THE THESIS 
The thesis is presented in the alternative format, as such; some chapters are in 
the form of a manuscript. Where this is the case this is clearly identified on the 
chapter title page and the nature of the authors’ contributions are also detailed 
there. This format was chosen so that these chapters may be understood 
independently with their own introduction, methods and discussion sections 
and reflects the various techniques and approaches adopted in the thesis.  
An introduction to the thesis aims and structure is provided in this 
chapter. Chapter 2 comprises a literature review introducing the human HF, the 
hair cycle and explores existing theories of the hair cycle mechanism. The 
chapter concludes that a systems biology approach may be adopted to address 
this problem. Additional literature reviews are also found in the relevant 
introductory sections of “manuscript” chapters. Chapter 3 is a viewpoint article 
that was published in Experimental Dermatology. This chapter argues that the 
HF is an ideal systems biology research tool, introduces systems biology and 
mathematical modelling and its status in terms of hair biology.  
The theoretical approaches utilised in the thesis are found in Chapters 4 
and 5, where Chapter 4 introduces dynamical systems theory and terminologies. 
Chapter 5 contains a proposed mathematical model of the human hair cycle 
using a dynamical systems approach. It concludes that the human hair cycle 
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rhythm is an autonomous process which requires the presence of bistability and 
feedback inhibition to produce the dynamic behaviour of the human hair cycle. 
Chapters 6-8 comprise the experimental work of the thesis beginning 
with experimental methodologies found in Chapter 6. The role of circadian 
genes and proteins in the human HF is presented in Chapter 7, which concludes 
that Period1 and Clock play a role in regulating the anagen-to-catagen transition 
in human organ-cultured HFs. Chapter 8 details a transcriptome study which 
identifies global gene expression profiles of human anagen and catagen organ-
cultured HFs. Novel genes that represent each state are identified. 
Finally, the conclusions along with future research perspectives are 
presented in Chapter 9.  
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2 CHAPTER 2: LITERATURE REVIEW 
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In this chapter the literature is reviewed in order to introduce HF anatomy, the 
hair cycle, current theories of the controls of hair cycling and the anagen-to-
catagen transition. There are additional literature reviews located in 
subsequent chapters that introduce specific topics relevant to the chapter.  
2.1 BASIC HUMAN HAIR DATA 
The human body is covered in 5 million hairs and, of that, approximately 80,000 
to 150,000 are found on the scalp (Krause and Foitzik, 2006). Hair is produced 
by the multi-cellular entity; the HF. There are two types of HFs in adult humans; 
vellus and terminal. These produce a small, fine vellus hair and thick, pigmented 
terminal hair respectively (Whiting, 2004, Paus and Cotsarelis, 1999, White and 
Cox, 2006). 
2.2 THE HAIR FOLLICLE 
The HF resides as an appendage of the skin and makes up one entity of the pilo-
sebaceous unit. The pilo-sebaceous unit consists of the HF, sebaceous gland, 
apocrine gland and arrector pili muscle. The HF, in adult life, undergoes cycles 
of growth (anagen), regression (catagen) and relative resting (telogen). 
Anatomically, the HF is most commonly described when it is in the mature 
anagen stage; anagen VI (Figure 2.1).  
In the mature anagen state the HF can be divided into an upper 
“permanent” portion the infundibulum and isthmus, which does not cycle, and a 
lower “non-permanent” segment comprising the suprabulbar region and the 
bulb (Figure 2.1A). It is the lower region of the HF which undergoes re-
modelling during the hair cycle.  
The infundibulum, at its proximal end, marks the opening of the hair 
canal to the surface of the skin. The infundibulum is lined by epidermis which is 
continuous with the surface of the skin. The lower part of the infundibulum is 
defined by the attachment of the duct of the sebaceous gland and it is via this 
duct that sebum is excreted into the HF and onto the skin’s surface (Schneider et 
al., 2009, Whiting, 2004). Distal to the infundibulum is the isthmus. The hair 
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shaft is not attached to either the isthmus or infundibulum and this allows free 
movement of the hair shaft. 
The isthmus of the HF extends upwards from the point of arrector pili 
muscle insertion, also known as the bulge area, to the sebaceous duct (Figure 
2.1B). The bulge region is of functional importance as it is here where 
melanocytic and epithelial stem cells reside and are responsible for activation of 
a new hair cycle (Cotsarelis, 2006). In human scalp HFs, the follicular 
trochanter, a protrusion of the outer root sheath (ORS), has been shown to 
represent the bulge region (Tiede et al., 2007). The isthmus marks where the 
inner root sheath (IRS) gradually disappears and is replaced by trichemmal 
keratin produced by the ORS until this layer is no longer visible. The lower end 
of the isthmus also marks the end of the “permanent” section of the HF. 
The supra-bulbar region is located between the isthmus and hair bulb 
(Figure 2.1). Proximal to the bulb, the IRS and ORS thicken and are well-defined. 
The keratinisation process in the IRS is completed half way up the supra-bulbar 
region of the HF (Whiting, 2004). 
The anagen hair bulb is the centre of the hair shaft factory (Figure 2.1C). 
The epithelial cells of the bulb; hair matrix keratinocytes (MKs) and 
melanocytes, surround the dermal papilla (DP). Melanocytes are interspersed 
between the MKs. The MKs are rapidly proliferating cells and the number of 
these cells determines the diameter of the hair shaft and hair bulb size (Legué 
and Nicolas, 2005). When these cells withdraw from the cell cycle (i.e. stop 
proliferating) they differentiate and migrate upwards to form concentric 
cylinders of cells (Figure 2.1D). Each cylinder comprises cells of different 
morphology which have followed separate differentiation patterns to form the 
various cell lineages of the hair shaft and IRS. 
The cells which make up the hair shaft are known as trichocytes. The 
shaft comprises three layers; the innermost medulla, cortex and cuticle (Figure 
2.1D). Hair matrix cells centrally located at the apex of the DP form the medulla 
of the hair shaft, whilst those lateral to these form cylinders around the shaft in 
a concentric formation. The hair shaft cells become compacted and keratinised 
as they move proximally in the HF. The outer area of matrix cells form the 
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cuticle of the hair shaft, which consists of 6-10 overlapping cuticle cells, and the 
IRS (Whiting, 2004). The hair keratins and their associated proteins, keratin 
associated proteins (KAPs), are the main structural components of the hair 
shaft. Hair keratins are structural proteins and can be subdivided into two 
families; the type I (acidic) and type II (neutral) hair keratins (Langbein and 
Schweizer, 2005). The expression patterns of type I and II keratins differ 
depending on their location in the hair shaft (see Figure 2.1E). Copolymers of 
type I and II hair keratins make up the intermediate filaments found in 
trichocytes. In the hair fibre, KAPs act to link keratin intermediate filaments 
within trichocytes. KAPs are classified according to their chemical composition; 
high sulphur KAPs, ultrahigh sulphur KAPs and high glycine tyrosine KAPs. 
mRNA expression of human KAPs has been mainly located to the cortex of the 
hair shaft with expression also seen in the hair cuticle and hair matrix-cortex 
cell region (Rogers et al., 2006). As with the hair keratins, the KAPs exhibit 
location specific expression patterns. In the hair cortex the KAP gene families 
KAP 1-4, 7, 8 are strongly expressed, whereas in the cuticle one finds KAPs 5, 10 
and 12. The KAP gene families found in the matrix-cortex region are KAP8 and 
KAP1J.  
The IRS comprises three layers; the Henley, Huxley and innermost cuticle 
layer. The latter interlocks with the cuticle of the hair shaft via outward 
projections. The IRS is itself surrounded by the ORS, though separated by the 
companion layer. The ORS derives from progenitor cells of polyclonal origin, 
which are different to those that form the IRS and hair shaft (Legué and Nicolas, 
2005). The ORS is continuous with the epidermis of the skin and is covered by 
the hyaline membrane laterally and this is continuous with the epidermal 
basement membrane surrounding the DP. The expression patterns of hair 
follicle keratins within the IRS and ORS is found in Figure 2.1E. The IRS hair 
keratins are K71-74 and K25-28, whereas those expressed in the ORS are K5, 
K6a/b, K14-17 and K19 (Porter, 2006, Schweizer et al., 2007). Another 
important structural component of the anagen hair follicle that is located in the 
IRS is trichohyalin. This large insoluble protein makes up a third of the total 
protein content of the IRS of the HF. It is also located in the medulla of the hair 
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shaft (Steinert et al., 2003). Trichohyalin is an important structural protein that 
forms multiple cross links between keratin chains in the IRS and serves to 
harden this layer of the HF (Steinert et al., 2003).  
The DP contains blood vessels and fibroblasts (Stenn and Paus, 2001, 
Tobin et al., 2003, Whiting, 2004) and has been shown to be important for 
determining the size of hair bulb, hair shaft diameter and the duration of anagen 
(Cotsarelis, 2006, Rendl et al., 2005, Stenn and Paus, 2001). Around this layer is 
the connective tissue sheath (CTS) which is continuous with the DP and 
surrounds the epithelial HF (Whiting, 2004). The CTS comprises loosely 
connected stromal cells and mesenchymal stem cells which act to replace DP 
cells (Tobin et al., 2003). 
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Figure 2.1 Histomorphology of the human hair follicle 
(A) Sagittal section human scalp anagen HF. (B) The isthmus region of the HF. (C) The hair bulb. 
(D) The concentric layers of hair follicle bulb. (E) Pattern of expression of the human HF keratins. 
APM Arrector pili muscle; BM, basement membrane; CL, companion layer; CTS, connective tissue 
sheath; DP, dermal papilla; GC, germative cells; He, Henley layer; Hu, Huxley layer; HS, hair shaft; 
ICU, IRS cuticle; IRS, Inner root sheath; K, keratin; ORS, outer root sheath; M, matrix; SG: sebaceous 
gland;. Figure comprised from Schneider et al 2009 and Schweizer 2007 with permission. 
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2.3 THE HUMAN HAIR CYCLE 
The hair cycle describes the continuous cyclical regression and regeneration of 
the HF (Figure 2.2). In 1924 Trotter documented the cyclical growth of hair in 
humans (Trotter, 1924). However, in 1959, Kligman first characterised and 
documented the structural changes in the HF during the human hair cycle 
(Kligman, 1959). The hair cycle commences immediately following 
morphogenesis of the HF and consists of distinct stages; anagen, catagen, 
telogen and exogen (Paus et al., 1999a, Milner et al., 2002). Each stage has an 
approximate length of duration, with anagen in scalp HFs ranging from 2 to 7 
years. Catagen normally lasts 10-14 days and telogen 2-4 months in humans 
(Krause and Foitzik, 2006, Whiting, 2004). Exogen describes the process of hair 
shedding (Higgins et al., 2009, Milner et al., 2002). There is a wide variation in 
HF size and hair cycle length between individuals and body regions (Saitoh et 
al., 1970). The variation in hair cycle length is attributed, in the main, to 
different lengths of the anagen phase (Krause and Foitzik, 2006). As hair is 
produced solely in anagen, this phase also determines the length of the hair. 
 
2.4 DYNAMIC CHANGES IN HAIR FOLLICLE ANATOMY DURING THE HAIR 
CYCLE 
As mentioned above, the HF is a mini-organ which perpetually cycles in three 
stages; anagen (active growth), catagen (apoptosis-driven regression) and 
telogen (relative “resting”) (Schneider et al., 2009). The HF is unique among 
mammalian organs in that it rhythmically undergoes these massive organ 
transformation events for the entire lifespan of the organism. During these 
organ remodelling events, the HF shows complex, patterned phenomena that 
are temporo-spatially restricted (Chuong et al., 2006, Widelitz et al., 2006).  
During anagen, matrix cells in the bulb of the HF proliferate and differentiate 
into the hair shaft trichocytes and IRS (Stenn and Paus, 2001, Legué and Nicolas, 
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2005). HF melanogenesis is tightly coupled to the anagen phase of the hair cycle 
(Slominski et al., 2005). This process is halted early in catagen and does not 
recommence until the next anagen. 
Catagen is coupled with the apoptosis of melanocytes (Slominski et al., 
2005). During catagen, apoptosis occurs in the lower two thirds of the HF 
involving the matrix, IRS and ORS cells. The hair shaft retracts upwards leaving 
behind an epithelial stela. During this process, the hair shaft and IRS slide 
upwards leaving trichemmal ORS below. The base of the retreating hair shaft 
becomes club shaped (club hair) and is surrounded by trichilemmal keratin, 
which produces a small white “cap” at the end of the hair shaft (often noticed at 
the end of shed hair). Apoptosis of the ORS produces a reduction in the volume 
of the ORS layer and there is a thickening of the surrounding hyaline layer. The 
DP is drawn upwards to the base of the permanent epithelial part of the HF until 
it lies close to the HF bulge. 
The HF has retracted to the level of the bulge when telogen commences. 
A germinal unit is found beneath the club hair and consists of trichilemma 
surrounded by basaloid cells. The telogen club is found to have a central mass of 
trichilemmal keratin, surrounded by trichilemma and a fibrous sheath which 
connects the telogen germinal unit and the hair shaft. It is thought that telogen 
ends when a signal arises between the DP and bulge region to initiate 
regeneration of the follicular epithelial cells which then act to regenerate the 
lower portion of the HF (Schneider et al., 2009, Stenn and Paus, 2001, Fuchs et 
al., 2001). This re-traces many HF morphological steps that occurred during HF 
development and the new anagen bud grows down the existing follicular stela 
forming an anagen HF. 
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Figure 2.2: The hair cycle 
The hair follicle enters a continuous cyclical process of organ regression (catagen; lasting a few 
weeks), a relative “resting” phase (telogen; lasting approx. few months) and a growth and 
pigmentation phase (anagen which lasts months in mice and years in man) in the hair cycle. This 
process is altered in hair disorders such as hirsutism in which HFs exhibit a prolonged anagen 
phase. This process demonstrates the dynamic nature of the HF with drastic molecular and 
structural changes associated with the passing of time (stage of hair cycle). The hair cycle occurs 
as a result of precisely co-ordinated and collective functioning of the component parts of the HF. 
Key: DP Dermal papilla, ORS Outer root sheath, HS Hair shaft, IRS inner root sheath, SG Sebaceous 
gland. Figure and figure legend presented as found in (Al-Nuaimi et al., 2010). Adapted after 
Schneider et al 2009 Current Biology (Schneider et al., 2009). 
2.5 THE RELEVANCE OF HAIR CYCLING TO HAIR DISEASES 
A wide range of pathologies affect the HF, its cycling and hair shaft structure 
(White and Cox, 2006). This section briefly introduces the relevance of the hair 
cycle to hair disorders. Pure structural diseases of the hair shaft are not 
addressed here.  
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Hair growth disorders may be divided into those causing hair loss and 
those leading to excessive hair growth. The common hair growth disorders 
include androgenetic alopecia, alopecia areata, telogen effluvium, anagen 
effluvium, hirsutism and hypertrichosis. The hair cycle is intrinsically important 
to these hair disorders as all of these pathologies exhibit alterations in normal 
hair cycling (Paus, 2006, Paus et al., 1999a).  
Anagen length is shortened in androgenetic alopecia, aging HFs and the 
effluviums (telogen effluvium and anagen effluvium). This results in shortened 
effective hair (White and Cox, 2006). In addition, in androgenetic alopecia, 
miniaturisation of the HF occurs which involves a transformation of the HF from 
a terminal to vellus follicle. The cyclical nature of the HF is therefore central to 
the occurrence of HF transformations (Stenn and Paus, 2001, Tobin et al., 2003). 
Transition from a vellus to terminal follicle results in a prolonged anagen phase 
as occurs in hirsutism and hypertrichosis (Schneider et al., 2009, Krause and 
Foitzik, 2006). The transition from anagen to catagen is of high clinical 
importance as an alteration in anagen length results in changes in the resultant 
hair shaft. 
In humans, synchronised hair cycling is lost in post-natal life and exhibits 
a mosaic or asynchronous cycling pattern (Whiting, 2004, Paus and Foitzik, 
2004). Therefore, the normal dynamics of multiple human HFs in relation to 
each other entails the asynchronous HF cycle in terms of one HF in comparison 
to its neighbours. This may also be described as the population cycling 
dynamics. Therefore, an abnormality of normal human HF dynamics is 
synchronisation. The synchronisation of populations of HFs leads to a patch or 
the whole scalp of hair shedding together. This occurs in the pathologies anagen 
effluvium and telogen effluvium whereby anagen is abrogated by factors such as 
chemotherapy and stress, respectively (Hadshiew et al., 2004, Paus, 2006) (see 
Figure 2.3). 
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Figure 2.3: Management of common hair disorders by hair cycle manipulation 
This figure demonstrates how different points within the hair cycle may be manipulated to treat 
hair disorders. (+) indicates stimulation and (–) inhibition of the transition from one cycle stage to 
the next. Figure obtained and reprinted from (Paus and Foitzik, 2004) with permission from 
Elsevier publishing.  
 
Therefore, understanding how hair cycling is controlled is clinically 
important as many hair diseases can be attributed to changes in normal hair 
cycling (Paus and Cotsarelis, 1999, Paus and Foitzik, 2004, Cotsarelis and Millar, 
2001, Stenn and Paus, 2001). Indeed, as Albert Kligman stated in 1959:  
“normal dynamics provide the basis for understanding how the follicle 
behaves in disease” (Kligman, 1959). 
A patient will notice the problem when HFs are affected as a population 
rather than in an individual HF. Determining how the hair cycle is controlled 
and, subsequently, deciphering how to modify this may identify new treatment 
options and address the clinical need for improved treatment of hair disorders.  
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2.6 WHAT CONTROLS THE HUMAN HAIR CYCLE? 
Here, the literature is reviewed regarding the postulated controls of the human 
hair cycle. A varied approach has been taken by researchers in this arena and 
therefore this section is split into two main sections; the first is concerned with 
the postulated theories of the controller(s) of the hair cycle and the second 
reviews a small selection of molecular candidates that have been identified as 
possible regulators of the hair cycle i.e. in the co-ordinated transition of the HF 
from one stage of the cycle to the next.  
2.6.1 Current theories of the hair cycle mechanism 
Here we consider the existing proposed theories on how HF cycling may be 
controlled. Here, mathematical models concerned with hair growth and cycling 
are not detailed. The reason for this is they do not explicitly consider the 
internal mechanisms that govern individual HFs through the hair cycle 
(Nagorcka and Mooney, 1982, Plikus et al., 2011, Halloy et al., 2000, Halloy et al., 
2002). These papers are explored further and discussed in Chapters 3 and 5. 
2.6.1.1 Inhibition-disinhibition switch theory 
Chase led this field when, over half a century ago, he identified that there was a 
need for the conceptualisation of the hair cycle mechanism as this would enable 
understanding of hair biology (Chase, 1954). Chase proposed that since “The 
hair cycle is clearly only the result of a cycle of follicular activity” the focus of 
investigation should be directed to the HF itself and its immediate surrounding 
environment (Chase, 1954). He described the hair cycle as a dynamic and 
continuous process and suggested that anagen is initiated by the release of an 
inhibitory substance i.e. an inhibitor of mitosis is lost in order for anagen to 
occur. This process involves the HF itself, but this concept of inhibitor-release is 
extended also to include communication between adjacent skin allowing waves 
of HF cycling to occur if a threshold is overcome.  
The theory offered by Chase is a very brief discussion of hair cycle 
control, therefore only a few sentences are provided regarding the postulated 
mechanism. There is no attempt to explain what the inhibitor(s) may be 
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specifically, nor where they are located exactly, but they are referred to as 
mitotic inhibitors. An inhibitory-release mechanism for hair cycling control has 
also been suggested by other authors (Argyris and Trimble, 1964, Argyris, 
1972). However, the work they present attempts to explain the propagation and 
stimulation of populations of HFs rather than the individual control mechanism 
of the hair cycle in a single follicle. Even Chase overlaps between the two 
processes and describes his observations regarding mouse hair cycling in 
waves. He then briefly discusses the release of the inhibitor as being involved in 
inter-follicular population controls of hair cycling (Chase, 1954). There is 
experimental evidence for an inhibitor release mechanism being involved in the 
control of the hair cycle; for example in the function of bone morphogenetic 
proteins with their antagonist noggin. This will be discussed in the molecular 
candidates section below. 
2.6.1.2 Epithelial theory 
Other theories on the mechanism of the hair cycle have been proposed over the 
years. Some suggest that the epithelial part of the HF is responsible for the 
initiation of the mature hair cycle. 
 Stenn proposes that the hair cycle is a regenerative system and compares 
the HF to the regenerating limb (Stenn in (Stenn et al., 1999)). In this context, 
the epithelium is known to be essential for regeneration to occur and, therefore, 
Stenn states that the epithelium is the key component of the hair cycle 
mechanism with the HF components that represent regenerative tissue being 
the hair germ and the papilla. The theory states that the signal for anagen 
initiation is under the control of a unique clock. The reasoning provided for why 
the clock is thought to be unique is that the HF does not exhibit a rhythm that is 
in synchronisation with the seasons, or the day-night rhythm and scalp HFs, for 
example, have a clock lasting years. Stenn proposes that the stem cells of the HF 
are the providing source for the regeneration of the HF during each cycle and 
thus are postulated to be the core controllers of the hair cycle. In addition, the 
stem cells exhibit very slow dividing behaviour in line with the long periodicity 
seen in the HC. Stenn postulates that the transient amplifying cells are 
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responsible for determining the anagen duration (Stenn in (Stenn et al., 1999)). 
As these arise from the stem cells, the clock is therefore hypothesised to be 
centred in the epithelial stem cells of the HF. The signal for anagen initiation is 
postulated to arise from the release of an inhibitor and the signal is then carried 
by a “special” communication between neighbouring epithelial cells. The role of 
the mesenchymal portion in this explanation is minimal. It is suggested that 
there is signalling between the mesenchyme and epithelium and that the 
inhibitory signal arises from the epithelium to the mesenchyme. Stenn then 
explains HF growth as a mechanical spring that is under inhibitory control. The 
inhibitory control is likened to a clamp on the spring, and release of this occurs 
in order for anagen to commence. The nature of what the “special” 
communication between epithelial cells is not expanded upon here. It is also not 
clear why only the epithelium is the controller in the HF, particularly when 
stated by the author himself that the mesenchyme is known to be important. 
There are parallels draw by Stenn (Stenn in (Stenn et al., 1999)) with Chase’s 
inhibitor release mechanism (Chase, 1954). 
2.6.1.3 Resonance theory 
Nixon postulates that the hair cycle arises from the tissue as a whole rather than 
one compartment or cell type that initiates the rhythm of the hair cycle (Nixon 
in (Stenn et al., 1999)). This has been coined the “Resonance theory” (Stenn and 
Paus, 2001). Nixon states that the “clock” responsible for the hair cycle may not 
be located in one place, but arises from the tissue as a whole. Nixon draws upon 
the well-known pattern formation reaction-diffusion mechanisms and suggests 
that spatio-temporal oscillations of “morphogen” molecules in the HF set up the 
changes that occur during the hair cycle. This may be considered a systems 
biology viewpoint of the hair cycle mechanism (see Chapter 3). The property 
described as “resonance” by Nixon could be considered as “emergence”; the 
behaviour that exists when a system is whole and not apparent when the 
system of interest is taken apart (Huang and Wikswo, 2006). 
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2.6.1.4 Quartz alarm clock theory 
In another postulated theory of the hair cycle, the hair cycle mechanism is 
suggested to be analogous to an alarm clock (McKay in (Stenn et al., 1999)). An 
impulse initiates oscillations of the clock and causes the hands to move. Once a 
trigger is reached the alarm is tripped and this co-ordinates the dissemination 
of the signal to the surrounding tissue. The author states that this analogy is 
useful for hypothesis building to aid the thought process into thinking about 
what the timing mechanism may be within the HF. This has some commonality 
with the HCC theory below. The offer of how the hair cycle mechanism is 
controlled is that the alarm trips and the clock moves from telogen into anagen.  
 This argument thus leads one to predict that a counting mechanism 
should exist during telogen to allow for the trigger to be tripped. What exactly 
this may be is not stated for certain, but the author suggests that this may be 
several things such as accumulation of glucose or the process of shortening of 
telomers. In addition, the author hints at photoperiod systems involving 
melatonin  also being involved in hair cycling (McKay in (Stenn et al., 1999)). 
Unfortunately, these processes are not further explored in the explanation. The 
theory fails to suggest either what the initiating stimulus for the clock to 
commence oscillations may be, or what the different phases such as anagen-
catagen transition are controlled by. There is also no clear explanation as to 
what exactly the “quartz chip” is within the HF anatomy (Paus and Foitzik, 
2004). 
2.6.1.5 Morphogenesis theory 
In another theory of the hair cycle Jahoda suggests that the “HCC” is established 
during morphogenesis (Jahoda in (Stenn et al., 1999)). The cyclical nature of the 
hair cycle is thought to have arisen as an evolutionary result of being capable to 
regenerate after damage; similar to a regenerating limb in amphibians. 
Therefore the “clock” driving the hair cycle has been set since morphogenesis. 
However, there is no explanation as to what the nature of this mechanism is in 
the proposed theory. Jahoda’s theory stands as a contrast to that of both Stenn 
and Paus (Stenn et al., 1999) who draw a distinction between the process 
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governing morphogenesis, coined the “morphogenesis clock” (Paus et al., 
1999a) and the controls governing the cyclical regeneration of the mature HF: 
the “HCC”. Jahoda supports his proposed morphogenesis theory by stating that 
rat vibrassae HFs cycle with a pattern that mirrors their sequential 
embryological appearance in the skin. Although it remains unclear which school 
of thought is right,  in the human hair cycle, it is apparent that the cyclical 
behaviour of populations of adult HFs differs strikingly after the neonatal 
period, with previously synchronised HF cycling becoming mosaic (or 
asynchronous) (Barth, 1987). 
2.6.1.6 Bulge activation theory 
The bulge activation theory was proposed after epithelial stem cells were 
localised to the bulge region of the HF experimentally (Cotsarelis et al., 1990). It 
was previously thought that the matrix cells located in the hair bulb were stem 
cells prior to this work. The bulge activation theory states that the DP stimulates 
the stem cells at the end of telogen or the beginning of anagen. This stimulates 
the proliferation of stem cells which then produce the hair germ and leads to 
growth of the lower HF. This causes the DP and bulge to no longer be in 
proximal contact and the authors suggest that this causes the stem cells to 
return to a less active, slowly dividing state. Another key component suggested 
by the authors is that during mid-anagen MKs stimulate DP fibroblasts to 
proliferate. This is supported by experimental evidence of proliferation 
occurring in the DP in anagen VI and also that MK proliferation precedes events 
in surrounding mesenchymal HF cells such as the growth of surrounding 
vasculature. They suggest that this burst of proliferation is key during the hair 
cycle to ensure the large size of the DP which determines the hair shaft width 
and bulb size (Cotsarelis et al., 1990). The third essential component of the hair 
cycle, as detailed in the bulge activation hypothesis, is that MKs determine the 
length of anagen as they proliferate with a finite duration and this property also 
explains why anagen length is not easily perturbed (Ebling 1976). The last 
property essential to the bulge activation theory is the process of upward 
movement of the DP during catagen as this allows the proximity of the DP to the 
41 
 
bulge and thus activation of stem cells to occur. The authors explicitly note that 
the activating factor(s) from the DP that stimulates the stem cells is not known, 
but they postulate that it may be growth factors or cell-cell contact. 
 The bulge activation theory (Sun et al., 1991) provides a well-
constructed account of the possible communication set up between 
compartments of the HF during the cycle. Spatio-temporal considerations are 
incorporated into the theory, namely allowing for the altering structure of the 
HF and thus the changes in proximity of the stem cell population to the DP. This 
sets up an anatomically orientated account of the control set up within the hair 
cycle and the theory is supported and inspired by experimental evidence. 
Indeed, stem cells are the source of cells for reconstruction of the HF during 
each cycle (Cotsarelis, 2006). As pointed out by the authors, the nature of the 
“activator(s)” of the stem cells from the DP is not known. In addition, what is the 
determinant of the proliferative burst seen in mid-anagen of DP fibroblasts and 
what is the nature of the activation of DP cells by the MKs during anagen? Also, 
what causes the MKs to cease proliferation at the end of anagen? 
 Although the bulge activation theory provides a detailed explanation of 
events that occur during the hair cycle, with some details of direction and timing 
of “controls” for example by stating that DP activates stem cells at the end of 
telogen and MKs stimulate DPs in mid-anagen, it is not clear how these events 
happen to culminate at this point. Also, this theory has been criticised for being 
unable to convincingly explain all the catagen-associated transformation 
processes, including HF keratinocyte and HF melanocyte apoptosis, HF 
basement membrane shrinkage and massive remodelling of the HF 
mesenchyme (Paus and Foitzik, 2004). The spatio-temporal incorporation of 
events seems to be a very important aspect of the hair cycle mechanism and is 
not explicitly adopted by the other theories. There is good evidence of 
proliferation and changes in stem cell dynamics during the hair cycle. This 
concept of bulge activation is also very much supported by recent work 
regarding stem cells, transient amplifying cells and the relationship between 
these in the HF and during the hair cycle (Hsu et al., 2011). However, the theory 
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would require to be tested by checking for activation molecules or processes at 
the points suggested by Cotsarelis and colleagues (Cotsarelis et al., 1990).  
2.6.1.7 Papilla morphogen theory 
The last theory that we shall discuss in this section is the papilla morphogen 
theory (Paus and Foitzik, 2004, Paus et al., 1999a, Stenn et al., 1999). The 
authors involved in the “papilla morphogen” (PM) theory addressed the control 
of the hair cycle from a distinctive perspective. There was a drive by these 
colleagues to fully address the need to understand the hair cycle mechanism. By 
constructing a hypothesis, just as Chase had postulated, and building a theory of 
the process this would enable clear, hypothesis-driven hair research (Paus et al., 
1999a, Paus and Foitzik, 2004, Stenn et al., 1999).  
 Firstly, when considering the PM theory for the hair cycle, the authors 
immediately draw upon other chronobiological timing mechanisms and bring 
the hair cycle mechanism into this context. The hair cycle is firstly likened to a 
clock and the term “hair cycle clock” to describe the core control mechanism of 
the hair cycle was coined (Paus et al., 1999a). In this theory, the HCC is thought 
to have at its centre an oscillator system responsible for the process. The DP is 
identified as the core component of this suggested theory for the hair cycle 
control. This is argued to be the case as the DP is necessary for the hair cycle to 
occur at all: its inductive properties in vivo and that it determines the width and 
size of the hair shaft.  
 The theory states that the DP fibroblasts secrete PMs exclusively during 
the G0 and G1 phases of the cell cycle (Paus et al., 1999a, Paus and Foitzik, 
2004). Anagen is initiated when the level of PMs exceeds a threshold level. The 
presence of PM is suggested to be necessary for the initiation and maintenance 
of anagen. The peak expression of PM occurs at the end of anagen. The PMs are 
suggested to alter signalling mechanisms that have been postulated to be 
essential to the mechanism of the hair cycle process. Catagen is heralded by a 
sudden drop in PM levels below a defined threshold. This arises when the DP 
fibroblasts enter the S, G2 and M phases of the cell cycle as they are no longer in 
the secretory phase. It is suggested that the lack of PM causes intra-follicular 
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apoptosis and all other signalling cascades that are associated with the anagen-
catagen transformation, such as termination of melanogenesis, deletion of the 
HF pigmentary unit, and remodelling of the HF mesenchyme. Anagen re-
initiates when the DP cells re-enter G0/G1 and, thus, PM levels reach the 
threshold level again (Figure 2.4).  
 In order for PM secretion to be maintained during the long phase of 
anagen, it is suggested in this theory that only a selection of the fibroblasts are 
proliferating at once and this crescendos with the greatest level occurring at the 
end of anagen. Along with the cyclical secretion of PM in line with the cell cycle 
of DP fibroblasts, this theory also suggests that an “inhibition-disinhibition” 
system is involved in the hair cycle control. Therefore, also secreted in anti-
phase to the papilla morphogens are mitosis inhibitors or “endogenous mitotic 
inhibitors”. These reach peak levels when PMs are commencing their decline in 
catagen. It is suggested that these may arise from the epithelial HF in response 
to the PMs. 
 
Figure 2.4: The papilla morphogen theory 
The figure shows the changes of papilla morphogen and endogenous mitotic inhibitor levels in 
terms of hair cycle stages and dermal papilla cell cycle stages. PM=papilla morphogen, PMA/PMmax 
= half maximal and maximum level of PM. EMI=endogenous mitotic inhibitor, DP=dermal papilla, 
T=Telogen, A= anagen, C= catagen. Figure reproduced with permission from (Paus and Foitzik, 
2004). 
 PM levels should be high in telogen skin, i.e. when hair growth is 
suppressed. In fact, limited experimental support for this theory has been 
provided by the demonstration that telogen, but not anagen, epidermis contains 
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a potent anti-mitotic activity that inhibits anagen development in mice (Paus et 
al., 1990). Signalling loops are thought to be present between the epithelium 
and mesenchyme driven by cyclical PM secretion. The inhibition-disinhibition 
concept is incorporated in the form of anti-phase expression to the papilla 
morphogens in this theory (Chase, 1954). In addition, the involvement of both 
the epithelium and mesenchyme is included. 
 Unfortunately, this theory conflicts with the fact that DP fibroblasts are 
not known to enter into the cell cycle at the time that has been suggested (i.e. 
anagen VI) (Paus and Foitzik, 2004). Nevertheless, the exercise in constructing 
the theory produced a testable hypothesis. Also, as argued by Jahoda (in (Stenn 
et al., 1999)), it remains possible that PM secretion by DP fibroblasts shows 
some form of cell cycle-linkage, yet without DP fibroblasts entering mitosis. 
Positively, the authors identify the need for theoretical consideration of how the 
hair cycle arises as they realise the importance of this. It brings forward the field 
by taking a detailed approach to the problem. This is also evident by the 
production of a thorough discussion and analysis of what the salient features 
are necessary to be addressed in a theory of the “HCC” (Paus et al., 1999a). The 
process adopted in trying to answer the question as to the nature of the hair 
cycle rhythm has been pioneering for the field. 
 On the negative, this theory tries to identify one region as being the HCC 
“command centre” (Paus and Foitzik, 2004, Paus et al., 1999a). Whilst this 
theory does incorporate the epithelial compartment more fully than other 
theories, the emphasis is placed on the DP as the coordinator. In addition, it is 
not known that if DP fibroblasts take turns in entering the cell cycle whether the 
necessary threshold of PMs would be reached. It is difficult to state whether the 
complex communication set up of inhibitory and excitatory loops detailed by 
the authors would behave in this way in reality without testing it, for example 
via mathematical modelling. This critique, however, holds for all the theories 
postulated above. A positive feature of the theory is that it is unique in that it 
focuses on the control of catagen as an essential component of the HCC. In 
addition, it gives a self-perpetuating explanation for the HCC. 
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 In the construction of the “Papilla Morphogen Theory” there was drive 
for the conceptualisation of the hair cycle mechanism and to determine what 
exactly a theory of the hair cycle should contain. In addition, the hair cycle is 
explicitly treated as a chronobiological rhythm. This theory is also unique in 
that the authors state that the hair cycle needs to be understood from the 
initiation of catagen rather than the initiation of anagen, whereas the other 
theories approach the problem from the initiation of anagen. 
2.6.1.8 Perspective on the current theories of the hair cycle 
A criticism of the current theories of the human hair cycle is that the majority of 
the theories aim to locate a cell type or region as being the controller of the hair 
cycle. However, it may be possible for there to be multiple regions involved; in 
particular regarding the complex multi-cellular composition of the HF. This is 
the essence of the argument provided in the Resonance Theory (Nixon in (Stenn 
et al., 1999)). In order for hair cycling to occur, it is apparent that there requires 
the communication to exist between the epithelial portion of the HF and the 
mesenchymal HF (Botchkarev and Kishimoto, 2003). This is supported by 
various studies that have shown the abrogation of the DP stops hair cycling 
(Stenn and Paus, 2001, Link et al., 1990).  
All of the theories manage to incorporate features that the authors feel 
are essential to the hair cycle. From the summaries and critiques of these 
theories, it is apparent that there is some discrepancy between individual 
researchers with respect to the features of HF cycling that are thought salient. 
The majority of theories are concerned with the control of anagen initiation, 
although a distinction was drawn between the completion of morphogenesis, 
which ends in an anagen-like stage, but must not be confused with anagen 
(Müller-Röver et al., 2001, Paus et al., 1999b). It has been postulated that the 
anagen-catagen transformation is more important for understanding the control 
of HF cycling, since at least morphologically, the hair cycle does not commence 
with anagen, but with catagen (Paus and Foitzik, 2004, Stenn and Paus, 2001).  
This literature review shows that the control of HF cycling is a complex 
issue and that none of the previously proposed theories provide a rigorous, fully 
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satisfactory explanation for the “HCC”. Moreover, none of these hair cycle 
theories have been tested using mathematical modelling. Given the complexity 
of the process and the numerous molecular players that are already known to 
be involved in its regulation (Stenn and Paus, 2001, Schneider et al., 2009) it 
appears almost mandatory to take a systems biology approach to understanding 
the regulated, rhythmic changes in HF function during the hair cycle. This is 
further explored and argued below (see Chapter 3).   
2.6.2 Molecular candidates in the human hair cycle 
Numerous molecules have been implicated in mediating the hair cycle. See 
(Schneider et al., 2009, Botchkarev and Kishimoto, 2003, Botchkarev and Paus, 
2003, Rendl et al., 2005, Stenn et al., 1994) for comprehensive overviews of the 
topic. Here, key methods adopted in experimental investigation of the hair cycle 
are provided and selected molecular candidates for controlling the anagen-to-
catagen transition are reviewed. The applicability of these findings to our 
interest in the human hair cycle is also considered further. More literature 
reviews are found in the introduction and discussion sections of each 
manuscript chapter following.  
2.6.2.1 Methods of investigating the human hair cycle 
The understanding of hair growth and hair cycling has been advanced by the 
development of molecular biology techniques. In particular, animal models of 
hair disorders arising via spontaneous or induced mutations have been a central 
method for advancing the functional roles of genes and their products in hair 
growth and cycling (Rogers and Hynd, 2001, Stenn and Paus, 2001, Stenn et al., 
1994). The murine model remains the most commonly used in hair research 
with the C5BL/6 type exhibiting colour differences in accordance to the hair 
cycle stage, thus allowing a readily accessible hair cycle study tool (Rogers and 
Hynd, 2001, Stenn and Paus, 2001).  
With regards to understanding the human hair cycle specifically, HF 
organ culture, which was developed by Philpott (1990), is a well established 
laboratory method used to study human HF biology and hair growth without 
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the need to experiment on human subjects (Randall et al., 2003, Rogers and 
Hynd, 2001, Kloepper et al., 2010). The ability of human HFs to grow at rates in 
culture that are almost the same as in vivo makes this experimental model 
useful for the study of hair growth and for investigating the response of human 
scalp HFs to test compounds added to the organ culture medium (Philpott et al., 
1994a, Rogers and Hynd, 2001, Kloepper et al., 2010). 
There are several advantages to human HF organ culture as opposed to 
fresh whole tissue analysis in the study of anagen and catagen HFs. For example, 
the occurrence rate of telogen and catagen HFs (5-10%) in vivo is very low 
compared to that of anagen HFs (90-95%) (Whiting, 2004). Organ culture 
allows access to a greater number of catagen HFs as they enter this stage within 
a few days in culture (Kloepper et al., 2010, Rogers and Hynd, 2001). As 
mentioned in the hair disorders section, understanding the anagen-catagen 
transition is of importance in hair disorders and therefore, this provides an 
instructive assay for investigating anagen-to-catagen transition in vitro.  
However, it is important to note that extra-follicular surroundings are 
likely to facilitate and modulate HF cycling. It is known, for example,  that 
human scalp HFs grow in follicular units and that there is better growth of HFs 
when they are transplanted as a whole unit rather than following separation 
(Jimenez and Ruifernández, 1999, Avram, 2006). A follicular unit consists of 1 to 
4 HFs and therefore one isolated HF, maintained in a well with 2 additional HFs 
may be a good approximate model for the in vivo follicular unit. Also, from 
studies of murine hair cycle waves, there is increasing appreciation of important 
extra-follicular inputs that impact within the skin on HF cycling (Plikus et al., 
2008, Plikus et al., 2011). In addition, neural inputs into HF cycling, which are 
also absent in human HF organ culture, must be considered, since the HF is one 
of the most densely innervated peripheral structures in the mammalian body 
(Peters et al., 2007, Peters et al., 2006, Botchkarev et al., 2004).  
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2.6.2.2 Molecular candidates of the hair cycle clock: anagen-to-catagen 
transition 
Numerous candidates have been implicated in regulating the hair cycle. In this 
section only a few key candidates have been chosen to be discussed. These have 
been selected as those that affect timing of the hair cycle and anagen to catagen 
transition. 
Insulin-like growth factor-1 (IGF-1) has been identified as a promoter of 
the anagen phase of the hair cycle. Growth of microdissected human scalp HFs 
has been shown to be stimulated by the addition of IGF-1 to culture medium and 
its withdrawal causes HFs to enter catagen (Philpott et al., 1994b). In-situ 
hybridisation and immunohistochemistry analyses of human skin has shown 
that IGF-receptor (IGF-R) mRNA and protein is down-regulated during the 
initiation of catagen, although these changes have not been quantified (Rudman 
et al., 1997). 
The Fuzzy phenotype exhibits accelerated hair cycling in mice with 
reduced proliferation and increased apoptosis of MKs (Mecklenburg et al., 
2005). This phenotype has been attributed to a mutation in Sgk3 (Campagna et 
al., 2008). Lack of the Sgk3 gene in mutant mice resulted in impaired 
maintenance of transiently amplifying matrix cells of the HF (Alonso et al., 2005, 
Okada et al., 2006). In addition, Sgk3-null mice exhibit accelerated hair cycling 
characterised by a shortened anagen phase and normal catagen and telogen 
phases (Alonso et al., 2005, Okada et al., 2006). This implicates Sgk3 as a 
possible “time-keeper” for the anagen phase in the murine hair cycle. The 
evidence regarding Sgk3 and the anagen to catagen transition has been reported 
in mice experiments. To date, Sgk3 has not been explored in the human hair 
cycle. 
Another growth factor implicated in the anagen to catagen transition of 
the hair cycle is hepatocyte growth factor (HGF) which has been investigated in 
both mice and man (Jindo et al., 1998, Jindo et al., 1995, Lindner et al., 2000). 
Human scalp HF growth was found to be promoted after the addition of HGF at 
several concentrations to the media during organ culture. The growth increased 
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in a dose-related manner when compared to the control group (n=6 in each 
group). DNA synthesis was also increased in the HGF-treated groups (Jindo et 
al., 1995). No other parameters, such as hair cycle parameters, were 
investigated in scalp HFs after HGF treatment.  
The expression pattern of HGF in HFs of C5BL/6 mice was found to be 
hair cycle dependent with HGF protein and gene expressed during anagen and 
down-regulated in catagen. HGF protein was found to be localised only to the DP 
of the mice HFs and its receptor Met localised in the follicular epithelium (Jindo 
et al., 1998). Injection of recombinant HGF in the dorsal skin of C5BL/6 mice, 
prior to spontaneous catagen onset, caused significant retardation of catagen in 
the HFs at the site of injection with a gradient effect seen on the periphery of the 
injection sites (Jindo et al., 1998). The expression profile of HGF in human HFs 
during the hair cycle is yet to be elicited. 
Fibroblast growth factor 5 (Fgf5) has been found to induce catagen. 
Deletion of the Fgf5 gene causes delayed onset in catagen, prolonged anagen, 
and produces angora phenotype mice which exhibit long hairs with no defect in 
HF structure (Hebert et al., 1994). In normal mice, total Fgf-5 mRNA was found 
to be expressed in the ORS of the HF with expression highest during late anagen 
(Kawano et al., 2005, Hebert et al., 1994, Rosenquist and Martin, 1996). The 
splice variant of Fgf-5, Fgf-5S, blocks the catagen-inducing properties of the 
complete Fgf-5 transcript. Fgf-5S is expressed in high concentrations during mid 
anagen and low concentrations during late anagen VI, catagen and telogen. The 
two variants of Fgf-5act together and it seems that communication with the DP 
may play a role in their function (Suzuki et al., 2000). The importance of Fgf-5 as 
a candidate in the anagen to catagen transition is highlighted in the work by 
Pena et al where a short hair phenotype of Bcl-xL transgenic mice was reversed 
in Fgf-5 deficient mice (Pena et al., 1999). 
Other agents found to promote catagen are neurotrophins (NTs). 
Multiple members of the NT family have been found to be up regulated in the 
proximal HF in late anagen and prior to catagen. Neurotrophin receptors have 
been shown to be expressed in the epidermal keratinocytes of the follicle and 
also the DP during the anagen to catagen transition (Botchkarev et al., 1998a). 
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In addition, NT-3 and brain-derived neurotrophic factor (BDNF) transgenic mice 
exhibit premature catagen entry and over-expression of BDNF causes shortened 
hair length; a hallmark of an abrogated anagen phase (Botchkarev et al., 1999b, 
Botchkarev et al., 1998b). 
The transforming growth factor-β (TGFβ)/Bone morphogenetic Protein 
(BMP) superfamily, consisting of cytokines and growth factors, is thought to be 
central in the modulation of the hair cycle and notably in the anagen to catagen 
transition. Transforming Growth Factor-β1 (TGF-β1) inhibits keratinocyte 
proliferation, induces keratinocyte apoptosis and causes premature catagen 
entry in isolated human HFs and in vivo in murine skin (Soma et al., 2002, 
Philpott et al., 1994a, Foitzik et al., 2000). TGF-β1 is most highly expressed 
during late anagen and early catagen in murine experiments (Foitzik et al., 
2000). Transforming Growth Factor-β2 (TGF-β2) has also been shown in both 
mice and man to be a potent catagen inducer. TGF-β1 and TGF-β2 have been 
localised to the IRS, ORS and CTS of HFs (Soma et al., 2002) and the TGF-β 
receptors type I and II are expressed in the IRS, ORS and MKs (Paus et al., 1997). 
Bone morphogenetic proteins (BMPs) are growth factors whose potent 
antagonist is noggin. Noggin is known to be mesenchymally derived 
(Botchkarev et al., 1999a) and acts by binding to BMPs and preventing them 
from binding to their receptor (Zimmerman et al., 1996). BMPs exert both pro- 
and anti-apoptotic effects; the pro-apoptotic action of BMPs is mediated by the 
BMP–MAPK pathway, while the BMP–Smad pathway is implicated in the control 
of survival (Botchkarev and Paus, 2003). The expression patterns for BMPs, 
noggin, and BMP receptors in the HF during catagen remain to be elucidated, 
though data obtained in genetic models suggest a role for BMP signaling in the 
control of catagen development. Deletion of BMP receptor IA (BMPR1A) in HF 
keratinocytes is accompanied by a markedly delayed entry of the HFs into first 
catagen (Andl et al., 2004) suggesting the involvement of BMPR1A in the control 
of the anagen–catagen transition. In addition, BMPs have been shown to have a 
functional relationship in the murine hair cycle with WNTs (Plikus et al., 2008) 
exhibiting rhythmical expression of BMP2 and 4 in an asynchronous phase to 
noggin and β-catenin expression. 
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In wild-type murine HFs, catagen is accompanied by changes in follicle 
morphology, including cessation in matrix cell proliferation and apoptosis in the 
hair bulb. However, in muscle segment homebox2 (Msx2) deficient HFs, these 
events are uncoupled (Ma et al., 2003). There is precocious onset of catagen in 
Msx2 knockout mice and this suggests that Msx2 normally plays a role in 
maintaining HFs in anagen (Ma et al., 2003). BMPs have been implicated in hair 
shaft-regulation via a link with Msx2 as BmpR1A mutant HFs exhibit absent or 
severely decreased expression of the hair-shaft regulatory gene Msx2 (Andl et 
al., 2004) thus suggesting that BMPs are upstream of Msx2. 
Novel candidates have been suggested as hair cycle controllers by time-
course gene expression profiling experiments in mice (Lin et al., 2004, Lin et al., 
2009). By clustering gene expression profiles by their pattern of expression 
during the murine hair cycle and subsequently grouping results by their 
function, novel candidates for regulators of the hair cycle were identified. 
Circadian genes (those responsible for the circadian rhythm, see Chapter 7 for 
details) were found to show a hair cycle-dependent oscillatory behaviour in 
mice (Lin et al., 2009). These novel candidates are thought to mediate their 
effect by cell cycle mediation as BMAL1 knockout mice exhibited delayed anagen 
onset and significant up regulation of p21, which indicates a block at the G1 
phase of the cell cycle (Lin et al., 2009). The effect was found mainly during the 
telogen to anagen transition, however, large oscillations in Period1 expression, 
for example, were also noted (but not further investigated) during the anagen to 
catagen transition (Lin et al., 2009). Circadian genes are thus rather novel 
candidates for the HCC and have been only briefly studied in the human system.  
Circadian genes, thus, are novel and intriguing candidates as components 
of the “HCC”, which have not yet been systematically studied in the human HF. 
Chapter 7 is concerned with circadian genes and proteins as possible co-
ordinators of human hair cycling, and argues why such a chronobiological focus 
on the problem of human HF cycling is particularly promising, both from a 
systems biology and from a clinical perspective.  
The evidence above relies heavily on murine data, with little or no 
parallel investigations performed on human HFs. The literature above points 
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towards several molecules that may coordinate the human hair cycle, however, 
we do not yet know whether this is the case in the human system.  
2.6.2.3 Epithelial-mesenchymal interactions in the control of the hair 
cycle  
The mature HF can be divided into the mesenchymal HF, consisting of the DP 
and CTS, and the epithelial HF (the remaining portions; including transient 
amplifying cells of the hair matrix that envelope the DP, hair shaft, IRS and ORS) 
(Figure 2.1). The communication between epithelium and mesenchyme is vital 
for understanding the cycling of the HF (Tobin et al., 2003, Paus et al., 1999a, 
Stenn and Paus, 2001, Rendl et al., 2005, Fuchs et al., 2001, Botchkarev and 
Kishimoto, 2003). The destruction of the DP, for example, has been shown to 
cause an inability for hair fibre growth (Cohen, 1961). DP cells in culture have 
been found to secrete morphogens that stimulate epithelial cells, supporting the 
notion that the DP cells act to mediate the epithelial compartment of the HF 
(Rogers and Hynd, 2001). DP cells have been found to exhibit their own 
molecular signature in comparison to their surrounding cells; the matrix and 
ORS cells. These contrasting signatures for signalling and transcriptional 
regulators may be essential for HF biology (Rendl et al., 2005, Botchkarev and 
Kishimoto, 2003). 
During catagen onset, there is down-regulation of factors promoting 
matrix cell proliferation and differentiation. As described above, promoters of 
anagen, such as IGF-1 and HGF are secreted by DP fibroblasts and stimulate the 
matrix cells, of epithelial compartment to proliferate and differentiate (Philpott 
et al., 1994b, Rudman et al., 1997, Lindner et al., 2000, Jindo et al., 1998, Itami et 
al., 1995, Shimaoka et al., 1995). HGF is known to function as an important 
mediator in epithelial-mesenchymal interactions in several systems and has 
been shown to be expressed solely in the DP and its receptor Met found only in 
the HF epithelium (Lindner et al., 2000). The interaction of the epithelial and 
mesenchymal HF is required for HGF-mediated HF growth. FGF-5 is expressed 
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in the ORS during late anagen and has been suggested to induce catagen by 
diffusion into the DP (Rosenquist and Martin, 1996). Another example of 
epithelial-mesenchymal interaction in the HF is that of BMP2, BMP4 and noggin 
(Kulessa et al., 2000, Plikus et al., 2008). There is evidence that BMP2, BMP4 
and noggin exhibit a BMP activity gradient in the HF (Kulessa et al., 2000). 
Thus the communication between HF epithelium and mesenchyme is 
crucial to hair cycle control, and we need to understand the exact mechanisms 
of these interactions in order to fully grasp the nature of the dynamic regulatory 
processes that underlie HF cycling.  
2.7 SUMMARY: THE BASIS OF THE THESIS 
In the hair cycle the HF exhibits a unique chronobiological rhythm, vast 
regenerative capacity, intricate communication between epidermal and 
mesenchymal-derived cells and dynamic spatio-temporal behaviour at the 
cellular and tissue level (Paus et al., 1999a, Schneider et al., 2009).  
There is still debate as to what comprises the so-called “HCC”. None of 
the “verbal” hair cycle theories published so far have been tested using 
mathematical modelling; therefore these models may not predict correctly the 
effect of certain feedback mechanisms or connections. 
On the molecular level, animal models have been central to advancing 
hair cycling research (Rogers and Hynd, 2001, Schneider et al., 2009). Murine 
systems such as balding, nude, hairless and angora display defects in HF 
formation and/or cycling through naturally occurring mutations. In addition to 
spontaneous mutant models, the use of transgenic and knockout mice has 
allowed further studies of the effect of genetic perturbations on hair cycling 
(Rogers and Hynd, 2001, Stenn and Paus, 2001, Schneider et al., 2009).  
Although numerous molecular pathways have been implicated in the 
control of HF cycling, the underlying mechanisms regulating its timing remain 
elusive. Namely, a fully satisfactory theory of HF cycling remains to be 
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developed, and the molecular nature of the “HCC” has still not been deciphered 
(Paus and Foitzik, 2004, Paus et al., 1999a, Schneider et al., 2009).  
The majority of research has relied on the murine model with gene 
expression and molecular signatures delineated in line with distinct hair cycle 
time points (Lin et al., 2004, Schneider et al., 2009, Lin et al., 2009, Rendl et al., 
2008). In contrast, the gene and protein expression profile of different stages of 
human HF cycling remains to be systematically defined. An experimental 
window exists to study human HFs as they can be isolated from skin and 
maintained in serum-free medium where they subsequently transit 
spontaneously from anagen to catagen before degenerating (Randall et al., 2003, 
Rogers and Hynd, 2001, Philpott et al., 1994a, Kloepper et al., 2010). 
Fortunately, this hair cycle window is also the clinically most relevant hair cycle 
switch, whose disturbance underlies most the of the hair growth disorders seen 
in clinical practice (Paus and Foitzik, 2004).  
In light of the above evidence and considerations, it is apparent that 
there is a disjoint between the phenomena observed at the tissue level and 
investigations performed at the molecular level. In addition, much of the 
molecular investigations are performed in rodent species as they allow the 
study of the whole hair cycle and provide an excellent tool for employing the full 
power of mouse genomics research. Evidently, it is quite uncertain to what 
extent the molecular controls of murine HF cycling correspond to those that 
drive the human hair cycle.   
The first basic tenet of the current thesis is that a systems biology 
approach to human HF cycling holds great promise to make substantial 
progress in reaching the ultimate goal, i.e. to understand the human “HCC” and 
to obtain novel pointers as to how it may be therapeutically manipulated more 
effectively. The above considerations will lead to the exploration of human HF 
cycling from a systems biology perspective with the focus directed to three key 
areas a) mathematical modelling, b) HF chronobiology, and c) gene expression 
profiling.   
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3.1 ABSTRACT 
In the post-genomic era, systems biology has rapidly emerged as an 
exciting field predicted to enhance the molecular understanding of 
complex biological systems by the use of quantitative experimental and 
mathematical approaches. Systems biology studies how the components of 
a biological system (e.g. genes, transcripts, proteins, metabolites) interact 
to bring about defined biological function or dysfunction. Living systems 
may be divided into five dimensions of complexity: 1) molecular 2) 
structural 3) temporal 4) abstraction and emergence and 5) algorithmic. 
Understanding the details of these dimensions in living systems is the 
challenge that systems biology approaches aim to address. 
Here, we argue that the hair follicle (HF), one of the signature 
features of mammals, is a perfect and clinically relevant model for systems 
biology research. The HF represents a stem cell-rich, essentially 
autonomous mini-organ, whose cyclic transformations follow a 
hypothetical intra-follicular “hair cycle clock” (HCC). This prototypic 
neuroectodermal-mesodermal interaction system, at the cross-roads of 
systems and chronobiology, encompasses various levels of complexity as it 
is subject to both intra- and extra-follicular inputs (e.g. intra-cutaneous 
timing mechanisms with neural and systemic stimuli). Exploring how the 
cycling HF addresses the five dimensions of living systems, we argue that a 
systems biology approach to the study of hair growth and cycling, in man 
and mice, has great translational medicine potential. Namely, the easily 
accessible human HF invites preclinical and clinical testing of novel 
hypotheses generated with this approach 
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3.2 INTRODUCTION 
 
“The problem of biology is not to stand aghast at the complexity  
but to conquer it” 
Sidney Brenner, Nobel Laureate (Duncan, 2004) 
 
Systems biology is a fast-evolving life sciences field that aims to establish how 
the components of a living system combine to cause function (Klipp et al., 2009, 
2007). Biological systems can be divided into five levels of complexity: 1) 
molecular; 2) structural; 3) temporal; 4) abstraction and emergence and 5) 
algorithmic (Table 3.1) (Huang and Wikswo, 2006).  
In the past, cell cultures (particularly yeast) were often used in systems 
biology research to handle the complexity of living systems (Westerhoff and 
Palsson, 2004, Bruggeman and Westerhoff, 2006, Sauer et al., 2007, Di Ventura 
et al., 2006, Klipp et al., 2009). These models are far-removed from the reality of 
mammalian organisms. Identifying mammalian models that are sufficiently 
complex to encompass these five dimensions, and approach physiological 
relevance is an important challenge for systems biology (Klipp et al., 2009, 
Makarow et al., 2008).  
The HF consists of multiple different cell populations of neural crest, 
ectodermal or mesodermal origin, which are distinct in their location, function 
and gene and protein expression characteristics (Fuchs, 1998, Schneider et al., 
2009, Stenn and Paus, 2001, Paus and Cotsarelis, 1999). Additionally, the HF is a 
uniquely dynamic mini-organ that undergoes continuous cycling throughout 
adult life during which elements of its own morphogenesis are recapitulated 
(Schneider et al., 2009, Fuchs et al., 2001) (Figure 2.2). This process may arise 
under the dictates of an enigmatic oscillator system (the hair cycle clock (HCC)) 
(Paus and Foitzik, 2004, Lin et al., 2009, Stenn and Paus, 2001). Hair growth 
disorders can be attributed, at large, to changes in the normal dynamic 
behaviour of the HF (Paus and Cotsarelis, 1999, Hadshiew et al., 2004, Paus and 
Foitzik, 2004, Stenn and Paus, 2001, Cotsarelis and Millar, 2001). Common hair 
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diseases such as alopecia areata, telogen effluvium, hirsutism and 
hypertrichosis remain major, unsolved medical problems that call for new 
approaches in developing effective remedies. The HF is an attractive research 
model as hair growth; cycling and colour are of profound interest to biological 
and medical researchers and a vast industry that caters to individuals who wish 
to manipulate these parameters. The study of HF cycling brings together 
systems biology, stem cell biology, regenerative medicine, chronobiology and 
translational medicine (Ito et al., 2004, Yu et al., 2008, Lin et al., 2009, Batista et 
al., 2007).  
Induction, spacing, orientation and morphogenesis of the HF (Schmidt-
Ullrich and Paus, 2005) represent classical scenarios of developmental and stem 
cell systems biology (MacArthur et al., 2009, Vanag and Epstein, 2009, Baker et 
al., 2009). The hair patterning process is a prototypic neuroectodermal-
mesodermal interaction system which is beautifully demonstrated by the 
pioneering work of Nagorcka and Mooney (Nagorcka and Mooney, 1982, 
Nagorcka and Mooney, 1985, Mooney and Nagorcka, 1985). Mathematical 
theory was utilised to explain the spatial patterns of morphogens and thus 
patterned HF formation. Systems biology research in HF development has been 
previously covered (Sick et al., 2006, Stark et al., 2007, Baker et al., 2009), 
therefore here we focus on the cycling adult HF as a systems biology research 
model.  
We argue that the HF, a signature organ of the mammalian species, is 
optimally suited to address challenges in medical and systems biology research 
by studying clinically relevant biological phenomena from a comprehensive 
systems biology perspective. 
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Table 3.1: The five dimensions of living systems and hair cycle relevance 
  
Dimension 
Research 
objectives 
Approach Challenges 
HF (HF) and 
hair cycle 
relevance 
 
Dimension 
1 
 
Molecular 
complexity 
 
Integrating 
molecules and 
pathways to 
genome-wide 
networks 
(“horizontal 
integration”) 
Molecular 
biology, 
genomics, 
proteomics, and 
other “omics,” 
bioinformatics, 
applied 
computer 
science 
Database integration, 
annotation; high-
throughput analysis at 
higher functional 
levels; real-time, 
multiplex 
measurements of 
expression profiles 
The cycling HF is 
governed by key 
molecules; exact 
drivers are yet 
to be elicited. As 
a research tool, 
the HF can be 
studied in vivo 
using murine 
model, or in 
vitro in human 
HFs. See 
Dimension 2 
also. 
Dimension 
2 
 
Structural 
complexity 
Transcending 
many size-
scales 
(nanometer to 
meter): 
Organelles–
cells–tissues–
organs–
organism 
(“vertical 
integration”) 
Microscopy, 
nanotechnology, 
microfabrication, 
biophysics, 
biomedical 
engineering, 
mechanical 
engineering, 
anatomy 
Visualization of 
dynamic protein 
complexes in cells; 
cellular 
compartmentalization; 
external sensing and 
actuation of molecular 
states; bridging the 
gap between 
macromolecules 
and tissues—spanning 
nanometer to 
centimetre scales 
The HF can be 
reduced into 
different 
structural levels; 
from cells, to the 
microdissected 
and isolated 
mini-organ, to 
hair cycle 
domains, to 
whole 
organisms. It 
provides a mini-
system with 
which to analyze 
these 
dimensions. In 
addition, the 
structure of the 
HF changes 
dramatically 
during the hair 
cycle 
(highlighting the 
interrelationship 
between 
molecular, 
structural, 
temporal and 
emergence 
dimensions 
involved in the 
cycling HF). 
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Table 3.1 Continued: The five dimensions of living systems and hair cycle relevance 
 
Dimension 
Research 
objectives 
Approach Challenges 
Hair follicle 
and hair cycle 
relevance 
     
 
Dimension 
3 
 
Temporal 
complexity 
 
Transcending 
many time 
scales 
(nanoseconds 
to gigaseconds 
= decades) 
System 
dynamics, 
nonlinear 
dynamics, signal 
processing, 
biomedical 
engineering, 
control theory, 
time-series 
analysis, 
physiology 
Noise measurement at 
various levels; non-
linear time series 
analysis; multi-analyte 
measurements in 
nonequilibrium 
systems—spanning 
nanosecond to 
gigasecond time scales 
The HF 
demonstrates 
various 
temporal 
processes and 
traverses 
various 
temporal scales. 
For example, 
exhibiting 
circadian 
rhythm and hair 
cycle changes. 
 
Dimension 
4 
 
Abstraction 
and 
emergence 
 
Modelling 
system-level 
“emergent” 
features 
System 
dynamics, 
pattern-
formation, 
cybernetics, 
complex system 
sciences, agent-
based models, 
mathematics 
Levels of abstraction, 
multiscale models and 
scaling; use of larger-
scale effective 
variables to describe 
smaller-scale 
phenomena; 
“statistical mechanics 
of biology” 
Use of 
abstraction of 
the hair cycle, 
through 
modelling has 
proved to be 
useful in HF 
cycle research 
and provides 
meaningful 
input to 
biological 
understanding 
and hypothesis 
generation. The 
HF is an 
emergent organ. 
 
Dimension 
5 
 
Algorithmic 
complexity 
 
Understanding 
information 
coding and 
computation 
by the 
biological 
medium and 
developing 
theoretical 
models that 
simulate 
biological 
systems 
Theoretical 
computer 
science, 
information 
theory, electrical 
engineering 
Identifying a core 
system that is 
computationally 
irreducible; new 
syntax for simulation; 
the integration of 
hybrid 
analogue/digital 
models 
HF during 
cycling will 
compute 
problems in the 
context of the 
cells, tissue and 
organism. In 
addition, the 
complexity of 
the models 
needed to 
simulate the 
organisms’ 
computations 
will need 
consideration. 
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3.3 SYSTEMS BIOLOGY IN A NUTSHELL 
Systems biology is the study of how the components of a biological system (e.g. 
genes, transcripts, proteins, metabolites) interact to bring about function (and 
dysfunction) of that system (Kitano, 2002, Bruggeman and Westerhoff, 2006, 
Klipp et al., 2009, Di Ventura et al., 2006, Huang and Wikswo, 2006). This 
discipline rose in the post-genomic era as advances in molecular biology, and 
the production of high-throughput data such as deciphering the genome in the 
human genome project (Aderem, 2005, O’Malley and Dupré, 2005, Huang and 
Wikswo, 2006), still left a gap in our ability to translate the vast amounts of 
molecular knowledge to understanding biological function (Sauer et al., 2007). 
Understanding biological systems by a transition from reductionist study on the 
molecular level to the systems level of life phenomena is systems biology 
(Kitano, 2002, Bruggeman and Westerhoff, 2006, Noble, 2008b, Westerhoff and 
Palsson, 2004). In the next section, we provide further details about systems 
biology, emergence, mathematical modelling in systems biology and a summary 
of some important successes of systems biology in medical research. 
 
3.3.1 Systems Biology and medical research 
An indispensible feature of biological systems is that of emergence. Biological 
systems are composed of multiple interacting components and involve 
“communication” at various levels (Table 3.1). For example, individual enzymes 
do not function in isolation but act within complex pathways. The properties of 
these pathways in vivo, i.e. the systems properties, depend on the interaction of 
all the components and therefore on the molecular properties of each of the 
involved enzymes. Systems properties only arise in the presence of these 
interactions. This phenomenon is called emergence (2007, Sauer et al., 2007, 
Aderem, 2005). 
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Table 3.2: Summary table of successes of systems biology research in medical 
studies. 
Research Problem Approach taken Results References 
Aim to predict the 
resistance to  HER2-
targeting receptor 
tyrosine kinase (RTK) 
inhibitors (cancer 
therapies) 
An in vitro model of 
the key pathways 
involved was made. 
Predictions were then 
tested in vivo on 
human cancer patients 
Key resistance factor a tumour 
suppressor gene (PTEN) was 
found using the kinetic model. 
PTEN levels in the clinic were 
related to resistance to 
treatment. Enabled patients to 
be given more personalized 
treatment for breast cancer. 
(Faratian 
et al., 
2009b) 
To understand the 
cause of cardiac 
arrhythmias in the 
context of physiology of 
the heart. To improve 
drug design and reduce 
fatal side effects 
Virtual human heart 
models constructed 
using quantitative data 
Use of model led to success in 
predicting the side-effects of 
drugs, such as chronic angina 
medication Ranolazine 
(Noble, 
2008a) 
Establish the dynamic 
behaviour of HIV virus 
in response to 
combination therapy in 
order to better treat 
HIV-AIDS 
Quantitative data 
generated to establish 
the decay of HIV virus 
following combination 
therapy. Mathematical 
models incorporating 
the data predicted 
virus decay rates 
 
Decay rates of the virus (both 
free and in infected cells) were 
estimated. Prediction of re-
emergence of the virus (even at 
levels below detection) using 
the model enabled better 
understanding of the dynamics 
of HIV virus following therapy 
and better future therapy 
approaches 
(Perelson 
et al., 
1996, 
Perelson et 
al., 1997, 
Nowak et 
al., 1996) 
 
 
To elucidate the 
relationship between 
COX inhibitor pain 
relief and plasma 
concentrations to 
improve and predict 
dose regimes for 
chronic pain 
management 
A model was 
developed 
to assess the factors 
that correlate to 
response to 
COX inhibitors 
Modelling endogenous 
mediators of inflammation 
helped to elucidate the relation 
between exposure to the drug 
and therapeutic 
response 
(Huntjens 
et al., 
2005) 
Early studies indicated 
that gemcabene, a new 
experimental drug, did 
not lower lipids as 
much as statins. Would 
combination therapy 
make the drug 
commercially viable? 
Could modelling 
improve this process? 
Pfizer undertook a 
model-based analysis 
to compare the lipid 
lowering effects of 
gemcabene versus 
ezetimibe in 
combination with a 
statin. 
Modelling results indicated that 
gemcabene did not offer 
superior lipid lowering benefits 
to ezetimibe when used in 
combination with a statin. This 
result contributed significantly 
to the decision to stop 
development of the drug. This 
rapid decision-making reduced 
drug development time and 
costs may have been futile 
(Mandema 
Jaap et al., 
2005) 
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In systems biology, the use of mathematical modelling and 
computational simulation is an important tool for tackling the complex 
relationships existing between entities in a system (Kell, 2004, Wiley et al., 
2003, Di Ventura et al., 2006, Klipp et al., 2009). Mathematical models can bring 
together the details of linear and non-linear processes, handle numerous 
variables simultaneously, deduce experimental hypotheses and qualitatively 
and quantitatively predict behaviour of its components and the system as a 
whole (Schnell et al., 2007). This iterative process between modelling and 
experiments is considered a hallmark of systems biology (Kitano, 2002).  
Multi-factorial diseases, for example cancer, diabetes and the epilepsies, 
are brought about by interactions of parts creating higher-level properties or 
functions that would not be expected via analyses of only the individual entities 
(Gatenby and Maini, 2003, Faratian et al., 2009a, Schadt, 2009). In order to fully 
understand multi-factorial diseases they should be considered systems biology 
diseases (Schadt, 2009). The same argument holds for advancing understanding 
of normal function. Systems biology is already progressing areas such as cancer 
research (Faratian et al., 2009a, Faratian et al., 2009b), cell migration in 
malignancies, regeneration and development (Friedl and Gilmour, 2009) and 
stem cell dynamics (MacArthur et al., 2009) (See Table 3.2). Thus, systems 
biology should be considered an important approach in medical research by 
tackling the complexity of the human system, as shown in Table 3.1 (Faratian et 
al., 2009a, Gatenby and Maini, 2003, Faratian et al., 2009b, Di Ventura et al., 
2006, Makarow et al., 2008, 2007, Hunter et al., 2008). Some successes of 
systems biology in medicine have already been reported (Table 3.2) and the 
challenges posed by medical problems are themselves beginning to fertilise 
systems biology (Makarow et al., 2008, 2007). 
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3.4 THE HAIR FOLLICLE AS A PROTOTYPIC SYSTEMS BIOLOGY ORGAN 
 
HF cycling displays a number of properties that recommend it for systems 
biology research. The HF can be investigated at different levels that mirror the 
five dimensions of living systems (Table 3.1) (Huang and Wikswo, 2006). We 
discuss some previous studies where this has already been explored in hair 
cycling research. 
 
3.4.1 Molecular complexity of the hair follicle 
Despite the divergent cell types and number of molecular players that interact 
within a HF, the total number of HF protagonists is finite compared to larger 
organs. Moreover, the murine HF is among the best-characterized mammalian 
organs at the gene and protein level (Stenn and Paus, 2001, Rendl et al., 2005, 
Schneider et al., 2009). 
Typically, profiling tools such as metabolomics, proteomics and 
genomics are used to acquire a systematic analysis of the molecular components 
in living systems (Huang and Wikswo, 2006). Time-course gene expression 
profiling of murine skin has led to the identification of novel candidates in hair 
cycle regulation. This method of eliciting gene expression during the hair cycle 
also addresses the temporal dimension of living systems (Lin et al., 2009). By 
clustering gene expression profiles by their pattern of expression during the 
murine hair cycle and subsequently grouping the clusters by gene function, 
novel genes and pathways have been identified as candidates in murine hair 
cycle control. Clock genes (those responsible for the circadian rhythm) have 
been demonstrated to be hair cycle-dependent and are prominently expressed 
in the secondary hair germ (SHG) of telogen and early anagen HFs (Panteleyev 
et al., 2001). Bmal1 knock-out mice displayed retarded anagen development and 
lack mitotic cells in the SHG, suggesting that clock genes regulate anagen 
progression via their effect on the cell cycle. These findings indicate that clock 
genes can regulate complex non-diurnal organ transformation such as HF 
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cycling (Lin et al., 2009). Additionally, the systems approach used enabled novel 
candidates to be identified and allowed understanding of dynamic gene 
expression during the HF cycle.  
 
 
Figure 3.1: Sgk3 mutation and the hair cycle: molecular causes of Fuzzy phenotype 
Schema representing the Fuzzy phenotype and the association with the Sgk3 gene mutation. Figure 
incorporated into the flow diagram is adapted after Mecklenburg, L., et al., Premature termination 
of hair follicle morphogenesis and accelerated hair follicle cycling in Iasi congenital atrichia (fzica) 
mice points to fuzzy as a key element of hair cycle control. Experimental Dermatology, 2005. 14(8): 
p. 561-70. Wiley-Blackwell Publishers 
 
The murine model is diverse as mutations (both natural and engineered) 
exhibiting defined hair phenotypes can be used to probe the functional 
importance of molecular players in vivo (Schneider et al., 2009, Stenn and Paus, 
2001, Schmidt-Ullrich and Paus, 2005, Nakamura et al., 2001). One example, the 
fuzzy phenotype, exhibits strikingly accelerated HF cycling which is linked to a 
mutation in the gene Sgk3 (Mecklenburg et al., 2005) (see Figure 3.1). 
Researchers often investigate one gene or protein of interest, however, 
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functional overlap of hair cycle candidates (such as via common pathways) 
exist. For example, Figure 3.2 demonstrates how Sgk3 and IGF-1 are functionally 
linked. Anagen HFs express growth factors, such as EGF and IGF-1. These 
growth factors activate the MAPK and Akt pathways via interacting with 
tyrosine kinase receptors. IGF-1 is known a catagen-inducer in human HFs in 
vitro (Philpott et al., 1994b). Alonso et al showed that loss of Sgk3 was similar to 
gaining EGF signalling function. Using cultured primary keratinocytes from 
Sgk3-null and wild-type mice, Sgk3 was found to negatively regulate 
phosphatidylinositol-3-kinase (PI3K) signalling and thus antagonise the effects 
of IGF-1 induced PI3K signalling (Figure 3.2). This work shows the possible 
function for Sgk3 in controlling cell fate by modulating tyrosine kinase growth 
factor signalling pathways. Therefore, the HF exhibits interesting molecular 
complexity. Full comprehension of how these molecules function with regard to 
HF cycling would be best achieved using a systems biology approach to identify 
the common pathways involved and the interactions between molecules, rather 
than investigating these in isolation (such as those between Sgk3 and growth 
factor signalling pathways). A systems biology approach aims to link 
overlapping pathways and function. 
The use of mouse mutants (Nakamura et al., 2001, Schneider et al., 2009, 
Schmidt-Ullrich and Paus, 2005) represents an ideal systems biology instrument 
to investigate how the perturbation of a single gene product impacts on the 
entire HF in vivo (Sundberg et al., 2005). This approach can be complemented in 
the human system via organ-culture of micro-dissected human anagen scalp 
HFs and perturbing their normal behaviour in vitro by utilising and evaluating 
the impact of defined test agents on hair shaft formation, follicular 
melanogenesis, catagen transformation, hair MK proliferation and apoptosis 
and the gene expression profile (Philpott et al., 1994a, Kloepper et al., 2009, 
Bodo et al., 2005, Bodo et al., 2007). This naturally connects molecular 
complexity to its structural and temporal complexities by altering HF structure 
(evident in the hair cycle) and cycle duration (a temporal phenomenon). 
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Figure 3.2: The links between SGK3 and growth factor pathways 
Schema of the possible role of the Sgk3 gene in the anagen-catagen switch in hair follicles. 
*Philpott M., et al. Reference no. (Philpott et al., 1994b), **Alonso et al. Reference (Alonso et al., 
2005) 
3.4.2 Structural complexity of the hair follicle 
The tissue compartments of the HF are stringently circumscribed and of well-
defined composition. This makes the HF a microcosm and an ideal target for 
systems biology research. 
The structure of the HF can directly address the second dimension of 
living systems that Huang and Wikswo describe (Huang and Wikswo, 2006). 
HFs are easily accessible for experimentation, observation and perturbation due 
to their superficial location on the surface of mammalian bodies. This feature 
makes the HF ideal for systems biology research as access to molecular, 
structural and phenotypic information is readily available. In addition, the HF 
can be reduced into different structural levels; from cells (such as stem cells, DP 
cells, epithelial cells) to isolated mini-organs (e.g. HFs) to whole tissues (e.g. 
68 
 
hair-bearing skin) and organisms (such as humans and mice) (Rogers and Hynd, 
2001). Importantly these different structural levels all exhibit systems 
properties within themselves. 
The structural unit of the HF can be considered an essentially 
autonomous organ as it is able to grow after dissection from its neurovascular 
supply and transplantation into another part of the integument (Maurer et al., 
1998). In addition, isolated human HFs can be maintained in organ culture 
(Philpott et al., 1990, Philpott et al., 1996). This is an exciting prospect for 
systems biologists as these mini-organs exhibit emergent properties of great 
biological relevance: controlled cell proliferation; differentiation; apoptosis and 
organ regeneration. In addition, the basic autonomous clock driving the HF 
cycle may reside in the HF itself (Paus et al., 1999a), plus the HF “system” is also 
sensitive to extra-follicular communication e.g. neurovascular stimuli (Plikus et 
al., 2008, Plikus et al., 2009), thus increasing the level of system complexity by 
analysing greater levels of structural complexity.  
The mature HF can be divided into the mesenchymal HF, consisting of 
the DP and CTS, and the epithelial HF (the remaining portions; including 
transient amplifying cells of the hair matrix that envelope the DP, hair shaft, IRS 
and ORS). The structural complexity of the HF is intertwined with the molecular 
complexity of this mini-organ and epithelium and mesenchyme communication 
is thought to be vital for understanding the hair growth cycling of the HF (Tobin 
et al., 2003, Paus et al., 1999a, Stenn and Paus, 2001, Rendl et al., 2005, Fuchs et 
al., 2001, Botchkarev et al., 1999a, Botchkarev and Kishimoto, 2003). The 
accessibility and exhibition of epithelial and mesenchymal communication in 
the HF make it an excellent tool for those interested in this type of 
communication; for example in cancer research (Hu and Polyak, 2008, Faratian 
et al., 2009a) and molecular communication through time and space in general 
(Klipp et al., 2009). 
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3.4.3 Temporal complexity of the hair follicle  
Living systems exhibit different temporal properties and scales. For example, in 
the heart, depolarisation of myocytes takes 1 millisecond; the cardiac cycle, 1 
second; and longevity of the organism, gigaseconds (Huang and Wikswo, 2006). 
The temporal dimension of living systems (Table 3.1) is well-reflected in HF 
biology since this organ exhibits its own unique temporal cycle; the hair cycle. 
These cycling events are typical examples of patterns, namely breaks of 
homogeneity leading to the emergence of new structure (Widelitz et al., 2006). 
Temporal complexity of HF cycling also relates directly to structural and 
molecular complexities as these themselves exhibit dramatic hair cycle-
dependent changes. During the hair cycle, the HF shows complex, patterned 
phenomena that are temporo-spatially restricted (Widelitz et al., 2006, Chuong 
et al., 2006). Despite the large number of molecular candidates implicated in HF 
cycling control, such as IGF-1 (Rudman et al., 1997), hepatocyte growth factor 
(HGF) (Jindo et al., 1998, Jindo et al., 1995, Lindner et al., 2000) (anagen 
promoters), fibroblast growth factor-5 (FGF-5) (Kawano et al., 2005, Hebert et 
al., 1994, Rosenquist and Martin, 1996) and neurotrophins (NTs) (catagen 
inducers) (Botchkarev et al., 1999b, Botchkarev et al., 1998b), the mechanisms 
regulating its timing remain elusive (Paus and Foitzik, 2004, Stenn and Paus, 
2001, Paus et al., 1999a). An integrated, systems, approach to this problem has 
been lacking with researchers often looking only at one gene or protein of 
interest (Stenn et al., 1994). 
Organ-cultured human HFs are able to synthesize a hair fibre (at rates 
(Philpott et al., 1994a) and with a keratinisation process (Thibaut et al., 2003) 
similar to that in vivo) and subsequently enter a catagen-like stage i.e. in the 
absence of extra-follicular tissue, neural, vascular or endocrine signals. A full 
hair cycle is not exhibited in this in vitro model, however, this model has 
advantages for researching the human anagen-catagen transition as the 
occurrence rate of catagen HFs in vivo is low (Whiting, 2004) compared to the 
majority of HFs that spontaneously enter catagen with this model (Rogers and 
Hynd, 2001). 
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Since oscillatory behaviour is a classical emergent phenomenon 
(Whittington et al., 2000), the cycling HF is an ideal mammalian system for 
systems biology studies. The full temporal complexity of HF cycling is evident by 
the recent discovery that clock genes may play an important role in this 
“intrinsic” HCC (Lin et al., 2009), thus joining circadian oscillator systems (daily) 
with the rhythmic organ remodelling process that spans weeks (mice) or even 
years (man). The HF and skin exhibit circadian rhythms in gene transcription 
and protein expression (Zanello et al., 2000, Bjarnson et al., 2001, Lin et al., 
2009, Bjarnson and Jordan, 2002, Kawara et al., 2002, Mehling and Fluhr, 2006, 
Tanioka et al., 2009) and therefore this tissue operates on various time-scales 
simultaneously (Mehling and Fluhr, 2006). To fully understand how these 
distinct chronobiological systems interact constitutes a systems biology 
research challenge. Routine hair research approaches cannot hope to master 
this challenge if hair biologists do not cooperate closely with chronobiologists 
and systems biologists (Lin et al., 2004, Lin et al., 2009, Mehling and Fluhr, 2006, 
Schneider et al., 2009). 
 
3.4.4 Abstraction and Emergence 
3.4.4.1 The Follicular Automaton 
In order to cycle, HFs exhibit oscillations in structural and molecular properties. 
However, on a high level of abstraction, HF cycling can be studied without 
explicit reference to the exact molecular mechanisms that produce it. As a 
starting point to understand HF cycling, a rather abstract mathematical model 
was proposed; the follicular automaton model (FAM) (Halloy et al., 2000, Halloy 
et al., 2002). The FAM aimed to establish a model of the dynamics of human 
scalp hair to predict long-term changes of scalp hair growth and thus 
understand (and, ideally, predict) the manner by which different balding 
patterns occur (Figure 3.3). 
The FAM has generated useful formation on the dynamics of human hair 
cycling, with a level of abstraction that may be advantageous (Huang and 
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Wikswo, 2006). On a population level, the distribution of HFs in the skin 
provides a striking example of a self-organised spatio-temporal pattern and 
molecular detail is not required to demonstrate this. In addition, the model 
simulation of the evolution of hair patterns is hypothesis-stimulating i.e. the 
pattern of hair growth on the human scalp can be manipulated to elicit male-
pattern baldness, diffuse alopecia and “normal” hair growth (Figure 3.3). This 
provokes hypotheses about HF parameters such as ‘heterogeneous distribution 
of follicular parameters produces a diffuse pattern’ whereas ‘gradients in mean 
duration of anagen phase (e.g. from centre to periphery of the scalp) cause a 
central balding pattern’. The authors also determine that the independence of 
HFs and variability in the length of the anagen phase are major determinants of 
collective dynamics of human hair cycling. This model could be advanced, 
predictions tested, implemented and improved by including molecular signals 
and further refined by experimental data and hair cycle staging. Despite the 
limitations (see legend, Figure 3.3); this model is an elegant example of how 
combined experimental and theoretical methods can be optimally utilized to 
explore specific scientific problems (here: to provide a basis for long-term 
prognoses of human scalp hair growth in response to manipulations), make 
predictions and create new hypotheses. The dynamic behaviour of single HFs 
and HF populations can be approximated by a simple model (abstraction) and 
the FAM thus perfectly illustrates a classical systems biology approach to hair 
research. 
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Figure 3.3: Spatiotemporal simulations of the follicular automaton model showing 
different patterns of hair growth 
Experimental (phototrichogram) data collected over 14 years was used to approximate the 
distribution of durations of hair cycle stages in each HF for each patient by using a log normal 
distribution. The follicular automaton model of the hair cycle in human scalp hair was defined 
using the assumptions that (i) each follicle is independent; (ii) each follicle traverses the cycle in 
the order of anagen-telogen-latency phases; and (iii) after latency the follicle may either enter a 
new cycle or undergo death or miniaturisation. The figure shows the simulation of human scalp 
hair growth over “25 years” using the follicular automaton model and various parameters. The 
model demonstrates how different patterns of alopecia could be achieved by simulating of a 
population of HFs on a “scalp”. Alopecia was achieved by enforcing a limit on the total number of 
cycles each HF could traverse and by introducing a gradient in the mean anagen duration of HFs 
across the area of the “scalp”. (A) “Hair follicles” were arranged on a grid (“scalp”) with hair 
follicles programmed with different mean durations of the anagen phase across a gradient as 
shown in left column (decreasing mean from periphery of the “scalp” to the centre). The hair 
follicles were also programmed to “die” after a set number of cycles. The final hair pattern at 25 
years corresponds to a diffuse alopecia commonly seen in women. (B) As in A, but steeper gradient 
set across the scalp to produce more dramatic balding pattern in the centre. (C) Grid programmed 
with temporal conditions as well as central gradient to achieve typical male pattern baldness. The 
final hair pattern at 25 years corresponds to androgenetic alopecia (male pattern baldness) as 
shown in Figures 4B and 4C. This model has limitations, for example, the method by which data 
was collected (phototrichogram method) provides only approximate temporal information 
regarding the durations of hair cycle stages as these durations represent what is observed from the 
skin’s surface and provides no more specific information of the molecular and temporal changes at 
the HF (rather than scalp) level. The assumption that the results obtained with this method can 
relate quantitatively to the molecular timings of the human hair cycle is tentative. This is 
demonstrated, for example, by the fact that catagen (which lasts a few weeks in human scalp hair) 
is not captured using this method. Adapted after Halloy, J., et al., Modeling the dynamics of human 
hair cycles by a follicular automaton. Proceedings of the National Academy of Sciences of the 
United States of America, 2000. 97(15): p. 8328-33. Copyright 2000 
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3.4.4.2 Intra- and extra-follicular communication in hair follicle dynamics 
The HF exhibits emergent properties, i.e. properties that exist in complex 
systems that are not demonstrated by the components alone and cannot be 
predicted through understanding the separated parts. For example, 
understanding the properties of hydrogen and oxygen does not equate to 
understanding the properties of water (Aderem, 2005). The HF is an emergent 
organ; the group of cells comprising the HF do not function in the same way 
when isolated than when operating together within the mini-organ. For 
example, isolated DP cells will not produce a hair shaft (Tobin et al., 2003, Rendl 
et al., 2005).  
Recently, Plikus et al. have shown that adult pelage HFs in mice exhibit 
hair cycle domains (i.e. spatially distinct HF populations that cycle 
synchronously within a defined skin territory) (Plikus et al., 2008). These hair 
cycle domains show the propagation of regenerating HFs as wave patterns (Ma 
et al., 2003, Suzuki et al., 2003). (Figure 3.4). Through directed experimental 
techniques, spatial-temporal patterns in HF activity were directly linked to 
expression levels of the BMPs (Bmp2 and Bmp4) within hair cycle domains 
(Figure 3.4). Cyclic changes were found in Bmp2 and Bmp4 that were 
asynchronous to hair cyclic changes, WNT/β-catenin signalling and noggin (a 
BMP antagonist) expression.  
On the basis of these studies, the hair cycle was redefined (in the context 
of a population of HFs and the intra-follicular status of the skin (Plikus et al., 
2008)), from the traditional anagen, catagen and telogen stages, into functional 
phases of propagating anagen, autonomous anagen, refractory telogen and 
competent telogen (Figure 3.4). This study addresses the population dynamics 
of cycling murine HFs, i.e. the population behaviour of HFs to either propagate 
and cycle in waves or not. Human HFs, however, behave differently to murine 
HFs in that they do not exhibit hair cycle domains and behave independently 
and stochastically or at the very most, in follicular units (Jimenez and 
Ruifernández, 1999). This murine study cannot be extrapolated to explain the 
behaviour of human HFs as yet, however, it could be that a similar mechanism 
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may exist between follicular units rather than cycle domains, but there is as yet 
no evidence to support this idea. 
The functional phases of the hair cycle proposed in this study, in terms of 
ability to propagate a wave, can be used to define spatial-temporal relationships 
and controls within murine skin. Plikus et al. (Plikus et al., 2008) demonstrate 
that stem cell regeneration is subject to control of biological rhythm. This work 
shows how the intra-follicular clock communicates with intra-cutaneous (but 
extra-follicular) timing mechanisms and lend themselves to the quantification 
and mathematical modelling of BMPs, noggin, WNT and β-catenin levels as a 
function of time and thereby predict and elucidate their function in the hair 
cycle. 
Plikus et al. (Plikus et al., 2008) have managed to demonstrate that the 
emergent properties of HFs within its macro-environment are essential for 
explaining function. Moreover, this study is a fantastic example of how 
emergent properties and molecular, structural and temporal complexity are all 
involved in the process of cycling HFs. This provides yet further evidence that 
the HF is a classic systems biology tool.  
 
3.4.5 Algorithmic complexity of the cycling hair follicle 
Living organisms must be able to “compute” inputs and convert these to 
outputs. As an example, gene regulatory networks within cells process a signal 
e.g. hormone level (input) into gene expression patterns and cellular phenotype 
(outputs) (Table 3.1). The “computational centre” (HCC) that drives the hair 
cycle in the HF has not been identified (Paus and Foitzik, 2004). The existing 
theoretical models that simulate hair cycling (Halloy et al., 2000, Halloy et al., 
2002, Kolinko and Littler, 2000) do not model the “computations” of the HF 
during this process. A systems biology approach to hair cycling research should 
carefully identify the drivers of the hair cycle (internal computer or HCC) 
whereby inputs to the cycling HF are converted to the outputs; such as a hair 
shaft formation, regression of the HF, stem cell activation and HF regeneration 
and so on. In addition, we need to ensure that we have the computational means 
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to create models that can handle the complexity of such simulations (Huang and 
Wikswo, 2006). 
 
Figure 3.4: Emergent property of murine hair follicles in hair cycling domains and 
BMP signalling 
Employing a technique whereby murine dorsal skin was cut longitudinally and arranged spatially 
and temporally; in situ-hybridisation was carried out. These spatio-temporal experiments revealed 
how the propagation of hair cycle waves on the dorsum may arise. Spatio-temporal patterns in HF 
activity were directly linked to expression levels of the BMPs within hair cycle domains. Cyclic 
changes were found in Bmp2 and Bmp4 that were asynchronous to hair cyclic changes and that of 
WNT/β-catenin signalling; which is required for HF stem cell activation and thus hair 
regeneration. Noggin, a BMP antagonist, was found to be expressed in a similar pattern to WNT 
signalling.  The figure shows the schematic summary of the hair-cycle rhythm (in black) and the 
dermal rhythm (red) as defined by Plikus et al. Together, they define four new functional stages 
that correspond to the ability to propagate and respond to hair cycle propagation, these are 
functional phases of propagating anagen, autonomous anagen, refractory telogen and competent 
telogen. Refractory telogen is characterised by low noggin, high BMPs and low WNT signalling. 
Competent telogen is defined by low noggin, low BMPs whereas, during propagating anagen high 
noggin levels and low BMPs are found. Autonomous anagen is distinguished by the expression of 
high noggin and high BMPs. Catagen is omitted for simplification. 
Reprinted by permission from Macmillan Publishers Ltd: Nature, Plikus, M.V., et al., Cyclic dermal 
BMP signalling regulates stem cell activation during hair regeneration. Nature, 2008. 451(7176): 
p. 340-4. Copyright 2008. 
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3.5  PERSPECTIVES – TACKLING THE HUMAN HAIR CYCLE 
We have described how the HF is an ideal tool for systems biology research; 
being a unique mammalian feature, easily accessible, defined in form and 
function and able to address all the dimensions of living systems as an 
essentially autonomous mini-organ. It is evident that the dimensions of living 
systems overlap and are intertwined and the HF demonstrates this flawlessly, 
for example molecular changes in BMPs are co-ordinated with spatio-temporal 
changes in the propagation of hair cycle waves and associated structural 
alterations of HFs as they traverse the hair cycle (Plikus et al., 2008, Plikus et al., 
2009). 
Human hair cycle research highlights the intertwining pathways that are 
relevant in the regulation and function of a multi-cellular mini-organ. 
Interesting recent findings show that circadian genes are differentially 
expressed in anagen and catagen human HFs (Al-Nuaimi et al., 2009). The 
cycling HF is thus relevant to regenerative medicine researchers, 
chronobiologists and stem cell biologists to name but a few (Yu et al., 2008). We 
would hope that more comprehensive and dynamic analyses of the human hair 
cycle, via perturbation with siRNAs, for example, and microarray and protein 
analyses, with the concomitant use of mathematical modelling would be an 
important direction for human hair research and systems biologists alike and 
systems biology may make it more possible to unravel the mystery of the 
enigmatic HCC. This understanding could facilitate the development of novel 
therapeutic agents for the more effective management of common hair growth 
disorders.  
 
3.6 CONCLUSIONS 
In summary: 
 HF cycling in mice and man offers an excellent, clinically relevant, 
research model for systems biology and also stem cell, chronobiology, 
regenerative medicine and neuro-endocrinology research; 
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 The HF model deserves to be fully discovered by dermatological and 
systems biology research communities; 
 We propose that a systems biology approach to human HF cycling via the 
use of mathematical modelling coupled to experimental work would 
greatly further hair cycle research. 
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4 CHAPTER 4: AN INTRODUCTION TO 
DYNAMICAL SYSTEMS 
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4.1 ABSTRACT 
Dynamical systems theory is a field of applied mathematics used to construct 
and explore dynamical systems and is used as an important tool in systems 
biology research. In this chapter we describe essential features of a type of 
mathematical model used for the description of temporal biological processes; 
nonlinear ordinary differential equations. 
We present a tutorial-style exploration of the basic concepts and definitions of 
this field that are important in the context of this thesis. In order to demonstrate 
key principles, we provide a two dimensional non-linear system formulated in 
the style of apoptosis and proliferation driven cell population dynamics. Using 
this system we explore its key bifurcation structures and as such demonstrate 
mechanisms by which oscillations and bistability may arise. This chapter 
therefore serves as a point of reference for the following chapter detailing a 
theory of human hair follicle dynamics.  
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4.2 INTRODUCTION 
Dynamical systems theory is an applied mathematical field of study concerned 
with describing and exploring dynamical systems (Strogatz, 1994). These are 
mathematical formulations of complex interactions, referred to as mathematical 
models that can be investigated in terms of their evolution from a pre-defined 
starting point as time progresses. Often, the formulation is in terms of 
differential equations, so that the evolution of important system components 
(the variables) can be expressed as continuous changes with respect to time. 
Other possibilities are discrete mappings which describe the evolution as 
discrete updates with respect to time. In both of these cases the systems 
variables (measurable quantities) are assumed to be continuous, i.e. expressed 
as real numbers. On a more abstract level of description, when both the time 
and the variables are updated in a discrete way, one speaks of cellular automata. 
In formulating interactions in these or other ways and examining the behaviour 
of the models, we learn about the mechanisms involved in the real-world 
counterpart of the mathematical system. This approach has interdisciplinary 
applications and is an essential tool in understanding and analysing complex 
systems in systems biology (Klipp et al., 2009). Here, we describe essential 
features of the most basic type of mathematical models used for the description 
of temporal biological processes, the nonlinear ordinary differential equations. 
4.3 USE OF DYNAMICAL SYSTEMS IN THE THESIS 
In the present context, an important feature of the HF is its ability to display 
characteristic dynamics, which at the macroscopic scale is observed by the 
rhythmic regeneration and regression of the HF known as the hair cycle. 
Crucially, most hair disorders of clinical interest are thought to be defined by 
abnormalities in these dynamics (Paus, 2006, Paus et al., 1999a). In addition, the 
mechanisms leading to normal or abnormal rhythms in the HF are unknown. 
The formulation and investigation of a mechanistic mathematical model of the 
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HF dynamics can therefore inform on the mechanisms underlying these 
rhythms.  
For an expanded motivation of the use of dynamical systems to develop a 
prototypic model of the HF oscillations the reader is referred to Chapter 5. In 
what follows, we give a brief overview relating to terminology and concepts 
used in Chapter 5. The reader may refer to (Strogatz, 1994) for a more 
comprehensive guide to non-linear dynamics.  
4.4 A BRIEF EXPLANATION OF DIFFERENTIAL EQUATIONS AND RELATED 
DYNAMICS 
Ordinary differential equations (ODEs) are concerned with systems’ evolution 
in continuous time, as opposed to discrete-time difference equations. Although 
HF cycling is often verbally described in terms of distinct stages, the 
morphological processes and observations are continuous on the macroscopic 
level. Therefore, we try to capture the dynamics of the HF in continuous time 
using a model composed of systems of ordinary differential equations. In this 
framework, key variables in the system are identified. These are the 
components of the system that change within the time scale of interest and that 
reflect the mechanisms that we are interested in. These are either directly 
measurable or indirectly related to measurable quantities and as such form the 
link between model and experimental data. The population of keratinocytes in 
the human HF is an example of an important variable in relation to the hair 
cycle (see Chapter 5). A mathematical model is formulated by relating how the 
selected variables change over time with regards to key interactions between 
variables (see Equation (1)). Therefore, the model is a formulation of the 
mechanisms of interest. When the output of the model is compared to data from 
the real system inference regarding these mechanisms can be made.  
 
  
  
               (1) 
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Equation (1) gives a general formulation for the ODE. Variables are represented 
by the vector x, and one can see in equation (1) that their changes over time 
(expressed as first-order derivatives with respect to time) at a given temporal 
instance are defined by some function (f) of their respective values at that time. 
The interactions specified by the ODE also contain static quantities known as 
parameters (µ). These capture quantitative effects that do not vary on the time 
scale of interest and might include, for example, the rate of increase of a 
population due to intrinsic, un-modelled processes or the weighting given to the 
interaction between two variables.  
The number of variables in the vector x, determines the dimension of the 
system. f is a function that defines the interactions of the system and its 
evolution in time. Given the variables, parameters and evolution equations (f), 
the final ingredient of the mathematical model is its initial condition. This 
specifies the value of all variables at t=0 and determines a unique trajectory as 
time evolves. The trajectory is composed of the subsequent values of x at all 
time points, i.e. x(t), t>=0. One can visualise the trajectory of the system as a 
time series plot with time on the abscissa. Alternatively, one can plot values of 
variables against each other. This gives a view of the phase space (or state space) 
of the system (see figures below). The phase space is the set of all points the 
system can possibly take, and is therefore of dimension equal to that of x. A 
vector field describes the direction of flow of the system at each point in space 
and is usually visualised by arrows pointing in this direction and with size 
representing the magnitude of velocity (see figures below).  
In general, if f was linear, the system could either evolve to a fixed point 
or blow up to infinity. Fixed points are solutions to          and therefore 
represent points at which the trajectory no longer changes over time (hence 
fixed point or steady state). Describing the number and location of fixed points 
is an important first step to characterising a dynamical system. In addition, one 
should know the stability of a fixed point. Stable fixed points attract nearby 
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trajectories such that if one is perturbed away from the fixed point, the system 
will eventually evolve back to that point. Unstable fixed points on the other hand 
are those at which nearby regions of phase space diverge, such that a 
perturbation of the system away from this point causes the trajectory to evolve 
to a different region of phase space. Unstable fixed points are thus not 
observable experimentally. An additional class of (unstable) fixed point is the 
saddle, which has both stable and unstable properties depending on the 
direction of perturbation away from it.  
In addition to fixed points, non-linear dynamical systems (where f is a 
non-linear function of x) can display more complex structures to which the 
trajectory is attracted or repelled from. Stable limit cycles, for example, are 
closed loops in phase space to which the system is attracted and will stay upon 
as time evolves, resulting in periodic or oscillatory behaviour. Similarly as 
above, unstable limit cycles are oscillations on which the system can evolve, but 
will deviate from if perturbed by an arbitrarily small amount. They are thus 
experimentally unobservable as are unstable fixed points. Their knowledge is 
nevertheless of interest as they play a role in ordering phase space structure. 
In general, a dynamical system can be qualitatively described by its 
number of structures (fixed points and limit cycles, see below) and their 
stability. In the first instance, we can explore the stable solutions of the model as 
these will provide an indication of how the equivalent real life system may 
behave. Stable structures can be found by numerical simulation of the equations 
using algorithms that approximate x given previous values and knowledge of f 
(in this thesis the MATLAB “ODE45” solver is used).  
Therefore, an initial pertinent description or exploration of the model 
dynamics can be found by simulating the system for different values of 
parameters. When one plots the outcome of these simulations (for example by 
extracting values of fixed points or the maxima and minima of oscillations) a 
bifurcation diagram is formed. This can be a useful technique in general but is 
especially important when model parameters cannot be determined 
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experimentally. This case frequently arises if abstractions of important 
processes are considered (which is generally the case in biology) or if 
experimental techniques do not facilitate the quantitative evaluation of their 
associated parameters. In these cases, the relative effect of these processes can 
be determined by examining the dynamics of the system over changes in its 
parameters. 
As the parameters,  , vary a bifurcation is said to occur if the qualitative 
characteristics of the system change. A bifurcation point is the point where 
specific parameter values are seen to produce the change. Thus, bifurcations can 
model, for example, the emergence of rhythms as a stable fixed point loses 
stability and forms a stable limit cycle. This is the scenario of a very common 
bifurcation known as the Hopf bifurcation and is a classic way for a dynamical 
system to generate oscillations.  
In order to demonstrate some of these important concepts, we introduce 
a simplified two dimensional system, which retains some of the properties of 
the HF model referred to in Chapter 5. The ODE and parameter set are given as 
follows:  
    
  
  
    
  
     
  
        
       
    
   
   (2) 
    
  
  
        
 
Table 4.1: Parameter set for example ODE 
Parameter a b c d e k Km1 Km2 Ca 
Value 0.1 0.1 Varies 0.7 0.02 2 0.1 0.1 Varies 
 
In relation to the previous notation x = (x, y), µ = (a, b, c, d, e, k, Km1, 
Km2, Ca) and f = (f1, f2). The system is two dimensional since there are two 
variables of interest. Seven parameters, the functional form of f and the set of 
initial conditions x(0) specify a solution to this system of ODEs.  
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In the first line of eq. (1) (variable x) there are two terms with positive 
sign that describe processes leading to the growth of the population (positive 
rate of change) and two processes with negative sign that describe processes 
leading to the decay of the population (negative rate of change). One of the 
growth terms is just a constant and therefore independent of variable x. The 
other growth term depends on x in a hyperbolic fashion and is therefore 
nonlinear. One of the decay terms depends on x linearly. The other decay term 
depends on x in a more complex fashion. The qualitative shape of the function is 
determined by the value assigned to parameter k. The second equation has no 
specific interpretation, it is meant to represent some other process which 
depends on the state of the population x. It can also be thought of as a 
condensed way of representing all other processes that depend on the state of 
the population.  
When Ca =0, the equation for variable x only depends on parameters and 
x itself and is said to be independent of the state of the other variable, y. As the 
evolution of y is assumed to depend on x (see equation for y), whenever one 
chooses to set Ca >0, the two variables compose a system of interwoven 
dependencies. Parameter Ca can thus be said to represent the strength of 
coupling or feedback of y on x. Mathematically then, one way of investigating the 
model is to first look at the equation for the population x in isolation (Ca =0), 
and then compare this to the dynamics of the full model with feedback Ca >0.  
With the parameter set described above 
Table 4.1) including Ca =0 and c=1.8, our simple system has two fixed points, 
one stable and one unstable. The stable and unstable fixed points can be seen in 
the following phase space diagram (Top panel, Figure 4.1):  
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Figure 4.1: Phase space diagram. 
Phase space diagram of model as detailed in Equation (2) with Ca=0 and c=1.8. Open circle 
indicates unstable fixed point and the full circle a stable fixed point. Bottom panel shows a plot of 
f1 over a range of x. Red arrows indicate the direction of flow with respect to x.  
 
In Figure 4.1 the two dimensional space is plotted in which the system 
resides. The arrows indicated on the upper panel of this figure constitute the 
vector field which describes the magnitude and direction of the change (or flow) 
of the system at each point in phase space. One can see that the vector field 
points towards the stable fixed point if approached from any direction. One can 
extract information regarding the flow in the x and y directions by examining 
the solutions to f1=0 and f2=0. In our simple system, f2=0 simply requires x=y. 
This is plotted as a nullcline on the figure (dashed line y=x). Information 
regarding direction of flow with respect to x is extracted from f1=0 which is 
plotted in the bottom panel of Figure 4.1. Note that in this case, f1 is independent 
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from y since Ca=0. Fixed points are located where both f1=0 and f2=0 and can be 
seen on the figure. The red arrows in the bottom panel indicate that when f1>0 
the direction of travel is in increasing x and vice versa for f2<0.  
Some example trajectories are given for different initial conditions as 
thin blue lines. It can be seen that in each case the system converges to the 
stable fixed point at (x,y)=(18.5,18.5). This is also demonstrated in the time 
series of the two variables, as shown in Figure 4.2. Note that the two variables 
assume identical final values due to the specific construction of the equation for 
y. In general their final values will differ. 
 
Figure 4.2: Time series of x and y simulated from random initial conditions.  
 
The stability of fixed points in our example were calculated by 
determining the eigenvalues of the Jacobian matrix of the system. The Jacobian 
is the matrix formed by all partial second derivatives of the system, which in our 
example gives: 
   
   
   
   
  
   
   
   
  
  
The eigenvalues, λ, of J are given as solutions to the following equation:  
      
and in practice are determined using: 
             
A fixed point is stable when all eigenvalues satisfy Re(λ) <0 and unstable 
if any of the eigenvalues satisfy Re(λ) >0. Here Re() refers to extracting the real 
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part of λ. When Re(λ)=0, conclusions on stability cannot be drawn from this 
method. In particular, Re(λ)=0 defines the point of bifurcation where the 
stability of a fixed point changes. 
In Figure 4.3 we demonstrate the presence of stable and unstable fixed 
points for our system eq. (2) in a bifurcation diagram. In this case, we set Ca =0 
and track the system behaviour over changes in c. We note that since the 
variable, x, in this system is analogous to a cell population density in Chapter 5, 
we limit solutions to those satisfying x >=0.  It can be seen that as parameter c 
changes, the number of stable and unstable fixed points, as well as their value, 
can change. We note the presence of bistability in this model when 0.4  c  1.4, 
which means that the system can evolve to one of two stable fixed points. The 
fate of the system, in terms of which of these fixed points it is attracted to, is 
determined by the initial conditions. Each stable fixed point has a basin of 
attraction. Any initial condition within the basin of attraction of a fixed point 
will evolve towards that fixed point as time progresses. In our case, the 
boundary between the basins of the two fixed points in the bistable region is 
given by the unstable fixed point between them (dotted line in Figure 4.3). 
 
Figure 4.3: Bifurcation diagram showing fixed points in the model with Ca = 0.  
Solid lines indicate stable points and dotted line indicates unstable points. There is bistability 
shown between approx. 0.4 and1.4 (values of c) 
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When we set Ca to 1 in the model system, oscillations can be produced. 
We demonstrate this in the bifurcation diagram below (Figure 4.4), again for 
changes in c.  
 
Figure 4.4: Bifurcation diagram for the model with Ca = 1 showing changes over c.  
Inset gives a close up of the oscillatory region between c = 1.93 and 2.04 
 
The oscillations are found in the range 1.93  c  2.035. The two time 
series of an oscillation at a given value of c are shown below (Figure 4.5):  
 
 
Figure 4.5:  Time series for the model where Ca = 1 and c=2.  
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In the phase space diagram below, we can see that at the parameter set 
of Figure 4.6, the trajectories of the system converge to the stable limit cycle 
shown as a thick black line. Thus the system oscillates indefinitely as time 
progresses. However, the stable fixed point near (10, 10) persists indicating that 
here the system is bistable between a fixed point and a limit cycle. This will be 
discussed below.  
 
 
Figure 4.6: Phase space diagram for the model where Ca = 1 
 
The details of the dynamics can be understood by considering the 
bifurcations in the model. As can be seen in Figure 4.4, its dynamics over 
changes in c present two important branches of fixed points. A contributing 
factor to the generation of the stable limit cycle, which exists for 1.93  c  
2.035, is the sub-critical Hopf bifurcation on the top branch at c=1.91. This 
bifurcation describes the transition from an unstable focus to a stable focus as 
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the real part of the pair of complex eigenvalues becomes negative. The term 
focus here refers to a fixed point whose eigenvalues have non-zero imaginary 
part, and leads to damped oscillatory dynamics in the vicinity of the fixed point 
if the fixed if it is stable. The transition in the eigenvalues of this focus can be 
seen in Figure 4.7 (the zero-crossing of the real part in the top panel; the 
transition from empty circles to filled circles in the bottom panel). As the focus 
gains stability, an unstable limit cycle emerges around it (shown in red in Figure 
4.8). The transition thus constitutes a so-called subcritical Hopf bifurcation. (In 
contrast, in a supercritical Hopf bifurcation a stable limit cycle is generated). 
Crucially, this unstable limit cycle separates the phase space of the system such 
that just next to the bifurcation point the two fixed points can now co-exist. The 
unstable limit cycle is therefore referred to as a separatrix, and the system is 
said to be bistable because one can observe either state for the same setting of 
parameters. The details of this bistability are shown in Figure 4.8.  
 
Figure 4.7: Eigenvalues of the fixed point on the top branch over changes in c  
(compare to the inset of Figure 4.4). At c=1.91 the fixed point gains stability in a sub-critical Hopf 
bifurcation as the complex eigenvalues cross the real axis. Top panel: changes in the real part of 
the eigenvalues over c. The horizontal dashed line is drawn at Re(lambda)=0. Middle panel: the 
imaginary components do not vary with c. Bottom panel shows the change in stability of the fixed 
point – open circle is unstable and closed circle is stable. 
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Figure 4.8: Bistability in the model with c=1.925.  
The panels show x and y nullclines (solid and broken black lines, respectively), stable and unstable 
fixed points (solid and open black circles, respectively), unstable limit cycle (broken red line) and 
example trajectories from different initial conditions (blue lines). The left panel shows all 
structures of interest, whereas the right panel shows a close-up of the different behaviours at either 
side of the separatrix. 
 
Then, as c is increased slightly, the stable fixed point on the bottom 
branch loses stability, as shown in Figure 4.9 (the zero-crossing of the real part 
in the top panel; the transition from filled to empty circles in the bottom panel).. 
As the eigenvalues of this fixed point are complex at the moment of transition, 
this constitutes a supercritical Hopf bifurcation. 
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Figure 4.9: Eigenvalues of the stable fixed point on the bottom branch.  
Top panel: real part which goes positive at c=1.93, leading to instability of the fixed point. Middle 
panel: imaginary part of the eigenvalues indicating the node temporarily becomes a focus. Bottom 
panel: location of the fixed point. Note that the fixed point disappears before c=2.05 (due to 
collision with the other unstable fixed point) 
 
This loss of stability of the fixed point on the bottom branch means that 
the two stable structures remaining are the stable limit cycle and the stable 
fixed point at the centre of the unstable limit cycle.  
The offset of oscillations at c=2.035 can also be explained. This is due to a 
fold bifurcation of limit cycles. This is closely related to an important bifurcation 
of fixed points, known as the fold bifurcation, or saddle-node bifurcation. This 
bifurcation occurs when two fixed points, one a saddle and one a node collide 
and annihilate each other. Similarly, limit cycles can collide as they grow or 
shrink with changes in the system parameters. In our system, as c increases, the 
unstable limit cycle around the stable fixed point on the top branch grows 
outwards and eventually (at c=2.035) collides with the stable limit cycle. This 
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annihilates both limit cycles leaving only the stable fixed point on the top 
branch remaining. This transition is demonstrated in Figure 4.10. 
 
Figure 4.10: Fold bifurcation of limit cycles.  
Shown are stable and unstable structures, together with nullclines for increasing c (from left panel 
to right panel). The stable limit cycle is shown in thick black lines and unstable limit cycle in broken 
red lines. Stable and unstable fixed points are solid and open black circles, respectively. A trajectory 
in the right panel is shown as a solid blue line.  
 
In general, a fixed point in the model relates to a stable situation in the 
real-world analogue, which in our case might be, for example, a keratinocyte 
population neither growing nor shrinking. In the region of oscillatory behaviour, 
however, the model predicts a periodically growing and shrinking population. 
As the analysis shows, this latter behaviour is only possible when one of the 
model’s fixed points becomes unstable. Thus, bifurcation analysis yields the 
conditions under which cycling (or rhythmic) behaviour can be expected. 
Following this brief introduction to dynamical systems we shall in the 
next chapter present the mathematical model of the human HF cycling. 
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5 CHAPTER 5:  A PROTOTYPIC MATHEMATICAL 
MODEL OF THE HUMAN HAIR CYCLE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In preparation for submission to the Journal of Theoretical Biology  
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5.1 ABSTRACT 
 
The human hair cycle is a complex, dynamic organ-transformation process 
during which the hair follicle (HF) repetitively progresses from a growth 
phase (anagen) to a rapid apoptosis-driven involution (catagen) and 
finally a relative quiescent phase (telogen) before returning to anagen. At 
present no theory satisfactorily explains the origin of the hair cycle 
rhythm. Based on experimental evidence we here propose a prototypic 
model that focuses on the dynamics of hair matrix keratinocytes. We argue 
that a plausible feedback-control structure between two key 
compartments (matrix keratinocytes and dermal papilla) leads to 
dynamic instabilities in the population dynamics resulting in rhythmic 
hair growth. The underlying oscillation consists of an autonomous 
switching between two quasi-steady states. Additional features of the 
model like bistability and excitability lead to new hypotheses about the 
impact of interventions on hair growth. We show how in silico testing may 
facilitate testing of candidate hair growth modulatory agents in human HF 
organ culture or in clinical trials. 
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5.2 INTRODUCTION 
The HF is unique to mammals and displays fascinating dynamic behaviour in the 
hair cycle. This cutaneous mini-organ undergoes continuous, self-organised, 
cyclical regeneration and regression events during which a pigmented hair shaft 
is produced and shed during each cycle. The hair cycle is the only organ 
transformation event that repeats cyclically for the entire lifetime of the 
mammalian individual. It represents a unique chronobiological rhythm that 
encompasses a complex set of changes at the tissue level. In addition, it shows 
diverse rhythmicity, dependent on where exactly on the integument a HF is 
located (e.g. scalp versus eyelashes versus eyebrow hair) (Dawber, 1997). The 
“control” system that governs the hair cycle is proposed to be an autonomous 
oscillator (Paus and Foitzik, 2004, Paus et al., 1999a). Its exact constituents, 
however, have essentially remained elusive. 
HF cycling commences immediately after HF morphogenesis and consists 
of three main phases: anagen, a phase of massive epithelial cell proliferation, 
during which pigmented hair shafts are generated in the anagen hair bulb; 
catagen, a phase of rapid, apoptosis-driven organ involution; and telogen, an 
interspersed stage of relative quiescence (Stenn and Paus, 2001, Paus and 
Foitzik, 2004, Schneider et al., 2009). Active hair shaft shedding occurs during 
exogen (Higgins et al., 2009, Milner et al., 2002). Each phase in the cycle is of 
distinct length (e.g. with anagen lasting several years, catagen several weeks, 
and telogen usually a few months in human scalp HFs). All human HFs show 
major site-specific variations in the length of each of these phases (Saitoh et al., 
1970, Kligman, 1959).  
Hair cycling is of clinical relevance as the majority of hair disorders are 
characterised by a pathological change in normal HF cycling dynamics 
(Cotsarelis and Millar, 2001, Paus, 2006). If anagen is abrogated and catagen 
induced prematurely, this will result in hair loss (effluvium). In contrast, when 
anagen is induced prematurely or lasts overly long, this leads to unwanted hair 
growth (hirsutism, hypertrichosis). In addition, dramatic transformations in HF 
size and state can occur during just one hair cycle, which may underlie the HF 
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transformation events seen when very small (vellus) HFs become large, or very 
large HF miniaturise during hirsutism, hypertrichosis or androgenetic alopecia, 
respectively (Tobin et al., 2003, Stenn and Paus, 2001, Paus and Foitzik, 2004, 
Schneider et al., 2009). 
Over the years, a multitude of genes, secreted molecules, enzymes and 
receptors have been identified that modulate HF cycling, hair shaft growth and 
hair pigmentation (Stenn et al., 1994, Stenn and Paus, 2001, Schneider et al., 
2009, Plikus et al., 2009, Geyfman and Andersen, 2010). It is the general 
consensus that controlled changes in the expression, secretion or activity of 
these molecules leads to switches in the local signalling environment, which 
ultimately drive the HF through its cyclic transformations (Paus and Foitzik, 
2004). However, we remain unsure of the “pacemaker(s)” that autonomously 
govern the coordinated and timely progression of the whole organ through the 
hair cycle (Paus et al., 1999a, Paus and Foitzik, 2004).  
5.3 THE “HAIR CYCLE CLOCK” 
The need to explain the origin of hair cycling was first systematically addressed 
over half a century ago by Chase who proposed an inhibition-disinhibition 
theory of how the hair cycle rhythm arises (Chase, 1954). More recently, this 
hair research challenge has been re-examined as an important, as yet 
unanswered, biological problem of general importance (Stenn et al., 1999, Paus 
et al., 1999a, Paus and Foitzik, 2004).  
Mathematical modelling may be employed to construct and test a theory 
of where the cyclic transformation activity of the human HF originates and how 
it is controlled. Unlike other biological cycles, such as the cell cycle and the 
circadian rhythm, the hair cycle is comparatively unchartered territory in the 
mathematical modelling arena. However, a small number of mathematical 
models concerned with hair growth, cycling, or the synchronisation of cycling 
between larger HF collectives (hair waves) have been proposed (Halloy et al., 
2000, Halloy et al., 2002, Nagorcka and Mooney, 1982, Kolinko and Littler, 2000, 
Golichenkova and Doronin, 2008, Plikus et al., 2011). 
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Nagorcka and Mooney mathematically modelled the differentiation of 
wool and mammalian hair shaft during anagen, but did not address the cyclical 
processing of the human HF (Nagorcka and Mooney, 1982).  Similarly, mouse 
hair shaft growth was modelled with respect to theoretical proliferative activity 
of MKs (Golichenkova and Doronin, 2008). A cellular automaton model has been 
adopted to both simulate and predict the dynamics of populations of human 
(Halloy et al., 2000, Halloy et al., 2002) and mammalian HFs (stem cell 
activation) (Plikus et al., 2011). A statistical model of human hair cycle laser 
treatment has been created that was namely concerned with predicting optimal 
timing for laser hair removal (Kolinko and Littler, 2000).  
The existing models either concentrate solely on hair growth (i.e. hair 
shaft formation) or relate primarily to highly synchronized hair wave pattern 
formation in rodents. Although it has been shown that the human HF relies most 
heavily on its intrinsic processes to cycle (Plikus et al., 2011), none of the 
existing models address the intrinsic processes within the human HF that may 
explain the fundamental nature of the hair cycle rhythm. As a consequence, a 
persuasive mechanistic theory of how the human hair cycle is induced and 
maintained is still missing. 
In the current contribution, we aim to outline a dynamical systems 
theory of the human hair cycle using mathematical modelling. We address the 
above question from the point of view that a dynamical instability underlies 
human HF cycling. 
5.4 MODEL DESIGN 
No molecules, genes or individual cells have as yet been identified as being the 
“pacemaker(s)” for the hair cycle rhythm. Here, we propose an abstraction from 
the consideration of the vast number of specific genes, molecules, interlinking 
pathways and cell-cell interactions that may potentially be involved in HF 
cycling. We begin by detailing basic criteria that a plausible hair cycle theory 
should meet and then define the key dynamic features that characterise the hair 
cycle. This ultimately leads us to a simple but prototypic mathematical model of 
human HF cycling. 
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5.5 ESSENTIAL FEATURES OF A GOOD HUMAN HAIR CYCLE THEORY 
A satisfactory theory of the human HF cycle should be able to explain, firstly, the 
autonomy of the cycle. It is particularly apparent that in the human HF the 
“oscillator system” governing the hair cycle rhythm is located in the HF itself. 
This is supported, for example, by the maintenance of location specific hair cycle 
features in transplantation surgery. A second key feature of a hair cycle theory 
should explain its unique rhythmicity i.e. a long anagen phase, extremely rapid 
catagen stage and relatively short telogen phase. Thirdly, the central role of the 
HF mesenchyme (DP and proximal CTS) in hair cycle control must be 
incorporated and explained (Paus et al., 1999a, Paus and Foitzik, 2004).  
Another important aspect that the theory should address in human hair cycling 
is the diverse periodicity seen in vivo between different HFs (for example how 
HFs located in anatomically different sites may come to vary). Lastly, a 
satisfactory theory of the hair cycle should address or be able to hypotheses as 
to how HFs might respond to specific treatment and how known hair disorders 
may arise from the normal healthy HF cycle. 
 
5.6 IDENTIFYING THE KEY PROCESSES AND DYNAMICAL CHANGES IN 
THE HAIR CYCLE 
The HF is a highly dynamic mini-organ in which multiple distinct cell 
populations that originate from mesoderm or (neuro-)ectoderm intimately 
interact in a precisely coordinated fashion in order to temporarily and 
rhythmically generate a (usually pigmented) hair shaft. The HF is 
predominantly constituted by epithelial cells, whose activities are controlled by 
specialised mesenchymal cells, i.e. inductive fibroblasts of the DP and the CTS. 
Jointly, these epithelial and mesenchymal cell populations control the activity of 
neural crest-derived, specialised melanocytes of the HF pigmentary unit (HFPU) 
(Schneider et al., 2009, Tobin, 2011). All three interacting cell populations arise 
from and are replenished by epithelial (or melanocyte) stem cells that are 
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mainly located in the so-called bulge region or secondary hair germ, or from 
stem cells located in the HF mesenchyme. 
Dramatic structural changes, inextricably linked to a dynamic 
redistribution of cell populations, occur in the HF as it processes cyclically 
through the three stages of the hair cycle after morphogenesis 
(catagentelogenanagen catagen) (Paus and Foitzik, 2004). In order to 
establish the core events that may be responsible for the hair cycle rhythm, the 
necessary cell populations, processes and interactions characterising the major 
cyclical HF transformations must be defined. A summary of these features 
during each hair cycle phase is provided in Table 5.1. Where available, estimates 
of population numbers are given. The bulge region and the secondary hair germ 
of the HF houses epidermal stem cells. Approximately 100-200 stem cells are 
located in the bulge of mouse pelage HFs. Proliferation of these epithelial stem 
cells occurs during late telogen and early anagen probably following activation 
by DP fibroblasts (Zhang et al., 2010, Waghmare et al., 2008, Ito et al., 2004, 
Greco et al., 2009). The stem cell progeny (transient amplifying cells (TACs)) 
proliferate to create the ORS, IRS and hair matrix (Ito et al., 2004, Zhang et al., 
2009). It is not clear at present whether these processes of proliferation and 
migration cause the number of stem cells to increase during the hair cycle or 
whether this activity leads to the production of semi-differentiated cells (TACs) 
to maintain the stem cell niche at an approximately stable number (Zhang et al., 
2009, Wilson et al., 1994, Ito et al., 2004, Lavker et al., 2003) (see Table 5.1 and 
Figure 5.1) Apoptosis has a negligible role in the stem cell niches and these cells 
are spared from the extensive apoptosis that characterises catagen. This 
preserves a cell pool that remains permanently available for HF regeneration (if 
epithelial HF stem cells get depleted, this results in scarring alopecia) (Harries 
and Paus, 2010).Therefore, an important tenet for the design of the hair cycle 
model is the assumption that the stem cell population within its niche remains 
largely constant and serves as a permanent pool for hair MKs and the HF 
(Figure 5.1).  
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Figure 5.1: Dynamic profiles of populations in the hair follicle 
Each cell population exhibits a unique dynamic profile in line with stages of the hair cycle. Anagen 
(A), catagen (C) and telogen (T). The figure shows an anagen hair follicle. Dynamic profiles are 
estimates of population dynamics of several core hair follicle cell populations obtained from the 
available evidence. The schemas depict the size of each population during each cycle stage. This 
investigation into the hair cycle on the population level summaries the behaviour from a 
compartmentalised viewpoint. In this model, we focus on the hair matrix keratinocytes (which at 
numbers close to zero also captures hair germ cells in this compartment). The matrix keratinocytes 
population is able to capture, in the simplest form, the core events of remodelling, regression and 
rest during the hair cycle. In addition, the matrix keratinocytes directly supply hair shaft cells 
(trichocytes). 
 
MKs arise from the differentiation of TACs, which themselves arise from 
stem cells the number of MKs differs greatly during the hair cycle (Table 5.1). 
During anagen, MKs undergo rapid proliferation and then terminally 
differentiate into various epithelial lineages that form the hair shaft and the IRS. 
The ORS appears to be largely generated by the immediate progeny of the TACs 
that have arisen from HF epithelial stem cells in the bulge (Panteleyev et al., 
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2001, Ito et al., 2004). When MK cells proliferate they do so to replace those that 
have already undergone terminal differentiation into the hair shaft and IRS 
Figure 5.1. Thus, another important tenet of our hair cycle theory is that the 
population size of MKs determines the size cell population available for hair 
shaft and IRS production.  
In adult human scalp skin, hair shaft production follows an 
approximately linear growth pattern in vivo, with the hair shaft thinning at the 
end of anagen (Ibrahim and Wright, 1982). Even microdissected and amputated 
hair bulbs of terminal human scalp HFs in anagen VI demonstrate the same hair 
shaft production speed as the living human scalp (Philpott et al., 1990). In 
Figure 5.2, we demonstrate the hair shaft elongation rate of anagen scalp HFs 
isolated from 18 different human individuals, whereby the linearity of hair shaft 
production is shown. Therefore, our mathematical model proposed below aims 
to produce a similar, approximately linear, human hair growth pattern. 
However, while hair shaft formation is linear, HF cycling is not. Each hair cycle 
phase is of very divergent length (for example, lasting weeks in catagen to years 
in anagen in human terminal scalp HFs).  
Catagen heralds the complete elimination of MK cells via apoptosis. The 
population remains at or near zero during telogen until the onset of the next 
anagen phase. When MKs undergo apoptosis in catagen, the supply of cells to 
the hair shaft is interrupted and hair production ceases. Very early during the 
anagen-catagen transformation, intrafollicular melanogenesis and all 
melanosome-based transfer of melanin from HFPU melanocytes into future hair 
shaft keratinocytes (trichocytes) is abruptly terminated (Slominski et al., 2005, 
Tobin et al., 1998, Tobin, 2011). As a result, the old hair shaft from the 
preceding anagen phase is transformed into a so-called “club hair”, whose 
proximal end is non-pigmented. This club hair is subsequently shed during 
exogen or is pushed out by the new hair shaft that is generated in the next 
anagen phase (Higgins et al., 2009). 
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Figure 5.2: Elongation of human hair follicles in organ culture 
Human hair follicle elongation data obtained from 18 patients (each patient is shown as the light 
grey lines) and the average percentage elongation of the 18 patients is shown by the thick black 
line. 
 
The dynamics of the MK cell population encompasses all key 
phenomenological cyclical events of a) hair production during anagen, b) 
cessation of hair production during catagen and telogen, and c) production of a 
new hair with each anagen phase. MK apoptosis during the catagen phase 
results in involution of the lower two thirds of the HF whereas MK proliferation 
during anagen represents a key event of cyclical HF regeneration. Since MKs 
produce hair via anagen-coupled terminal differentiation, the dynamics of the 
MK population have a crucial role in abnormalities such as hair loss, which are 
understood to be pathologies of HF dynamics (Paus et al., 1999a, Paus, 2006). 
Therefore, the MK population shows the most overt and dramatic changes of 
cell populations within the HF with proliferation, differentiation and apoptosis 
identified as key processes dictating these changes (Figure 5.1 and Table 1). In 
addition, MKs are extremely sensitive to damage (e.g. by drugs, reactive oxygen 
species, radiation, inflammatory mediators, metabolic and hormonal 
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abnormalities) and thus play a crucial role in multiple different hair loss 
disorders (Bodó et al., 2010, Paus, 2006). Therefore, we identify MKs as an 
excellent cell population to focus on when developing a simple mathematical 
model of HF cycling that operates at the level of tissue level dynamics. 
The CTS and the DP constitute the HF mesenchyme, without which 
proper HF morphogenesis and cycling are impossible. Indeed, inductive signals 
from CTS and DP fibroblasts are essential for the epithelial-mesenchymal 
crosstalk that drives HF cycling (Botchkarev and Kishimoto, 2003, Yang and 
Cotsarelis, 2010). The DP sits in the centre of the hair bulb and is directly 
connected to the CTS by the dermal stalk, with MKs enveloping the DP from all 
sides during anagen (Figure 5.1). A special, dynamically remodelled basement 
membrane separates MK and DP cells and is needed for proper epithelial-
mesenchymal communication in the HF (Link et al., 1990). The unique nature of 
the bi-directional communication between these two cell populations is evident 
from the fact that this membrane becomes fenestrated during anagen and that 
DP fibroblasts have cell processes that protrude into the innermost layer of the 
hair matrix (Matsuzaki and Yoshizato, 1998, Stenn and Paus, 2001, Nutbrown 
and Randall, 1995). Without fully functional bi-directional communication 
between MKs and DP cells HF cycling becomes grossly disturbed and eventually 
ceases altogether; if the disturbance persists, HFs become dystrophic and 
eventually disappear. 
The dynamics of the DP are mainly determined by bi-directional, hair 
cycle-dependent fibroblast migration between the DP and the proximal CTS 
(Table 5.1) (Tobin et al., 2003). Under physiological conditions, there is 
extremely little, if any apoptosis in the DP during the hair cycle, even in catagen 
and even under conditions that induce massive MK apoptosis (such as 
chemotherapy (Lindner et al., 1997)).  Also, fibroblast proliferation within the 
DP is a rare event and may essentially be limited to a narrow window during 
anagen development (Tobin et al., 2003, Paus and Foitzik, 2004). 
Therefore, as MK-DP cell interactions are undoubtedly crucial for normal 
HF cycling, signals emanating between the two compartments need to be 
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incorporated in the model. However, for simplicity’s sake, DP cell numbers shall 
not be explicitly modelled. 
To summarise, the hair cycle in man (and all other hair-bearing 
mammals) is underpinned by dynamic changes at the level of defined 
populations. Among these, MKs are an important cell population on whose 
analysis a theory of HF cycling can be based. This is since MK dynamics most 
perfectly reflect all key phenomena that underlie HF cycling, i.e. rhythmic 
changes in i) proliferation, ii) apoptosis, and iii) differentiation. In addition, 
since communication between e MK with the mesenchymal HF is essential for 
hair cycling, our attempt of a dynamical theory of human HF cycling will be 
based on a mechanistic mathematical description of MK cell numbers (changes 
in which result from MK proliferation, terminal differentiation or apoptosis) 
supported by communication with the DP (Figure 5.3). By highlighting the 
behaviour of selected HF cell populations and understanding the processes that 
govern the changes in cell numbers, we are able to specify a set of fundamental 
observations that should be captured in an adequate model for hair cycle 
dynamics. The most salient of these features is the asymmetric duration of each 
phase of the hair cycle. Based upon the aforementioned evidence, we now 
proceed to a mathematical formulation of human HF cycling. 
 
Figure 5.3: Schema representing the mathematical model’s core component and 
links to other cell and compartments within the hair follicle 
The core population of matrix keratinocytes are related to epithelial stem cells that supply new 
cells to the hair follicle (via differentiation). Matrix keratinocytes then differentiate into the hair 
shaft. The last important compartment involved is the dermal papilla that provides essential 
communication for hair cycling.  
  
Table 5.1: The population dynamics of distinct cell populations in the hair follicle.  
The number of cells in each population may be affected by; proliferation, differentiation, apoptosis and migration and these events are marked as present 
abundantly (++++) or not present (-) in line with hair cycle stages anagen, catagen and telogen. SC Stem cell, DP Dermal papilla, MK Matrix keratinocytes, CTS 
Connective tissue sheath, TAC Transient amplifying cell, ORS Outer root sheath, IRS Inner root sheath. 
Population  Anagen Catagen Telogen References 
SC No. of cells 100-200 100-200 100-200 (Zhang et al., 2010, Waghmare et al., 2008, Hsu et 
al., 2011) 
 Proliferation ++. Early anagen. Slows by late 
anagen. 2-5 divisions in one 
hair cycle. 
- - (Zhang et al., 2009, Wilson et al., 1994, Ito et al., 
2004, Hsu et al., 2011, Waghmare et al., 2008) 
 Differentiati
on 
+++ stem cell niche/germ 
transition zone. To TACs and 
MKs 
- - (Zhang et al., 2009, Lavker et al., 2003, Hsu et al., 
2011) 
 Apoptosis - - - (Ito et al., 2004, Hsu et al., 2011) 
 Migration To hair germ & basal layer ORS 
(May already be TACs) 
Lateral migration 
in newly 
generated club 
hair 
Bulge cells 
leave the 
niche 
(Zhang et al., 2010, Hsu et al., 2011, Zhang et al., 
2009, Lavker et al., 2003) 
 
MK No. of cells 100s 0  20-40 cells (Zhang et al., 2009, Ito et al., 2004). 
 Proliferation ++++ - -  
 Differentiati
on 
++++. Into IRS and HS - -  
 Apoptosis - +++++  - (Lindner et al., 1997, Matsuo et al., 1998). 
 Migration - - - (Taylor et al., 2000). 
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Table 5.1 continued: The population dynamics of distinct cell populations in the hair follicle 
The number of cells in each population may be affected by; proliferation, differentiation, apoptosis and migration and these events are marked as present (+) or 
not present (-) in line with hair cycle stages anagen, catagen and telogen. SC Stem cell, DP Dermal papilla, MK Matrix keratinocytes, CTS Connective tissue sheath, 
TAC Transient amplifying cells, ORS Outer root sheath, IRS Inner root sheath. 
Population  Anagen Catagen Telogen References 
HS No. of cells Proportional to no. of MKs. 
Fine distal tip, thicker mid-
region, narrow proximal club  
Ceases in early 
and mid-catagen 
0 (Tobin et al., 2003, Ibrahim and Wright, 1982) 
 Proliferation - - -  
 Differentiation +++ - -  
 Apoptosis - Mid & late catagen - (Matsuo et al., 1998, Lindner et al., 1997) 
 Migration - - -  
DP No. of cells Double no. in telogen.  
Ratio DP:MKs determines hair 
width  
- ½ anagen (Tobin et al., 2003, Ibrahim and Wright, 1982) 
 Proliferation ++++ Greatest anagen IV. Rare 
at anagen VI  
- - (Tobin et al., 2003) 
 
 Differentiation - - -  
 Apoptosis - - - (Lindner et al., 1997, Matsuo et al., 1998, Soma et 
al., 1998) 
 Migration +++ Into DP from CTS. In 
anagen VI cells migrate from 
DP to CTS 
Early catagen: 
(~50% migrate to 
CTS) 
-  
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5.7 A PROTOTYPIC HUMAN HAIR CYCLE MODEL 
5.7.1 Model formulation 
On the basis of the features elaborated above (see Figure 5.4 and Table 5.1) we 
formulate the following model for human HF cycling. The model focuses on the 
dynamics of MK cells with respect to the population level processes of 
proliferation, apoptosis and differentiation. A schematic overview of the model 
is provided in Figure 5.4. 
In general, the dynamics of MK cells, x, under these processes, can be 
captured mathematically as follows (Equation 1): 
 
                                                (1) 
 
The two functions, f and g, represent proliferation and apoptosis, 
respectively, and are in general non-linear. We note that both are assumed to 
depend on the state of the system, i.e. the size of the MK population. Parameter 
a represents a constant input to the population from stem cells and the term bx 
encompasses all processes leading to a decrease in the number of MKs apart 
from apoptosis, including differentiation. 
We assume saturation in growth, which is modelled with a saturation 
function e.g.  . This assumption is justified as growth of MKs is likely to 
saturate depending upon factors such as the supply of nutrients (which are not 
modelled explicitly here). The simplest case is when n=1 which leads to a 
hyperbolic function. The apoptotic function, g, follows a similar form, however 
we also include the possibility for feedforward inhibition via the parameter, k: 
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n
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Within this framework, we introduce communication between the MKs 
and the DP. It is assumed that feedback with the DP affects either proliferation 
or apoptosis of MKs, for example via papilla morphogens or endogenous 
inhibitors (Paus et al., 1999a, Stenn and Paus, 2001, Botchkarev and Kishimoto, 
2003). These processes enter as additional terms in f and g, dependent upon a 
new variable, z. Here, we consider negative feedback only, introducing terms for 
feedback inhibition of the proliferative term and feedback activation of the 
apoptotic term. This leads to the following form:  
 

dx
dt

p1.x
p2  x
/(p3 Cprol * z1)
(p4 Capop * z1)* x
(p5  x
k )
 (a bx)                    (3) 
 
Here, constants Cprol and Capop regulate the strength of feedback of z on 
the population equation for x. In the present contribution we focus on the role of 
proliferation control (governed by parameter Cprol). We briefly explore the effect 
of apoptotic control (governed by parameter Capop) on the cycling behaviour but 
leave a detailed investigation of this term for future research. The index in 
variable z refers to the two-compartment version described below. 
Since communication between the hair matrix and DP are key to the hair 
cycle these spatial considerations are taken into account in the model (Figure 
5.4). We start with the simplest formulation of communication between two 
compartments, which is assumed to be mediated by signalling molecules. 
Specifically, we use the following set of differential equations (eq. 4): 
 
Compartment 1: 
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Compartment 2: 
   
  
              
   
  
                         (4) 
 
It is assumed here that the MK population produces a signalling molecule 
y (at rate c1) which produces no further direct effect on the population 
dynamics. However, it diffuses away from the compartment and can thereby 
either disappear altogether (being degraded or diffuse into compartments 
where it exerts no effect either) or it can diffuse into compartment 2 (the DP) 
where it induces the production (or activation) of a regulatory molecule z at 
rate c2. This regulator, in turn, exerts no effect in the DP but can diffuse in to 
either the surroundings or into compartment 1. The diffusion process is 
modelled by incoming molecules facilitating the production of native 
intermediaries. The inclusion of   accounts for the extent to which created the 
native intermediaries are lost above the rate at which they are created. Thus 
this accounts for escape and degradation. In compartment 1, control of the 
keratinocyte population is then performed by the regulator via proliferation 
inhibition or apoptosis activation as in the model equation (4) above. The 
diffusion processes take place at two different rates (Dy and Dz) which are the 
permeation constants in the present model. They would turn into formal 
diffusion constants in a space-continuous reaction-diffusion model. For all these 
processes we use first order differential equations as used e.g. for (bio)chemical 
reactions (see Chapter 4). 
5.7.2 Addition of hair shaft growth to the model 
Hair shaft production is the most distinctive output of the HF. It can be 
considered a marker for healthy HF function and normal cycling dynamics. 
Therefore, hair shaft (h) production was added to the model via an additional 
variable. A growth rate; dh/dt= x, is assumed in accordance with the 
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relationship between the MK cell population size and hair shaft production as 
discussed in Section 5.6 (Figure 5.2). Without loss of generality, we assume  =1. 
In order to simulate the termination of hair growth during telogen (relative 
quiescence) we introduce an algorithm which “wraps” the hair length back to 
zero during this stage. This is achieved by locating the plateau as a period of 
small increase in growth and applying a threshold to the derivative of the hair 
growth variable h. During time periods below this threshold, the hair length is 
reset to zero; with hair beginning to grow again once the threshold is traversed. 
 
 
Figure 5.4: Schema of the two compartment model. 
x denotes the matrix keratinocyte population in compartment 1 (epithelial hair follicle). Processes 
affecting the size of x are a constant input a (stem cell input), a proliferation process, an apoptotic 
process and a constant linear output denoting the differentiation of matrix keratinocytes into the 
other cell types i.e. layers of the inner root sheath and hair shaft. Bidirectional communication 
between compartment 1 and 2 is set up by the production of variable y that diffuses into 
compartment 2 causing the production of z. z diffuses back into compartment 1 where it affects the 
proliferation and apoptotic processes for x 
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5.7.3 The unperturbed model  
In this section we analyse the model eq. (4) in terms of its key nonlinear 
components, the power k in the apoptotic term and the influence of feedback in 
the proliferation term. Using the hair growth variable h as output, we then 
demonstrate the capability of the model to reproduce key features of the human 
hair cycle. Since we are ultimately interested in applying the model to hair 
pathology and its treatment, we also investigate some features of abnormal 
(non-oscillatory) dynamical behaviour. In the following section we report some 
results on the model’s response to external stimuli. 
5.7.4 Steady State for Cprol=0 and k=1 
Figure 5.5 shows bifurcation diagrams scanning one of the system parameters, 
namely, the growth rate p1, for different values of Cprol and k. All other 
parameters are fixed to the values displayed in Table 5.2. The simplest case is 
Cprol=0 and k=1, i.e. there is no feedback loop in the model and the apoptotic rate 
is modelled as a hyperbolic function just as the proliferation rate. This reduces 
the model to a one-dimensional system that can only have steady state 
solutions. Figure 5.5a shows the corresponding bifurcation diagram. For the 
values of p1 displayed there is only fixed point behavior. At p1≈0.04 there is a 
transcritical bifurcation leading to an abrupt change of slope in the otherwise 
linear dependence of the steady state value on p1. Such a behavior predicts that 
the dependence of an observed temporally stable keratinocyte population 
shows different rates of change as a function of the population growth rate. It 
cannot, however, account for autonomous cycling of the population. Nor does it 
allow for an interpretation of discrete growth states (anagen and telogen). 
 
5.7.5 Hopf oscillations for Cprol=1 and k=1. 
When Cprol=1, the keratinocyte population is additionally influenced by the 
regulatory factor z, implying that the model is now composed of 5 dependent 
variables. Therefore we noe have acontrol loop that results in feedback 
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inhibition because an increase in the concentration of z reasults in a decrease of 
the growth rate of the keratinocyte population. Feedback inhibition is 
implemented in our model via a two-species mechanism involving 
communication between the two compartments (Figure 5.4). 
 
 
Figure 5.5: Bifurcation diagrams  
Each subgraph demonstrates the bifurcations at different values of k and Cprol. In subgraph (a) k=1, 
Cprol = 0, in (b)  k=1, Cprol = 1. (c) demonstrates the results when k=2 and Cprol = 0. In (d) k=2, Cprol = 
1,  These graphs demonstrate that the human hair cycle requires feedback inhibition in order to 
produce cycling behaviour Cprol=1, in addition, bistability when k=2 as shown in subgraph (d) this 
leads to inhibition of apoptotic process when x is large (feed-forward inhibition) and results in the 
asymmetrical waveform and low frequency oscillations exhibited in the human hair cycle 
 
 
Such feedback is necessary and in our case sufficient to produce cyclical 
behaviour (Figure 5.5). The oscillatory behavior is seen for a wide range of 
parameter p1. Its amplitude depends strongly and nonlinearly on the value 
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chosen and shrinks to zero as either bifurcation point is approached. A time 
series of the oscillation is shown in Figure 5.5a (grey) and a phase space 
representation of the underlying limit cycle is shown in Figure 5.5b(grey).  
Mathematically, the oscillations result from a dynamical instability of a steady 
state. The specific instability in equation (4) is a supercritical Hopf bifurcation 
with the real part of a pair of complex eigenvalues passing from negative to 
positive. This happens twice and therefore the oscillatory region is bounded by 
stable fixed point behaviour. All mathematical terms relating to this feedback 
loop are linear with the exception of the control of the MK population by species 
z, originating in the DP. Therefore, the nonlinearity that causes self-organising 
instabilities in our model, resides in the equation for the keratinocyte 
population.  
This form of the equation with Cprol =1 and k=0 is therefore a variant of 
the kinetic feedback inhibition oscillator proposed by Goodwin (1963). Here, 
the delay in the feedback to the keratinocyte population is in part due to 
transport processes that mediate the feedback. A fast oscillating keratinocyte 
population is produced by these conditions and thus, feedback is demonstrated 
to be important to gain cyclical behaviour in the human hair cycle according to 
this model.  
5.7.6 Bistability for Cprol=0 and k=2 
If instead of switching on the feedback control (as described above) forward 
inhibition of the apoptotic process by the keratinocyte population is included 
(i.e. k=2) the dynamics of the keratinocyte population remains independent of 
other processes but shows a new type of dynamical phenomenon. Figure5.5c 
shows that this situation generates a region of bistability (compare with 
Figure5.5a). Two fixed point solutions (represented by black lines) can be 
observed for a finite range of parameter p1.  
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Figure 5.6: Hair cycle model time series and phase space  
(a) Time series of the hair cycle model, the output of the model simulates the characteristic 
dynamic behaviour of the hair matrix keratinocytes during the hair cycle (black line) where k=2. 
The output is contrasted with the case when k=1 (grey line). (b) The relationship between the level 
of matrix keratinocytes and z1. The large phase space is contrasted with the small trajectory when 
k=1 (grey). 
 
This is due to the appearance of three (real) steady state solutions in the fixed 
point equation for x (dx/dt=0). In such a situation, when parameter p1 is varied 
across the borders of the region of bistability, the system can be induced to 
change from one steady state to the other (e.g. switching from a near-zero to 
large value when p1 is increased above a value of 0.09 (see Figure 5.5c). We 
therefore explore a bistable switch as a possible mechanism for HF dynamics. 
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The lower steady state would represent “telogen” and the upper steady state 
“anagen”. In our model one possible realisation of switching would be that 
random fluctuations of the keratinocyte population result in (self-organised) 
switching between the states. Mathematically, the two stable states are 
separated by an unstable state which corresponds to a critical population size 
that lies between the no growth and the growth state (Figure 5.5c). This critical 
population size presents a decision point. If a random fluctuation of a 
population in the no growth state exceeds the critical size, the population will 
continue to grow until it reaches the growth state and then remain there. 
Switching back happens when a random fluctuation of the population in the 
growth state reaches a value that lies below the critical state. The population 
will then keep shrinking until it falls to the “no growth” state. In contrast, if a 
perturbation leads to a change close to the critical size but not quite reaching it, 
the population reverts to the original state.  
Adding a noise term to the model equation (4) with k=2 and Cprol 
=Capop=0, the amplitude of the noise can be adjusted such that it leads to random 
variation about a given steady state. When preparing the model in the bistable 
region near the critical parameter value where the no growth state disappears 
(p10.09), we can adjust the model in the presence of noise perturbations such 
that the mean duration in anagen is much longer than the duration in telogen as 
is the case in human hair cycling. However, careful preparation of the 
parameters of the model is required to reproduce these characteristics. As in the 
case of Figure 5.5a, the exclusively steady state solutions found do not allow for 
the explanation of an organised cyclical process. 
 
5.7.7 Relaxation oscillations for Cprol=1 and k=2 
In light of the above considerations, where neither the supercritical Hopf 
oscillations nor the bistability alone may fully account for the dynamics of the 
HF, we further explore the parameters using the combination of both. Now 
there is a feedback control of the keratinocyte population by variable z and 
there is a forward inhibition by the population itself, i.e. Cprol=1 and k=2. Figure 
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5.5d shows the corresponding bifurcation diagram where a region of bistability 
and a limit cycle region are indicated by a dotted bar. In this case, the forward 
inhibition again generates a region of bistability. However, compared to the 
situation with Cprol=0 (bistability of two fixed points), the bistability now is 
between a near-zero fixed point and a limit cycle (compare Figures 5.5c and d). 
The bistable region starts with a fold of limit cycles bifurcation at p10.415 and 
ends with a subcritical Hopf bifurcation at p10.51.  
The limit cycle is generated in the afore-mentioned fold of limit cycle 
bifurcation at p10.415 and vanishes with a saddle-node on limit cycle 
bifurcation at p10.56. In comparison with the situation in Figure 5.5b (no 
forward inhibition) the oscillations now start and vanish abruptly, i.e. with finite 
amplitude at the bifurcation point. The variation of amplitude In this region is 
much smaller than in the situation with k=1. Further differences between the 
dynamics of the limit cycles in the cases of Figure 5.5b and 5.5d are shown in 
Figure 5.6 where time series (Figure 5.6a) and phase space portraits (Figure 
5.6b) are plotted for k=1 and k=2. The Hopf cycle (k=1) has a small amplitude, 
high frequency, and a comparatively harmonic waveform. The cycle with k=2, in 
contrast, has a large amplitude, low frequency, and strongly asymmetric 
waveform. Notable generic features of this latter, non-harmonic limit cycle are: 
i) Two plateau-like phases where the change of state is comparatively 
slow. One is near zero and the other has an amplitude between 4 and 
6.8 approximately. Both phases can be related to the two respective 
fixed points in the bistable situation with Cprol=0 and k=2 as shown in 
Figure 5.5c.  
ii) Comparatively fast transitions between the two plateau-like states. 
iii) Notably, the durations of the two plateau-like states differ strongly 
with a long upper state and a short lower state being a consistent 
finding in the present model.  
Taken together, features i) and ii) define a type of dynamics classified as 
relaxation oscillations. The notable properties above directly relate to the 
dynamics of the HF (Figure 5.1 – matrix keratinocytes). The long upper steady 
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state is interpreted as anagen, the short lower state telogen and the rapid 
transition from growth to rest; catagen. Asymmetry in phase durations in each 
stage is representative of the durations of anagen (long), catagen (very rapid) 
and telogen (intermediate, but relatively short compared to anagen). The strong 
asymmetry in the cycle is explained by the vicinity of a saddle-node on limit 
cycle bifurcation which causes slowing down of the anagen phase but not of 
telogen. Therefore, the dynamics of the HF model requires both bistability and 
feedback inhibition, as achieved here with k=2 and Cprol=1 to approximate the 
key features of the HF cycle. 
In this version of the hair cycle model; the oscillatory time series of the other 
variables (y and z) produce, in comparison, a qualitatively similar waveform to 
the one described for the keratinocyte population. However, at a shorter time 
scale there are significant phase shifts between oscillations in the two 
compartments and between the oscillations of the keratinocyte population and 
the concentration of the feedback species z1. 
So far, we have only considered feedback on the apoptotic term in eq. (4). If 
the feedback loop to the keratinocyte population is instead closed in the 
apoptotic component, this results in a similar overall result to the above 
formulation. Model simulations with a parameter setting of Cprol=0 and Capop=1 
equally produce relaxation oscillations with an asymmetric waveform and 
distinct growth and resting phases Figure 5.7. The phase space structure is not 
identical but qualitatively similar, the only significant difference being the large 
amplitude in the present case (compare Figure 5.6 and 5.7). The differences are 
due to the asymmetry of the proliferation and apoptosis terms with k=2. Model 
settings with both feedback controls switched on (e.g. Cprol=, Capop=1) also 
produces large amplitude low frequency relaxation oscillations.  
For simplicity, we only explore feedback on the proliferation term (Cprol=1, 
Capop=0) in all studies below. A detailed exploration of apoptotic control is left 
for an extended version of the model including greater details of the 
communication channels between the DP and the keratinocyte compartment. 
 We finally consider hair production in the model in relation to the state 
of the matrix keratinocyte population. The near zero-state of the population 
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defines a no growth phase and the upper state defines a period of strong 
growth. As a passive output of the oscillatory model in Figure 5.8 hair shaft 
growth has a saw tooth-like waveform interrupted by brief “no growth” periods 
(shown in Figure 5.8, middle and right bottom panel). We verified the 
experimental growth pattern of isolated human HFs (total number of HFs = 
347) in organ culture from 18 patients. The growth pattern fits the model 
output, showing an almost linear Figure 5.2.  Human HF organ culture has been 
shown to grow at approximately the same rate as that in vivo (Kwon et al., 2006, 
Philpott et al., 1990) and therefore the reproduction of this supports the model 
as an approximation of the hair cycle and hair growth. 
 
Figure 5.7: Alternative mechanism for the hair cycle where Cprol=0 and Capop=1.  
(a) Time series showing the model output when k=2 (thinker black line) in contrast to the Hopf 
oscillations with no Bistability (thin grey line). The frequency is faster when compared to the other 
mechanism. (b) The relationship between the level of matrix keratinocytes and z1. The large phase 
space is contrasted with the small trajectory when k=1 (grey). 
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Table 5.2: Default parameter values used in the hair cycle model. Alterations to the 
parameter values in the study are listed in the figure legends or in the text in the 
relevant sections.  
Parameter Value Parameter Value 
a 0.1 Cprol 1 
b 0.01 Capop 0 
p1 0.48 C1 1 
p2 0.1 C2 1 
p3 0.1 Dy 0.5 
p4 0.5 Dz 0.1 
p5 0.1   1 
 1, 2,  3 , 4 2   
 
5.8 PERTURBATIONS OF THE HAIR CYCLE 
We now take the oscillatory model output presented in Section 5.7 as 
representing healthy hair cycle dynamics and study its properties (as well as the 
properties of the “no growth” state) under external perturbation. The 
investigation here aims to realize the impact of i) temporal variation of the 
environment; ii) external pulses applied during regular growth; and iii) pulse 
perturbations (“treatment”) under abnormal (“no growth”) conditions. 
 
5.8.1 Variation of parameters demonstrates a range of dynamics in hair 
cycling that may account for both normal hair cycling and 
pathological states 
The model predicts different hair cycling lengths depending upon the efficacies 
of the underlying mechanisms; i.e. different regions of parameter space. The HF 
does not always cycle and can be arrested in telogen for an abnormally long 
time period, e.g. in situations of advanced alopecia, and demonstrates 
transformation in size and dynamic properties depending on skin location or in 
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the context of hair pathology (Dawber, 1997). HFs are of greatly varying size 
and produce different types of hair shafts of very divergent length and width, 
depending on the body region. The model, as evident by the bifurcation diagram 
Figure 5.5d, is able to reproduce variations in the hair cycle lengths depending 
on the certain conditions in the model. In Figure 5.8 we demonstrate the output 
of the model with different values of p1 on the number of MKs and also the 
resultant hair shaft. This could potentially explain the various HF sizes and hairs 
seen in vivo and additionally the potential output of no hair growth (Figure 5.8, 
bottom left panel). 
 
 
Figure 5.8: Time series of matrix keratinocytes and hair shaft production 
Growth of hair can be widely altered depending on the parameter values in the model. Altering one 
parameter, here p1, demonstrates the “no hair growth” (no cycling, p1=0.35, left panel), small hairs 
(high frequency hair cycle, p1=0.48, middle panel) and long hairs (very low frequency cycling, 
p1=0.56, right panel). The transition of the hair follicle in alopecia via the process of 
miniaturisation may be captured in these transitions whereby the hair follicle shrinks and 
produces small, ineffective hair (e.g. p1 alters from right to left here). In severe cases of alopecia no 
visible hair is seen which may be captured by; either short hairs that do not reach the surface 
(middle panel) or a transition to the no growth situation (left panel). 
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5.8.2 Pulse perturbation results in changes in normal hair cycling and 
pathological states 
We explored the effect of a pulse perturbation in the key parameters a (stem 
cell supply), p1 (proliferation rate), and p4 (apoptosis rate). Initially the time, 
duration and amplitude of an individual pulse to each of these parameters was 
fixed. Figure 5.9 shows the result of selected perturbations to the HF oscillator 
in the standard state (monostable relaxation oscillations). In Figure 5.9a one 
sees a pulsed increase in parameter p1 during telogen that leads to a 
subsequent prolonged anagen phase (in this case approximately a 50% increase 
compared to the unperturbed phase) and consequently the production of a 
longer hair shaft.  
A similar pulse perturbation of parameter a (stem cell input) produced 
an increase in anagen phase duration (in this case about 90% increase 
compared to unperturbed phase) and hair length (Figure 5.9b). Since the 
increase in parameter a is proportionally higher than that of p1 (i.e. 90% 
increase in parameter value), the effect of this increase is larger and produces a 
much longer hair shaft.  
The administration of a pulse to parameter p4 within the resting phase 
produced a prolonged resting phase and also led to greater duration and 
amplitude of the subsequent growth phase. In contrast, when a pulse in the 
same parameter was administered during the growth (anagen) phase, anagen 
duration and the resultant hair length were shortened (Figure 5.9a). Therefore, 
a phase dependent effect is seen here. Regular maintenance of the change would 
require regular administrations of pulse perturbations or “treatment” at the 
correct phase of the hair cycle.  
5.8.3 Switching in bistability and excitability as methods to switch from 
“no hair growth” to the cycling mode  
We now explore the model’s features outside of the parameter range where the 
relaxation oscillator is the only solution. The parameters are chosen in the 
region of bistability where both relaxation oscillations and a lower “no growth” 
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steady state exist. In this setting we explore the possibility to perturb the 
system with a pulse to switch behaviour from fixed point to the oscillatory state, 
i.e. to induce oscillations without permanent change in any parameter. 
 
 
Figure 5.9: Pulse perturbation time series 
(a) Pulse in p1 commencing at time t=1995, with a maximum value of a= 1.9. (b)  Pulse in a 
commencing at time t=1995, with a maximum value of a= 1.9, denoted as a red arrow below. (c) 
and (d) Pulse perturbation of parameter p4 resulted in different effects on the hair cycle and hair 
growth. The effect was phase dependent with abrogation of anagen if pulsed during anagen (c) or 
stimulation of a longer hair cycle and hair if perturbation was timed with telogen (resting) phase 
of the cycle (d). Pulse in p4 at t=2100, with amplitude maximum value of p4=1.9. Pulse timing is 
marked by red arrow. 
 
The time series (Figure 5.10a) demonstrates a switch from the lower 
steady state into the oscillatory regime. Oscillations, and consequently hair 
growth commences as soon as the perturbation has ended. Importantly, as the 
oscillatory regime is stable, the cycling continues indefinitely in the model. We 
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test perturbations in all parameters and find parameter p1 to be the most 
sensitive in achieving the transition (i.e. inducing permanent oscillations with a 
minimum of relative change). For example, an 8.8% increase in p1 achieves the 
transition. Parameter c requires only a slightly larger change (10%) to achieve 
permanent oscillations. 
 
Figure 5.10: The hair cycle model predicts possible mechanisms for the treatment 
of hair loss.  
(a) Demonstrates how switching may be achieved from the lower steady state in the bistable 
region to the oscillatory state. One pulse in p1 achieved this result. The pulse starts at t=1000 and 
is of length=5 time points and is a step to a value of p1=0.49. (b) The pulse starts at t=1000 and is 
length=5 time points and is a step to a value of p1 =0.49. This demonstrates how apparent no hair 
cycling and thus no hair growth may be perturbed into a whole hair cycle. This is due to excitability 
demonstrated by the system currently lying outside of the bifurcation point. (c) sinusoidal pulses as 
in (b) to p1, i.e. regular administered therapy, in this case achieves repeated cycling behaviour. 
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The fact that the lower fixed point loses stability in a subcritical Hopf 
bifurcation implies that it might be excitable in the monostable state (Figure 
5.5d, p1<0.415), implying that a short pulse (treatment) could start a full cycle. 
The monostable state would be interpreted as a non-cycling hair (such as occurs 
in severe alopecia). To test this we apply a pulse perturbation in parameter p1 
to the system prepared in the no growth steady state outside of the bistable 
region. When the pulse is below a threshold, the effect of the stimulation is 
negligible and leads to a trivial damped oscillatory return to the no growth 
state. As such the perturbation can be considered ineffective. If, however, the 
pulse is suprathreshold as in Figure 5.10b the model produces a large amplitude 
excursion of nearly the amplitude and rather similar in period to the oscillatory 
solution (compare with Figure 5.10a). The duration of the pulse was 5 time 
points, however longer pulses also produce a longer cycle. Therefore, the MK 
population is in an excitable condition and a comparatively moderate stimulus 
can induce one full cycle of the HF oscillation. After the one cycle the system 
returns to the no growth fixed point and remains there, as it is the only stable 
solution. To maintain cyclical regeneration of hair growth, one must repeat the 
pulse once the MK population returns to the resting state. This is shown in 
Figure 5.10c, where a regular pulse of appropriate frequency into the 
monostable no growth system (with p1=0.3) induces “regular” cyclical 
behaviour. This uses the property that an excitable system performs the full 
cycle once induced by a suprathreshold stimulus. The period of this induced 
cyclical behaviour is less than the period in the autonomous cycling, mainly 
because the system is allowed to settle to the resting state before it is perturbed 
again. Comparing Figure 5.10b and 5.10c it can be noted that the amplitude of 
the periodically pulsed system is even slightly bigger than the amplitude of the 
cycle in the single stimulus simulation Figure 5.10b. If induced regular cycling 
with full hair growth is desired, the period of the stimuli cannot be decreased 
above a certain minimum length as a stimulus during the cycle or at the 
beginning of the resting phase, when the system is refractory, does not lead to a 
full new cycle. A smaller period than the one chosen in Figure 5.10c leads to 
irregular hair growth with hairs of different length and decreased average hair 
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length. Also phenomena like “missed beats” and induction of a full cycle for 
every second stimulus are observed in these cases. 
5.9 DISCUSSION 
The human HF exhibits a unique chronobiological rhythm known as the hair 
cycle. The molecular or cellular “control” mechanism(s) responsible for this 
regenerative process has not been identified. In this study, we reviewed 
essential dynamical features of the hair cycle and presented a prototypic 
mathematical model to advance a theory of the human hair cycle.  
The ODE model was constructed from features regarding HF dynamics 
and interactions derived from the literature and incorporated into the model on 
the cell population level while specific molecular processes were not included. 
However, the two compartment model opens the exploration of how human HF 
dynamics may arise from control processes governing the spatial scale of multi-
cellular MK population as a whole. 
An important finding in our study is that neither feedback inhibition nor 
the presence of bistability alone is sufficient to explain the full dynamics of the 
HF. However, both have been postulated as mechanisms for the hair cycle. 
Concerning delayed feedback inhibition Chase proposed that the hair cycle is 
based on an intrinsic inhibition-disinhibition switch (Chase, 1954) and, since 
then, several theories verbally described the oscillatory nature of the HF as a 
result of delayed feedback inhibition, although none have led to a mathematical 
formalisation so far (Paus and Foitzik, 2004, Paus et al., 1999a, Stenn et al., 
1999). We show that feedback inhibition indeed allows the production of 
oscillations in MK numbers and the oscillatory production of hair shafts. In our 
case part of the delay in feedback arises from transport processes between the 
two compartments rather than biochemical reactions. This produces 
oscillations that are described mathematically as the result of a supercritical 
Hopf bifurcation. Although the frequency of oscillations could be regulated to 
better fit the low frequency oscillations in the hair cycle via modulation of 
parameters in the feedback loop; we cannot assume the molecular processes 
(like synthesis and diffusion) to be much slower than population growth and 
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decay constants. Therefore, the resultant frequency of oscillations remains on a 
comparatively fast time scale in the absence of bistability (k=1). Importantly, it 
is unrealistic that feedback inhibition alone may account for the characteristic 
profile of the biological process as specified Figure 5.1. The reason for this is 
that a fast oscillating keratinocyte population would not clearly distinguish 
between durations of anagen, catagen and telogen phases in terms of periodicity 
as seen in vivo and therefore does not explain the asymmetric low frequency 
hair cycle profiles observed in human hair cycling. 
It is known that a simple linear sequence of biochemical reactions can 
explicitly produce time delays (see e.g. (Mocek et al., 2005)). The impact of 
negative feedback modelled by a chain of linear (first-order) reaction terms on 
the systems dynamics is well-studied, for instance in the Goodwin model 
(Goodwin, 1963). As the delay mechanism in our model is also described by 
linear terms, the feedback control (for example of the proliferation) can be 
expected to have similar impact on the population dynamics. As such the 
appearance of oscillatory solutions is not unexpected. However, the assumption 
of a feedback mechanism that involves diffusion between two spatially distinct 
compartments is a novel mechanism to realize the delay. It depends crucially on 
the communication between spatially separated compartments. 
The presence of a dynamical bistability to explain the two main dynamic 
“states” (anagen and telogen) of the HF was recently postulated but no 
mathematical model was provided (Bernard, 2010). The switching between the 
two states was proposed to be driven by random fluctuations. If we consider 
bistability alone as a possible mechanism for the hair cycle then this would 
imply that there is no continuous (monotonous) evolution towards the 
switching point. In reality, however, catagen HFs cannot transform back into e.g. 
anagen once they have started to enter catagen; instead, they have to run 
through telogen in order to re-enter anagen, since this “quiescent” state and its 
reorganisation of HF architecture appear to be important e.g. for proper 
reactivation of HF epithelial stem cells in the bulge and secondary hair germ as a 
prerequisite for anagen development. The in vivo situation is that different sub-
phases of the hair cycle are defined, but with continuous evolution of 
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morphological features (Kloepper et al., 2009, Müller-Röver et al., 2001). 
Therefore, if the mechanism of the hair cycle were to operate only via 
bistability, the ability to produce the wide range of dynamics typically seen in 
the HF would be impossible to achieve. 
Following these considerations, our theory of the hair cycle therefore 
requires both bistability and feedback inhibition to produce key dynamical 
features of the human HCC. When both bistability and inhibitory feedback are 
present, a cyclical switching occurs between a state of large population with 
strong growth (anagen), and a subsequent state of near-zero population with no 
growth (telogen). Anagen is explained as a period in which the proliferation rate 
and the apoptotic rate change continuously but at two time scales. One in which 
proliferation dominates over apoptosis such that the population level rises and 
one in which apoptosis dominates over proliferation and the population level 
falls. The slow decrease of the population during anagen is due to slow 
accumulation of the inhibitory feedback species. It continues until a threshold is 
reached and apoptotic processes take over so the decrease accelerates leading 
to catagen. The rapid decrease of the keratinocyte population results in 
abrogation of hair growth and shedding of the hair. The resting period (telogen) 
then maintains the near-zero population while the impact of the inhibitory 
species slowly decreases until a second threshold is reached and a new cycle 
starts leading to the creation and growth of a new hair. Thus, the crucial 
prerequisite for the switching mechanism is the combination of a bistability 
between a state of rapid growth and a no growth state with a cyclical process. 
Autonomous cycling between two pseudo-steady states yields the observed 
switching. The accumulation of inhibitory signals during anagen is described by 
Chase and it has been demonstrated experimentally that inhibitory signals are 
present during telogen in mouse skin (Paus et al., 1990). 
The model relies on several assumptions. Firstly, we assume that the 
behaviour of interest resides at the level of groups of cells; i.e. in the cyclical 
regeneration of the HF tissue sub-structures during the hair cycle and in the 
observation of hair growth. Thus, macroscopic cell population considerations 
form the basis of our theoretical treatment of the HF cycle. Indeed, important 
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processes will be involved at multiple scales and, in particular, molecular 
interactions that are often the subject of experimental investigations into the 
hair cycle will be described on the microscopic scale and here in the model 
presented we consider the high level of processes that may govern the whole 
cells and population of cells. This is in line with a current model of interacting 
populations of HF stem cells in mice (Plikus et al., 2011) and also with the initial 
dynamical hypothesis of Chase 1954 (Chase, 1954).  
Secondly, our population level approach focuses on the cells arising from 
epithelial stem cells that embody the dynamic changes in HF structure and are 
directly responsible for hair growth during the hair cycle, namely the MKs. 
Therefore, we assume that if we understand the controls governing the cyclical 
regeneration and regression of the MKs then we can understand the hair cycle 
mechanism. The MK population, at numbers close to zero, is likely to capture the 
stem cell progenitor population that derive from stem cells and become MKs. 
For simplicity and to emphasize key dynamic components, we did not explicitly 
differentiate between these cell types. Similarly, we assumed a simplified 
constant input of stem cells to the keratinocyte population. Biologically, the 
system is more complicated and we envisage future models to encompass 
processes on a multi-scale level. Despite the simplifications here, we have 
managed to account for a great amount of hair cycling or HF dynamic 
phenomena.  
Thirdly, we assume the process of the human hair cycle is autonomous. 
This is supported experimentally as described in the introduction and methods, 
but also by the experimental and modelling work performed by Plikus et al who 
predict the human HF to rely heavily on intrinsic processes in order to cycle 
(Plikus et al., 2011). 
In the model, we are able to observe the strong asymmetry between 
stage lengths in the human hair cycle caused by the vicinity of a saddle-node on 
limit cycle bifurcation that leads to slowing down of the anagen phase but not of 
telogen. The model thus offers an explanation for the unique periodicity of each 
phase of the hair cycle whereby human scalp hair can grow for some years 
before it sheds while telogen is typically of the order of a few months. The 
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previous postulated theories of hair cycling do not address how this salient 
feature may arise.  
Despite the abstraction of the hair biology involved; the model is able to 
capture the wide variation in dynamics exhibited by the HF and successfully 
addresses a large proportion of features that are thought essential to a 
successful theory of the hair cycle (Paus and Foitzik, 2004). The model produces 
unique asymmetric phases of the hair cycle, and a hair shaft output, as an 
autonomous process and additionally accounts for varied hair cycle lengths 
which is dependent on parameter values and even the provides some 
predictions of how hair disorders such as miniaturization of the HF and severe 
cases of “no growth” behaviour may arise. We show that the hair cycle and 
resultant hair may be different lengths by altering parameter values. These 
parameter differences may reflect the intrinsic properties of HFs located in 
different body regions or between individuals. This leads to the hypothesis that 
the intrinsic properties in HFs from one body region to the next (represented by 
variation in parameters such as p1) are the cause of the different hair lengths 
seen in vivo, for example between eyebrow and scalp hairs. Within the present 
framework, cycle to cycle variation can be accounted for by random fluctuations 
in model parameters.  
Great changes in hair cycle duration and hair growth were demonstrated 
to occur from one cycle to the next (Tobin et al., 2003) and this can be 
interpreted as variations of the period (and amplitude) of an autonomous 
cycling process due to environmental perturbations. In addition, we briefly 
studied how fluctuations in the lengths of anagen, catagen and telogen from one 
cycle to the next can be achieved by introducing random fluctuations in the 
input (supply from stem cells (a)) to the MKs and in the strength of activation of 
growth of these cells (p1) (Supplemental Figures 5.11 and 5.12). Random 
fluctuations in stem cells and p1 together seem to be important factors in the 
model, but for a future sensitivity analysis (to determine the processes that 
contribute strongest to the variability), estimates of the degree of fluctuations in 
each parameter are required. This gives a new account of the data presented in 
relation to the follicular automaton model, which suggests that the hair cycle is 
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a stochastic switching process assuming two underlying stable states but not an 
autonomous cycling process (Halloy et al., 2000, Halloy et al., 2002).  
As hair disorders are the result of a pathological alteration in normal hair 
cycle dynamics, the model allows us to capture not only normal variation in hair 
cycling behaviour, but also that of hair pathologies. The most common of these 
is androgenetic alopecia (pattern baldness) which is characterized by the 
miniaturization of the HF, shortening of the hair cycle and diminution of visible 
hair. This model provides several predictions to explain how these changes may 
arise. The opposite transition occurs in hirsutism whereby there is an increase 
in hair cycle length and hair size. For example, timed perturbation (e.g. increase 
in p1) of a short cycling HF can produce a longer hair cycle (Figure 5.10a) and 
the opposite is a possible mechanism for the terminal to vellus transition seen 
in pattern baldness (i.e. decrease in parameter such as p1). The results of these 
perturbations are occasionally non-intuitive but can be explained from the 
bifurcation and phase space structure of the model.  
The model predicts, firstly, in the bistable situation where the no growth 
state coexists with the periodic hair cycling there are possibilities of inducing 
regular cycling from the no growth state by applying a single, comparatively 
brief stimulus. Similarly, a single comparatively brief stimulus would be 
sufficient to switch the process from cyclical growth to no growth. In either case 
the minimum strength of the perturbation to achieve the transition depends on 
the critical population size as defined by the separating manifold (see Chapter 
4).  
This result would for instance predict the possibility that a normally 
cycling HF could switch to a “permanently” non-cycling follicle due to an 
accidental environmental stimulus if it is in this particular bistable state. This is 
a new hypothesis to explain the transition from growth to no growth that 
occurs, for example, in severe alopecia or in chemotherapy induced alopecia. 
The model also predicts that there might be effective treatments to cure this 
problem. Secondly, for the situation where there is a single stable state of no 
growth, such as may occur in advanced androgenetic alopecia (Cotsarelis and 
Millar, 2001), the model predicts that there is a potential way to cure. We 
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predict that the HF exhibits the dynamical property of excitability. Excitability is 
a generic feature in the vicinity of subthreshold Hopf bifurcation (Chapter 4). If 
the HF is in an excitable state (near the fold of limit cycle bifurcation in Figure 
5.5d), a short pulse (treatment) could start a full cycle. Of course the success of 
this intervention depends on whether the other model assumptions are fulfilled 
including, for example, sufficient supply from the bulge stem cells. Indeed, it has 
recently been shown that androgenetic alopecia arises from the lack of 
activation of stem cells rather than a lack or depletion in stem cell number, 
therefore, the possibility that such assumption of stem cell supply may be 
fulfilled (Garza et al., 2011). In addition, it is known that in advanced alopecia 
there is a prolonged telogen phase (Cotsarelis and Millar, 2001) and it may be 
that the HF is in this region and it takes some time for the stimulus to overcome 
the threshold and thus enter a full cycle again. Lacking a detailed quantitative 
model the threshold would have to be determined empirically, however, the 
model provides first hints as to which parameter(s) might be suitable and thus 
guide us in the means to realise the perturbation.  
The notion of HF excitability being an important feature in the dynamics 
of hair cycling is also reflected in Plikus et al. but at a higher spatio-temporal 
level (Plikus et al., 2011). If the goal of treatment is to maintain a cyclical hair 
growth in a single follicle under the excitable condition, it is necessary to apply 
appropriately timed periodic stimuli. In particular, at the end of catagen after 
shedding there is a refractory period during which a brief perturbation does not 
induce a new cycle (absolute refractoriness) or induces only a short cycle of 
small amplitude implying a short hair (relative refractoriness). The notion of 
refractory telogen had been postulated many years ago and the concept recently 
supported via experimental work (Plikus et al., 2008, Plikus et al., 2011). Our 
model further develops this concept in the dynamic behaviour of the single HF. 
In the future, this modelling approach may be used to dissect the seemingly 
complex interactions and roles of factors in the hair cycle to better understand 
the hair cycle mechanism an improve our approach to treating hair cycling 
abnormalities (Cotsarelis and Millar, 2001, Al-Nuaimi et al., 2010). 
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A major limitation of the study is the use of arbitrary parameters. The 
reason for working with arbitrary parameters is that the model is a reduced 
model and it is still unknown as to the mechanism of the hair cycle. The aim of 
this study was to conceptualise the hair cycle in terms of dynamics and to 
implement a theory of the process. The level of abstraction means that there is a 
lack of experimental data at this higher level. The parameters are likely to 
therefore represent “lumped” parameters. The use of multi-scale modelling 
would allow experimental data at the molecular level to marry with this higher 
tissue level processes that encapsulate the hair cycle. Now that we know some 
macroscopic properties of the system, we are able to build upon a directed 
experimental approach.  Biologically, an essential component in the hair cycle is 
the spatial interaction between compartments; in particular, bidirectional 
communication between the keratinocyte population and the DP. We 
implemented a two-compartment model assuming two (molecular) species to 
be involved in the communication. The communication process mathematically 
represents a feedback loop via coupling of compartments. Possible biological 
candidates include molecules that are known to diffuse between the DP and the 
hair matrix such as those interacting in SHH, WNT and BMP signaling 
(Botchkarev and Kishimoto, 2003). 
The autonomy of the HF is a pronounced feature in the human HF. This is 
demonstrated by the shedding of individual hairs rather than synchronised 
shedding and is a result of the population of HFs following an asynchronous 
cycle in relation to each other giving this mosaic pattern. In other mammals, 
such as mice, the HFs exhibit more synchronised cycling behaviour. This results 
in a patch of hair simultaneously growing or shedding. The mathematical model 
concerned with the coupling of HF stem cells in propagating the waves of the 
murine and rabbit hair cycles demonstrated in principle that human HFs must 
rely on their intrinsic signals rather than inter-follicular communication in 
activating each cycle. Our study greatly complements this work providing the 
missing investigation of the possible intrinsic hair cycle processes (Plikus et al., 
2011). We envisage coupling between HFs in our model may provide a model of 
murine and other mammalian hair cycling dynamics in the future. 
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The previous proposed theories of the hair cycle were verbally expressed 
and not tested mathematically. Therefore the present model is an advance from 
the important work of hair biologists (Paus et al., 1999a, Paus and Foitzik, 2004, 
Stenn et al., 1999, Chase, 1954, Sun et al., 1991). Likewise, previous 
mathematical models concerned with hair growth and cycling do not address 
the intrinsic processes that drive the HF through the cycle (Plikus et al., 2011, 
Halloy et al., 2000, Halloy et al., 2002). The mathematical model by Plikus et al is 
at a higher level of interest; namely the mechanism of HF coupling in the 
propagation of hair cycle waves in mice and other mammals (Plikus et al., 
2011). Our model complements this. The finding that alopecia may arise by 
reduction in activation of stem cells is exactly the result of the uncoupled stem 
cells that is shown to produce the independent HF cycling seen in adult human 
HFs. Again, the model does not explore what the internal mechanisms may be in 
the human case (Plikus et al., 2011). 
An important direction for the future use of the model would be to 
characterise hair growth modulators better and within this dynamical systems 
framework. For example growth factors that are considered to induce growth 
and proliferation (because they prolong anagen) may in reality act as inhibitors. 
As shown here an inhibitory effect in our model is predicted to be required at 
some level to maintain the long growth phase. This may explain why 
experiments may produce conflicting results depending on their outcome 
measurements and timing of interventions as the model also predicts that the 
phase of intervention is important in the result of certain perturbations. 
The hair cycle is a complex process involving multi-scale co-ordination of 
events. Mathematical modelling may play an essential role in dissecting the 
intricacies of the system (Al-Nuaimi et al., 2010). Here, our dynamical systems 
construction of the human hair cycle leads to a novel theory that the HF 
dynamics requires two key dynamical features; feedback inhibition and a 
bistable switch. The study represents a new approach to deciphering the core 
components driving the hair cycle and is a first attempt at mathematically 
modelling the dynamics of the HF. In addition, we predict that hair disorders 
may be treatable due to the HF exhibiting important dynamical features of 
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bistability and excitability. We envisage that this important step will be further 
developed and refined in future work. This will pave the way to exploring this 
complex system with the aim to understand and predict the systems properties 
of the HF. The model may be used to establish the key processes that produce 
the behaviour of interest in order to move towards understanding and 
eventually finding medical targets.   
5.10 CONCLUSION 
In this study, we use mathematical modelling to construct a theory of how the 
human hair cycle, a dynamic regenerative process, may be controlled. Previous 
proposed theories of the control mechanism of the hair cycle have been verbally 
expressed and not tested mathematically. Using this original, population based 
approach; we conclude that the human hair cycle may be explained by an 
autonomous relaxation oscillator whereby communication between matrix 
keratinocytes and the dermal papilla are essential to the process.   
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Supplemental figures 
 
Figure 5.11: Time course of keratinocyte population and hair growth under 
random fluctuations in parameters a and p1 
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Figure 5.12: Random fluctuations in a and p1 
 Anagen, catagen and telogen durations vary from one cycle to the next. This is achieved by 
introducing random fluctuations in parameters a and p1. Durations of each phase of the hair cycle 
were calculated by measuring the length of time each stage (anagen, catagen or telogen) lasted 
using the time series output of 16 consecutive hair cycles (i.e. such as in Figure 5.11). The graphs 
were then plotted for each cycle stage to show the variation achieved as the follicle proceeded 
through from one cycle to the next. 
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6 CHAPTER 6: RESEARCH METHODOLOGY 
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This chapter details the experimental protocols used in the project. The various 
methods are explained in turn. Where experiments are performed to generate 
data, the details of methodologies implemented are further detailed in the 
methods section of the corresponding chapter; this in-keeping with the 
manuscript style of these chapters.  
6.1 HUMAN TISSUE SAMPLE COLLECTION 
 
Human tissue was obtained from two sources following informed consent: 
1) Redundant human fronto-temporal and occipital scalp skin from females 
undergoing facelift surgery (the University of Luebeck, Faculty of 
Medicine, Germany Ethics Committee approved protocol 06-109.).  
2) Redundant human follicular units harvested from the occipital scalp of 
males undergoing hair transplantation surgery (the University of 
Manchester, Research Ethics Committee approved reference 
09/H1010/10) 
Tissue was placed in a universal container in “isolation media”; William’s E 
media (Sigma, Gillingham, UK) supplemented with 100 IU/ml penicillin and 
10µg/ml streptomycin (Gibco, Germany, Karlsruhe) and transported to the 
laboratory at 4°C. 
 
6.2 PROCESSING TISSUE 
Once in the laboratory, the tissue was processed as quickly as possible. For 
whole skin analysis, such as immunofluorescence and immunohistochemistry, 
whole skin was dissected into small blocks of approximate dimensions 1cm x 
0.5cm under the dissection microscope using a scalpel (Figures 6.1a and b). The 
skin was orientated (Figure 6.1c) and embedded in Shandon Cryomatrix 
(Pittsburgh, PA, USA). This was snap-frozen in liquid nitrogen and samples were 
stored at -80ºC until cryosectioned.   
Individual HFs were isolated from both whole skin and follicular units by 
micro-dissection as described below. Isolated HFs were either maintained in 
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culture (HF culture Section 6.4) or immediately embedded in Shandon 
Cryomatrix, snap frozen in liquid nitrogen and stored at -80ºC until used for 
further analyses. 
 
6.3 HAIR FOLLICLE MICRODISSECTION 
Human HFs were isolated for further study by the technique of HF 
microdissection. This is an established technique previously described (Philpott 
et al., 1990, Sanders et al., 1994). Briefly, this was carried out using aseptic 
technique under the dissection microscope (Figure 6.1): 
1) Tissue was orientated and amputated at the level of the dermis-subcutis 
junction using a scalpel (Figure 6.1d); 
2) The HFs were isolated by gently prising the HF out of surrounding tissue 
using tweezers(Figure 6.1f); 
3) HFs were assessed under a light microscope to ensure they had not been 
damaged during isolation and that, macroscopically, they appeared to be 
in anagen stage (Figure 6.1g) 
 
6.4 HAIR FOLLICLE ORGAN CULTURE 
Isolated anagen VI HFs were maintained in a 24-well plate; each well containing 
500µl serum-free Williams’ E medium (Sigma) supplemented with 2mmol/L L-
glutamine (Invitrogen, Paisley, UK), 10ng/ml hydrocortisone (Sigma), 10µg/ml 
insulin (Sigma) and 1% antibiotic/antimycotic mixture (100x, Gibco, Paisley, 
UK). Culture medium and supplement recipe follows that set up by Philpott et al 
(Philpott et al., 1990, Philpott, 1999, Philpott et al., 1994a). HFs were placed in 
an incubator at 37°C with 5% CO2 level. Supplemented media was changed 
every two days.  
This assay was employed as hair growth in culture has been shown to 
correlate with in vivo growth rates (Kwon et al., 2006) and it is considered the 
best available assay for studying human HFs at present (Rogers and Hynd, 
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2001). Elongation of hair shafts was measured using a Nikon binocular inverted 
microscope as previously described (Philpott et al., 1990).  
 
 
 
Figure 6.1: Microdissection of anagen VI hair follicles from adult human scalp skin.  
Fresh human scalp skin was obtained. In this figure (a) shows frontotemporal scalp skin from a 
female patient (b) Hair shafts now cut and small sections cut using a scalpel under the 
microdissecting microscope. (c) skin section orientated ready for either embedding or for 
amputation at the junction of the dermis and subcutis (d). (d) shows the plane at which the skin is 
amputated (at the dermis, subcutis junction). (e) The sample, is then orientated with the hair 
follicles facing upwards. (f) Using forceps, individual hair follicles are dissected out of the 
surrounding skin and placed in supplemented William’s E media (g). (g) Whole hair follicles are 
assessed under the microscope to ensure they are healthy, intact Anagen VI hair follicles (as shown 
in g). Figure courtesy of R. Paus. 
6.5 ANAGEN AND CATAGEN STAGING OF ISOLATED HUMAN HAIR 
FOLLICLES IN ORGAN CULTURE 
In order to investigate changes in expression of candidate genes and proteins in 
accordance with the hair cycle, HF organ culture experiments were performed 
whereby HFs were maintained in culture and assessed daily using light 
microscopy to determine whether they appeared, macroscopically, to be in 
anagen or early, mid and late catagen phases (Figure 6.2). The macroscopic 
characteristics of organ-cultured whole HFs were assessed under the dissection 
 143 
 
microscope. Epithelial, mesenchymal and pigmentary characteristics of the HF 
were used to stage HFs.  
 
 
Figure 6.2: Macroscopic appearance of isolated whole human hair follicles in 
different hair cycle stages.  
Hair follicles in organ culture. Images taken using bright field microscope magnification x200. 
 
Anagen HFs were characterised by having maximal melanin content, an 
onion-shaped DP and large hair matrix volume. Early catagen HFs exhibited a 
thinner, stretched hair matrix, reduced melanin content and an oval shaped DP. 
Mid-catagen HFs were identified by a smaller, round DP, further decreased hair 
matrix volume, a pincer-like appearance of the proximal hair matrix and further 
reduced melanin content. Late catagen HFs can be categorised as they often 
exhibit a club hair, no melanin in the bulb region, a very small round DP and thin 
hair matrix. HFs were then placed into anagen, early catagen, mid-catagen and 
late catagen groups according to these features (Figure 6.2).  
Samples of whole human HFs were taken by two methods; 1) once HFs 
were seen to have entered the correct stage, HFs were immediately embedded 
in Shandon Cryomatrix and snap frozen in liquid nitrogen or snap frozen for 
qPCR analyses 2) HFs were staged and once equal amounts of HFs were 
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identified in either anagen or catagen, then the sample was taken on the same 
day and embedded or frozen whole as described above. 
Microscopic staging of anagen, early, mid and late catagen HFs was 
performed using the same morphological features as already described above 
for the macroscopic criteria i.e. shape of the DP and hair matrix volume (this is 
demonstrated in Figure 6.3). Microscopic staging allows for easier staging of 
each HF as the anatomy is more readily visible. Therefore, staging relied on 
morphological appearance for anagen, early, mid and late catagen stages rather 
than on counting number of proliferative and apoptotic cells. However, cell 
numbers and number of Ki-67 and TUNEL positive cells were used to 
distinguish anagen and early catagen. These criteria were published for 
objectively distinguishing between anagen and early catagen stages in human 
HFs (Kloepper et al., 2009) (Appendix B). 
 
6.6 VALIDATION STEP FOR MACROSCOPIC STAGING 
The original macroscopic stage allocated to whole human HFs in organ culture 
was compared to the final stage of anagen, early catagen, mid-catagen or late 
catagen the same HF was allocated to after cryosectioning. Figure 6.3 shows the 
correlation between macroscopic and microscopic staging when the HFs are in 
organ culture (Figure 6.3  Top panel) and when they have been cryosectioned 
(Figure 6.3 Bottom panel). 
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Figure 6.3: Macroscopic and microscopic appearances of anagen and catagen 
human hair follicles  
Top panel shows the macroscopically staged human hair follicles in organ culture. The bottom 
panel shows the corresponding stage in cryosections of human hair follicles. The morphological 
appearance of the hair follicles in each stage is assessed in order to stage the hair follicles. 
 
Figure 6.4 shows the accuracy of staging based upon the macroscopic 
appearance of whole HFs compared to the confirmed stage using microscopic 
staging methods in the same HF. The data was achieved for this accuracy test by 
staging whole HFs in organ culture from two separate patient samples. The 
staging was performed during a “catagen” culture which was performed to 
collect anagen, early, mid and late catagen HFs for analyses. The sample from 
Patient 1 sample comprised 42 HFs in total and patient 2 consisted of 45 HFs. 
The stages allocated to the HFs were documented and the HF identified by its 
location in a 24 well plate. The HFs were embedded and frozen for subsequent 
immunofluorescence or immunohistochemisty staining with the HF identifiers 
also documented. Once the cryosections were used for staining, the slides were 
blinded and photographs taken of each HF. Microscopic staging was then 
performed and the results were compared against macroscopic staging (Table 
6.1). 
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6.7 TRH CULTURE EXPERIMENT 
In order to investigate the effect of thyrotrophin hormone (TRH) on human HFs 
in organ culture (see (Gáspár et al., 2010)); anagen VI HFs were isolated from 
human scalp skin as described above. Isolated HFs were maintained in a 24-well 
plate supplemented with the following substances which were changed every 
two days: 
 5 ng/ml, 10 ng/ml and 100 ng/ml of TRH every two days 
 control was HFs maintained with no addition of TRH.  
HFs were maintained for 6 days in organ culture as previously described 
(Ackermann et al., 2007, Zanello et al., 2000). Once completed HFs were either 
frozen whole (5 ng/ml and 100 ng/ml concentrations) for qPCR analysis or 
embedded for subsequent cryosectioning and immunohistochemistry staining 
(5 ng/ml and 10 ng/ml concentrations).  
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Table 6.1: Data for accuracy of macroscopic hair cycle staging  
Stage the HF was 
finally allocated to on 
microscopic staging of 
cryosections 
Stage the same HF had been assigned to 
when in organ culture 
 
Anagen Anagen 
Early 
catagen 
Mid 
catagen 
Late 
catagen Total 
Sample 1 12 0 0 0 12 
Sample 2 8 3 0 0 11 
Total 20 3 0 0 23 
% 86.96% 13.04% 0.00% 0.00% 100.00% 
      
Early Catagen Anagen 
Early 
catagen 
Mid 
catagen 
Late 
catagen Total 
Sample 1 4 2 0 0 6 
Sample 2 0 13 0 0 13 
Total 4 15 0 0 19 
% 21.05% 78.95% 0.00% 0.00% 100.00% 
      
Mid Catagen Anagen 
Early 
catagen 
Mid 
catagen 
Late 
catagen Total 
Sample 1 0 6 6 0 12 
Sample 2 0 1 11 0 12 
Total 0 7 17 0 24 
% 0.00% 29.17% 70.83% 0.00% 100.00% 
      
Late Catagen Anagen 
Early 
catagen 
Mid 
catagen 
Late 
catagen Total 
Sample 1 0 0 0 12 12 
Sample 2 0 1 2 6 9 
Total 0 1 2 18 21 
% 0.00% 4.76% 9.52% 85.71% 100.00% 
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Figure 6.4: Results of the accuracy tests for staging whole human hair follicles 
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6.8 HAIR FOLLICLE CIRCADIAN CLOCK SYNCHRONISATION AND 24 
HOUR TIME SERIES 
Dexamethasone (Sigma Alrich D1756) powder was reconstituted in 41.25µl 
DMSO at 25°C to produce the stock solution 1mg/ml. Serial dilutions were 
performed with a resultant 100nM Dexamethasone solution.  
HFs were obtained and microdissected as described. They were 
maintained in constant conditions (5% CO2 at 37°C) in a Petri dish. HFs were 
incubated in 10mls of 100nM dexamethasone for 30 minutes to establish 
synchronisation. After 30 minutes, the media with dexamethasone was removed 
and replaced with normal HF culture media. Collection of samples for 24 hour 
time series experiments was performed allowing 4 hours following 
synchronisation prior to collection. Samples were collected for qPCR and stored 
in RNAlater® or embedded in OCT for cryosectioning for 
immunohistochemistry/ immunofluoresence analysis. 
 
6.9 IMMUNOHISTOCHEMISTRY AND IMMUNOFLUORESCENCE 
Immunohistochemistry staining protocols for localisation and quantification of 
candidate proteins in human anagen and catagen HFs was established and 
performed on either; whole human scalp skin cryosections, isolated human 
scalp HF cryosections or on both whole scalp skin and isolated HFs. The 
thickness of cryosections was 8µm in whole scalp skin and 6µm for isolated HFs. 
Sections that needed direct comparison for quantification were always 
processed at the same time to ensure that any variation in results were not due 
to variation in experimental conditions, such as temperature. Negative controls 
were performed in all experiments by omission of primary antibody. In 
addition, positive controls; i.e. the use of tissues with known expression of the 
antigen in question, and blocking peptides (as additional negative control) were 
used in all experiments where these were available.  
Non-specific binding was minimised by treating sections for 20 minutes 
with serum from the same animal that the secondary antibody had been raised 
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(all normal serums from DAKO, Denmark). Primary antibodies were incubated 
overnight at 4C. Sections were washed in either phosphate buffered saline or 
Tris-buffered saline between steps. Immunohistochemistry sections were 
mounted using Pertex and immunofluorescent slides mounted with 
Fluoromount. Images were captured using the fluorescence microscope Biozero 
8000 (Keyence; Osaka, Japan).  When intensity of staining or fluorescence was 
to be measured, the same exposure times were used for sections that were in 
the same experiment to ensure consistency. Analyses of images was performed 
using the ImageJ software (Abramoff et al., 2004). 
6.10 KI-67/TUNEL STAINING 
This established double staining protocol was performed to localise and 
quantify proliferation and apoptosis concurrently within the human HF. Ki-67 is 
a marker of proliferation and TUNEL (terminal deoxynucleotidyl transferase 
dUTP nick end labelling) an apoptosis marker. The methodology has been 
previously published and the protocol provided below. TUNEL staining was 
performed using the Apoptag Fluorescein In Situ Apoptosis Detection Kit 
(Millipore, UK). All washing steps were performed with PBS (phosphate 
buffered saline). Cryosections were dried at room temperature for 5 minutes. 
Fixation was performed in 1% paraformaldehyde (PFA) at room temperature 
for 10 minutes. Following two 5 minute washing steps, the slides were post-
fixed in ethanol-acetic acid (2:1) for 5 minutes at -20°C. Following two further 
washes, equilibration buffer (from the commercial kit) was pipetted on each 
section and incubated at room temperature for 5 minutes. Subsequently, the 
sections were incubated in 30% TdT enzyme (in 70% reaction buffer) for 60 
minutes at 37°C, followed by 10 minutes in Stop buffer (consisting of 2mls Stop 
buffer and 68mls distilled water) at 37°C. 
Following this step, pre-incubation with 10% normal goat serum in PBS 
was carried out for 20 minutes at room temperature. This was followed by 
overnight incubation with the Ki-67 primary antibody mouse anti-human Ki-67 
antigen (clone MIB-1, DAKO) at 4°C. The following day, three washes were 
performed and the fluorescent staining for TUNEL was performed using 
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fluorescent labelled anti-digoxigenin antibody (commercial kit) at a ratio of 
56µl:59µl blocking solution: antibody solution; this was incubated for 30 
minutes at room temperature. The secondary antibody for Ki-67 was then 
applied to the sections following another washing step. Goat anti-mouse 
rhodamine red (Jackson Immunoresearch) at 1:200 concentration in 2% normal 
goat serum was applied to the sections and incubated for 45 minutes at room 
temperature. The sections were counterstained with DAPI for 1 minute after a 
washing step and then the slides were washed again and mounted with 
Fluoromount® (Southern Technologies). Negative controls were performed in 
every experiment whereby the primary steps - 30% TdT enzyme and Ki-67 
antibody - were omitted at these points of the procedure.  
 
6.11 MASSON – FONTANA STAINING 
Masson Fontana stains argentaffin granules and melanin. Staining was 
performed on HF cryosections that were fixed with ethanol-acetic acid (2:1) for 
10 minutes. Post-fixation was followed by a washing step in TBS and then 
distilled water for 5 minutes at each step. The cryosections were then heated for 
1 hour at 56°C until the resultant black stain was produced. Following a 
washing step in distilled water for 5 minutes, the sections were placed in 5% 
sodium thiosulphate solution for 1 minute followed by a wash in distilled water. 
The sections were then counterstained with haematoxylin for 1 minute and then 
washed for 5 minutes under tap water. The cryosections were then dehydrated 
by placement in 70%, 96% and 100% ethanol for 2 minutes at each 
concentration.  
Masson Fontana staining was analysed by taking digital images of all 
stained sections at using the Biozero 8000 microscope (Keyence) at x20 
magnification. All images were taken at the same exposure time to ensure no 
differences in staining intensities were due to that. ImageJ software (Abramoff 
et al., 2004) was used to measure the intensity of stains in the three reference 
areas as shown in Figure 6.5. 
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Figure 6.5: Quantification of masson-fontana staining 
Images show the reference areas (three rectangular areas) drawn in ImageJ to quantify masson-
fontana staining 
 
Analysis of the measured intensity values was performed using Graphpad 
prism. Statistical analyses performed was the Student’s paired t-test with a p 
value <0.05 was taken as statistically significant.   
6.12 PERIOD1 STAINING 
PERIOD1 immunofluorescent staining protocol was established during the 
project. HF cryosections were firstly dried for 10 minutes at room temperature 
and then fixed in acetone at –20°C for 10 minutes. Following a further 10 
minutes of drying at room temperature, the sections were washed in PBS. 10% 
normal goat serum (DAKO) was used for preincubation for 20 minutes at room 
temperature and 1:200 primary antibody rabbit anti-human Per1 with 2% 
normal goat serum was then pipette onto each section and allowed to incubate 
overnight at 4°C. The following day, the secondary antibody goat anti-rabbit 
fluorochrome (Jackson Immunoresearch) was applied for 45 minutes following 
a 5 minute washing step with PBS. The sections were counter stained with DAPI 
for 1 minute and washed with PBS before being mounted with Fluoromount 
(Southern Biotechnologies). The stained sample slides were stored at -20°C. 
Positive and negative controls were performed with this protocol. Firstly, 
the use of a blocking peptide was employed. This was prepared by incubating 5 
µl blocking peptide per 1 µl of antibody in a separately prepared primary 
antibody mixture. This was incubated at room temperature for 2 hours prior to 
commencing the experiment. At the primary antibody step, several sections 
were incubated with this blocking peptide mixture rather than the primary 
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antibody, 2% serum mixture. Lastly, two positive controls were used namely 
HaCaT cells and human pineal gland as they were known to express Period1 
protein (Ackermann et al., 2007, Zanello et al., 2000).  
 
6.13 PERIOD1 IMMUNOFLUORESCENCE IN ANAGEN AND CATAGEN HAIR 
FOLLICLES 
Immunofluorescent staining for PERIOD1 protein was performed on isolated 
anagen and catagen HFs from organ culture. Human HFs were maintained in 
organ culture and HFs were embedded, frozen and cryo-sectioned. PERIOD1 
immunofluorescence was performed and cryosections staged into anagen (n=8), 
early- (n=15), mid- (n=14) and late catagen (n=9). Sections were photographed 
using the Biozero 8000 microscope (Keyence). Exposure time and all 
microscope settings were maintained at the same settings for all photographs of 
each section to ensure comparisons could be made between the stages. 
Statistical differences were tested for using Mann Whitney U test and 
corrections for multiple testing was carried out via Holm-Bonferroni.  
6.14 ANALYSES OF IMMUNOHISTOCHEMISTRY IMAGES 
Immunolocalisation and intensity analyses were carried out by taking both 
brightfield and fluorescent images of immunohistochemistry stains using 
Biozero 8000 microscope (Keyence). The immunofluorescent sections were first 
assessed to establish the optimal exposure time for analysis of the stains. This 
ensured that images taken were standardised and would allow accurate 
assessment and comparison of fluorescent intensity. Images were analysed 
using ImageJ software whereby a reference area of HFs was outlined in order to 
take into account the differences in HF area and cell numbers (Figure 6.6).  
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Figure 6.6: Reference area for PERIOD1 immunofluorescent staining analyses 
Image showing the reference area chosen for analysis of PERIOD1immunohistochemistry using 
ImageJ  (yellow outline) 
6.15 BMAL1 STAINING 
The BMAL1 immunofluorescent staining protocol was established during the 
project. All washes were performed with TBS. HF cryosections were fixed in 1% 
PFA (in PBS, pH 7.4) for 10 minutes at –20°C. A drying step (room temperature 
for 10 minutes) both proceeded and followed the fixation step.  Sections were 
washed with TBS before and after endogenous peroxidase activity was blocked 
with 3% H2O2 in TBS for 15 minutes at room temperature.  Pre-incubation with 
10% normal goat serum (DAKO) in TBS was performed for 20 minutes followed 
by application of the primary antibody; 1:40 rabbit anti-human BMAL1 (Alpha 
Diagnostics) with 2% normal goat serum overnight at 4°C. The secondary 
antibody goat anti-rabbit FITC (Jackson Immunoresearch) with 2% normal goat 
serum was pipette onto each section at a concentration of 1:200 in TBS. 
Following 45 minutes incubation time with the secondary antibody, the sections 
were washed and then counter stained with DAPI for 1 minute. The sections 
were then embedded in Fluoromount after being washed. The sections were 
stored at -20°C. The analysis of BMAL1 immunofluorescent staining was 
identical to that as described for PERIOD1 above.  
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6.16 ANTIGEN RETRIEVAL  
This protocol was used for the positive controls human pineal gland prior to the 
immunofluorescence protocols for PERIOD1 and BMAL1. Human pineal gland 
sections were only available embedded in paraffin.  
Deparaffinisation was achieved by incubating the paraffin sections in 
ethanol for 30 minutes at room temperature, followed by dipping the sections 
into successively less concentrated ethanol; 100%, 95%, 70% and 50% ethanol 
respectively. The sections were then washed in TBS or PBS (depending on 
whether the BMAL1 or PERIOD1 staining protocol was going to be used). Citrate 
buffer (0.01M) was made up at pH 6.0. The sections were heated in the 
microwave in citrate buffer for 15 minutes. At this stage sections were 
frequently checked to ensure that the buffer was not evaporating. Citrate buffer 
was topped up if so to ensure the sections remained wet. After 15 minutes, the 
sections were cooled at room temperature overnight. The sections were washed 
and then used following from the fixation steps in the protocols. 
 
6.17 SMALL INTERFERING RIBONUCLEIC ACID (SIRNA) TRANSFECTION 
OF WHOLE HUMAN HAIR FOLLICLES 
This section details the protocol established for the knock-down of genes of 
interest in microdissected human HFs using siRNA technology (SantaCruz 
Biotech). The Santa Cruz system was followed according to manufacturer’s 
instructions. 
Whole human HFs were obtained by microdissection using the described 
methodologies detailed in section 6.3. On day 0, the microdissected HFs were 
placed in supplemented William’s E medium in a 6-well plate (15 HFs per well). 
Solution A and Solution B were prepared under sterile conditions: 
Solution A:  6µl  siRNA duplex  
100µl siRNA transfection medium 
Solution B:  6µl  siRNA transfection reagent   
100µl siRNA transfection medium 
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Solution A and B were mixed gently with a pipette and incubated for 45 
minutes at room temperature. Following the incubation time, HFs were washed 
with siRNA transfection medium (2ml per well). siRNA transfection medium 
(800µl) was added to the mixed Solution A and B; 1ml was pipetted into each 
well of the 6-well plates after the transfection medium had been removed after 
washing. HFs were incubated with the mixture for 5-7 hrs at 37°C in a 5% CO2 
incubator. Following the incubation period, the transfection mixture was 
removed and HFs were incubated as normal in supplemented William’s E 
medium. 
For every siRNA transfection experiment performed, a parallel control 
group was run alongside the siRNA transfection. The HFs in the control group 
were always from the same person as those in the siRNA group so that direct 
comparisons such as hair cycle stage, mRNA and protein expression could be 
made. Therefore, half of the HFs obtained from each person were allocated to 
the siRNA knockdown group and half to the control group. The HFs in the 
control group were treated by replacing the 6µl siRNA duplex with 6µl 
scrambled oligonucleotides in Solution A. All other reagents and conditions 
were the same in the control group as the siRNA treated group.  
The siRNA and control samples were taken for qPCR and 
immunofluorescent staining to confirm knockdown of mRNA and protein after 
24 hours. HF cultures were also run for an additional 4 days as detailed in Table 
6.2.  
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Table 6.2: siRNA transfection protocol for human hair follicles 
 Day 0 Day 1 Day 2 Day 3 Day 4 
siRNA 
transfection 
group 
 
Half of the total 
number of HFs 
obtained from 
each person 
placed in this 
group 
Microdissection of 
HFs 
 
Preparation of 
Solution A and B 
 
Incubate with 
transfection 
medium 
 
After 5-7h remove 
transfection 
Medium 
 
 Incubate HFs for 
18-24h in William’s 
E medium + 
supplements  
 
Take 24 hour 
samples 
(confirmation of 
knock-down by 
qPCR and IF by 
comparing 
expression in the 
knockdown 
group with the 
control group) 
Change 
media 
 
 Collection 
of HFs; 
whole HFs 
for qPCR, 
embed for 
staining 
 
 
Control 
group 
 
Half of the total 
number of HFs 
obtained from 
each person 
placed in this 
group 
Microdissection of 
HFs 
 
Preparation of 
Solution A (with 6µl 
scrambled 
oligonucleotides 
rather than siRNA 
duplex with) and 
solution B 
 
Incubate with 
transfection 
medium 
 
After 5-7h remove 
transfection 
Medium 
 
 Incubate HFs for 
18-24h in William’s 
E medium + 
supplements  
 
Take 24 hour 
samples 
(confirmation of 
knock-down by 
qPCR and IF by 
comparing 
expression in the 
knockdown 
group with the 
control group) 
Change 
media 
 
 Collection 
of HFs; 
whole HFs 
for qPCR, 
embed for 
staining 
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6.18 QUANTITATIVE PCR METHODOLOGIES  
6.18.1 RNA extraction protocol 
Total RNA extractions from whole human HFs were carried out using the 
PureLink RNA Mini Kit (Invitrogen) and Purelink DNase treatment Kit 
(Invitrogen). The manufacturer’s instructions were followed (Invitrogen). RNA 
was extracted from whole human HF samples at the same time to ensure 
comparisons between samples were not due to variations in experimental 
conditions during RNA extraction.  
TRIzol (800μl) was added to each sample of whole HFs and the sample 
homogenised using a pestle and mortar for 30 seconds followed by an electrical 
homogeniser for 30 seconds. The lysate was incubated at room temperature for 
5 minutes. This was to allow dissociation of nucleoprotein complexes. 
Chloroform was added to each sample (160μl) and the samples were vigorously 
shaken for 15 seconds and then incubated at room temperature for 3 minutes. 
The samples were centrifuged at full speed for 15 minutes and then 400μl of the 
colourless upper phase was transferred to a fresh RNase free tube by careful 
pipetting and an equal volume of 70% ethanol was added. After mixing the 
sample with a vortex, 700μl of the sample was transferred to a spin cartridge 
and then placed in the centrifuge for 15 seconds. The flow through was 
discarded and 350μl Wash buffer I was pipette onto the spin column (which 
contains the bound RNA). After centrifuging the sample again for 15 seconds the 
flow through was discarded and the spin cartridge inserted into a new 
collection tube.  The samples were then treated with DNase at this step. To each 
spin cartridge 80μl of the DNase mix was pipette directly onto the surface of the 
spin cartridge membrane (each mix comprises 8μl DNase reaction buffer, 10μl 
DNase and 62μl RNase-free water). Following a 15 minute incubation step at 
room temperature, 350μl Wash Buffer I was added to the spin cartridge and 
then centrifuged at full speed for 15 seconds. The flow through was discarded 
and the spin cartridge inserted into a new collection tube. Wash Buffer II with 
ethanol was then pipette onto the to the spin cartridge (500μl) and the samples 
centrifuged for 15 seconds. The flow through was discarded and the wash step 
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plus the centrifuge step was repeated.  After discarding the low through, the 
spin cartridge was dried by a 1 min centrifuge step. The spin cartridge was 
inserted into a recovery tube and 30μl RNase-free water was added to the 
centre of the spin cartridge. Following incubation at room temperature for two 
minutes, the spin cartridge was centrifuged for 1 minute and the resultant RNA 
was either stored on ice when used immediately or stored at -80°C for long term 
storage.  
Traces of genomic DNA were minimised by the use of DNase treatment 
steps as described above. Total RNA purity and concentrations were established 
by analysing the UV absorbance using the Nanodrop ND-1000 (Fisher Scientific, 
Loughborough, UK). 
 
6.18.2 Reverse transcription 
Reverse transcription was carried out using the cloned AMV First Strand cDNA 
Synthesis Kit (Invitrogen, Paisley, UK) according to the manufacturer’s 
instructions. Total RNA (volume varied as explained below) was added to a 
maximum volume of 9µl in each reaction with 1 µl oligo (dT) primers, 10mM 
dNTP mix and DEPC-treated water to make up 12 µl volume. If the total volume 
of RNA was 9 µl then no DEPC-treated water was added to the reaction mix. A 
denature step was performed by incubating the RNA and primer at 65°C for 5 
minutes and placing the samples on ice. Then, the master reaction mix was 
prepared and stored on ice; a total volume of 8 µl was added to each reaction on 
ice; comprising 4 µl 5x cDNA synthesis buffer, 1µl 0.1M DTT (Dithiothreitol), 1µl 
RNase OUT™, 1µl DEPC-treated water and 1µl Cloned–AMV RT. The reaction 
tubes were transferred to a pre-heated thermal cycler and incubated. The 
following temperatures and incubation times were performed; 50°C for 50 
minutes followed by 85°C for 5 minutes. The sample was stored at -20°C until 
used for qPCR experiments.  
The volume of RNA added to the reaction mix was adjusted for each 
sample in each experiment to ensure the same concentration of RNA was loaded 
in the reverse transcription reactions for each sample set. This was to ensure 
 160 
 
that samples whose results were going to be compared by qPCR were subjected 
to the same conditions and to minimise any variation being due to different RNA 
amounts included in the reverse transcription reaction rather than true 
differences. Controls were included for each sample whereby the reverse 
transcription reaction was carried out without any reverse transcriptase. This 
was to test for any genomic DNA contamination present in the RNA samples 
during qPCR. 
 
6.18.3 Assessment of amplification reaction efficiencies (qPCR) 
To utilise the delta delta Ct method for relative quantification in the qPCR 
experiments a standard curve was produced for the housekeeping gene, 
peptidylprolyl isomerase A (PPIA), and all target genes to check the efficiencies 
of the amplification reactions for these genes. This is because in order to use the 
delta delta Ct method, the efficiencies of the PCR amplification reaction for both 
the gene of interest and normaliser (housekeeper) should be approximately 
equal to ensure validity of relative quantification. The validations performed 
here were performed to check what conditions this would be true prior to 
proceeding to the data generating experiments.  
Serial dilutions were performed on cDNA obtained from isolated human 
HFs. This sample was representative of the samples to be used in later 
experiments. Quantitative PCR was carried out using the manufacturer’s 
protocol and delta Ct values plotted against template dilutions (relative 
efficiency plots). A linear line of best fit was plotted and a slope of absolute 
value <0.1 was determined as acceptable for employing the delta delta Ct 
method. If the efficiencies of the PCR reactions are equal, the plot of ΔCt against 
input amount would produce a slope of 0. The dynamic ranges for the assays of 
interest were established by determining the concentrations of input cDNA that 
produced a slope of <0.1 in the efficiency plots (Appendix C). 
Due to this work, the dynamic ranges were established as summarised in 
(Table 6.3) and detailed in Appendix C. In light of this analysis, the highest 
concentrations of cDNA (100ng or 10ng) were used in all qPCR experiments to 
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ensure the efficiencies between the normaliser and target genes were as equal 
as possible; minimising any errors in the effect of variation in amplification 
reactions. This controlled for the variation between target and housekeeper 
gene efficiencies seen with the lower concentrations of cDNA. Therefore, when 
performing the delta delta Ct method using these selected dynamic ranges, it 
was then assumed that the reaction was 100% efficient for analyses. 
 
Table 6.3: Acceptable cDNA concentrations to achieve 100% efficiencies in qPCR 
reactions 
Gene  Acceptable dynamic range (ng) 
Per1 0.1-100 
Bmal1 0.1-100 
Clock 0.1-100 
Cry1 0.1-100 
Cry2 0.1-100 
Nr1d1 1-100 
Cdkn1a 0.001-100 
c-Myc 0.1-100 
 
6.18.4 Real time qPCR 
Real time quantitative polymerase chain reaction (qPCR) was performed using 
human TaqMan® gene expression assays (Applied Biosystems, Warrington, UK) 
(Table 16). The TaqMan® gene expression assays are detailed in Table 16. The 
StepOne Plus™ Real-Time PCR system was used (Applied Biosystems). Each 
reaction well contained 1µl 20x TaqMan® gene expression assay, 10 µl 2X 
TaqMan® fast advanced master mix, 4 µl cDNA template (equal for all samples 
in an experimental study) and 5 µl RNase-free water. 
Genomic DNA contamination was tested for in the RNA samples by 
performed qPCR on the control reverse transcription samples as well as the true 
samples. No PCR amplification product was found with these samples. No 
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template controls (NTC) were performed for every gene analysed to exclude any 
contamination of reagents used in the qPCR reactions. Samples were run in 
triplicate and performed on the same plate.   
The conditions for qPCR were as follows;  20 seconds at 95°C, followed 
by 40 cycles of (denaturation, annealing and extension) 95°C for 1 second; 60°C 
at 20 seconds respectively. Real-time quantification plots were collected and 
stored by the StepOne™ software. Relative expression was determined using the 
delta Ct and delta delta Ct methods against the housekeeper gene PPIA. Results 
were plotted and analysed using Graphpad prism and excel. Statistical analysis 
of paired or unpaired Student’s t-tests, as appropriate, were performed and 
results were considered significant if p<0.05 (95% confidence interval).  
 
6.19 MICROARRAY EXPERIMENT ON HUMAN ANAGEN AND CATAGEN 
HAIR FOLLICLES 
Redundant human scalp skin was obtained from the scalp of three patients 
(females, ages 48, 54 and 68) all undergoing facelift surgery following informed 
consent. Individual HFs were isolated by micro-dissection as described. Anagen 
VI HFs for each patient were maintained in a 24-well plate in supplemented HF 
organ culture medium. HFs were placed in an incubator at 37°C with 5% CO2 
level, maintained in culture and assessed daily using light microscopy to 
determine whether they appeared, macroscopically, to be in anagen or late 
catagen phases. The supplemented media was changed every two days. Anagen 
and late catagen samples were taken for microarray analysis to determine gene 
expression pattern differences between these two distinct cycle points. 
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Table 6.4: TaqMan® Gene Expression Assays used for qPCR experiments during the 
project 
 
Gene 
symbol 
Genebank 
accession 
number 
TaqMan Assay 
ID 
Gene name 
CLOCK NM_004898.2 Hs00231857_m1 clock homolog (mouse) 
PER1 NM_001178.4 Hs00242988_m1 period homolog 1 
(Drosophila) 
BMAL1 NM_002616.2 Hs00154147_m1 aryl hydrocarbon 
receptor nuclear 
translocator-like 
CRY1 NM_004075.3  Hs00172734_m1 cryptochrome 1 
(photolyase-like) 
CRY2 NM_021117.1 Hs00323654_m1 cryptochrome 2 
(photolyase-like) 
Nr1d1 NM_021724.3 
Hs00253876_m1 
 
nuclear receptor 
subfamily 1, group D, 
member 1 
Cdkn1a NM_000389.4 Hs00355782_m1 cyclin-dependent kinase 
inhibitor 1A (p21, Cip1) 
c-Myc NM_002467.4 
Hs00905030_m1 
v-myc myelocytomatosis 
viral oncogene homolog 
(avian) 
 
SGK3 NM_013257.4 Hs00179430_m1 Serum glucocorticoid 
regulated kinase family, 
member 3 
MSX2 NM_002449.4 Hs00741177_m1 msh homeobox 2 
BMP2 NM_001200.2 Hs00154192_m1 bone morphogenetic 
protein 2 
BMP4 NM_130850.2 Hs00370078_m1 bone morphogenetic 
protein 4 
NOG  Hs00271352_s1 Noggin 
PPIA NM_021130.3 Hs99999904_m1 peptidylprolyl isomerase 
A 
ACTB NM_001101.3 Hs99999903_m1 actin, beta 
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  Total RNA was extracted from the anagen VI and late catagen HFs using 
TRIzol® and the PurelinkTM RNA Mini Kit (Invitrogen, UK). The total RNA was 
extracted at the same time to ensure that the conditions were equal between 
samples. The quantity and quality of the extracted total RNA was assessed using 
a BioAnalyzer 2100 (Agilent technologies Ltd., UK) and the samples were 
submitted to the University of Manchester Genomic Technologies Core Facility. 
Total RNA (100ng) from each sample was converted into cDNA used for 
microarray analysis. Human genome U133A oligonucleotide microarrays were 
performed following manufacturer’s instructions (Affymetrix®, UK). The data 
was processed firstly, by ensuring quality control using dChip (Li and Wong, 
2004) and secondly, by performing background correction, normalisation and 
expression using the GC-RMA method (Wu et al., 2004).  
The baseline or “control” group was taken as anagen and therefore the 
fold changes were calculated as the expression in catagen compared to anagen 
per patient. The data was tested for statistical significance by comparing the 
average expression of the anagen state (average fold change for three patients) 
against the catagen samples (average fold change for three patients) using 
paired Student t-tests. In addition, subsets of probes were created where probe 
up or down-regulation was greater or less than 1.5 fold change in all three 
patients. These subsets were named anagen signatures for the group that were 
down-regulated in catagen compared to anagen and the catagen signature for 
the up-regulated group. These sets were separately analysed for over 
represented gene ontologies (GO) using Database for Annotation, Visualisation 
and Integrated Discovery version 6.7 (DAVID 6.7) (Huang et al., 2009, Dennis et 
al., 2003). 
Validations experiments for the microarray results was carried out using 
qPCR, performed in a collaboration with Dr. T. Biró,  Department of Physiology, 
University of Debrecen, Debrecen, Hungary. Analyses of the obtained qPCR 
results were performed by the candidate. Student’s t-test was performed to test 
for statistically significant differences between groups (anagen versus catagen). 
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7 CHAPTER 7: CLOCK GENES MODULATE THE 
HUMAN HAIR CYCLE: A MEETING OF TWO 
CHRONOBIOLOGICAL SYSTEMS 
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7.1 ABSTRACT  
 
The hair follicle (HF) continuously undergoes cyclic tissue remodelling 
events controlled by an, as yet unknown, oscillator system. We 
hypothesised that peripheral circadian clock genes are involved in hair 
cycle control; namely the anagen-to-catagen transition. Human HF organ 
culture was used as a clinically relevant model for studying intersecting 
developmental, chronobiological and growth-regulatory mechanisms in 
the absence of central clock influences. Isolated, organ-cultured human 
scalp HFs show circadian expression of core clock genes (Clock, Bmal1, 
Period1) and hair cycle-dependent changes in the expression of Period1. 
Knock-down of Period1 or Clock in human HFs significantly prolonged 
active hair growth (anagen), stimulated hair matrix keratinocyte 
proliferation and melanogenesis, and down-regulated clock-controlled 
genes Cdkn1a and c-Myc. Thyrotropin-releasing hormone, a hypothalamic 
regulator of clock gene activity, which promotes human hair growth, 
modulated clock gene transcription. This provides the first evidence that 
peripheral clock genes, namely Period1 and Clock, modulate human hair 
anagen-to-catagen transition. We also show that Period1 and Clock are 
novel regulators of human pigmentation in situ. Therefore, clock gene 
activity is identified here as an important regulator of human peripheral 
tissue physiology and remodelling, and constitutes a promising novel 
target for therapeutic modulation of human hair growth and 
pigmentation.  
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7.2 INTRODUCTION  
The HF is a unique, highly dynamic mini-organ that, for the entire life-time of 
mammalian organisms, undergoes a cyclical remodelling process called the hair 
cycle (Kligman, 1959, Stenn and Paus, 2001, Schneider et al., 2009). In these 
rhythmic, precisely timed and controlled organ transformations, the HF 
cyclically recapitulates key aspects of its morphogenesis, undergoes massive cell 
death, before it regenerates again owing to its rich endowment with several 
different stem cell populations (Cotsarelis, 2006, Lavker et al., 2003, Fuchs, 
2009). The growth stage (anagen) is characterised by long-lasting, intense 
epithelial proliferation and production of pigmented hair shafts. This is followed 
by rapid apoptosis-driven organ involution (catagen) where the lower two 
thirds of the HF regresses, and by a phase of relative quiescence (telogen) 
(Figure 7.1).  
As an archetype of cyclic regenerative events, the hair cycle represents a 
fascinating system which exhibits its own autonomic, site-dependent 
periodicity. The HF is an ideal model for studying complex mesodermal-
neuroectodermal tissue interactions and lies at the intersection of 
chronobiology, developmental biology, regenerative medicine and systems 
biology. 
Despite an ever-increasing range of candidates involved in the co-
ordination of the timely cyclic activity of the HF, the autonomous oscillator 
system that drives HF cycling remains essentially unknown, especially in the 
human HF (Paus & Foitzik Differentiation 2004, Lin et al. 2009, Plikus, Mayer et 
al. 2008; Schneider, Schmidt-Ullrich et al. 2009, Plikus et al. 2011). Thus, 
dissecting the regulatory molecules involved in dictating the rhythmic organ 
regeneration and regression of the HF promises new insights into the molecular 
mechanisms through which powerful biorhythms impact on mammalian organ 
regeneration and remodelling. Elucidating the controls that drive human HF 
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cycling is also of great clinical importance, since the vast majority of hair growth 
disorders can  
 
Figure 7.1: The hair cycle 
The hair follicle undergoes a continuous cyclical process after morphogenesis involving regression 
and regeneration of the lower two-thirds of its structure. This process, named the hair cycle, 
consists of three stages, firstly catagen is initiated (red) involving apoptosis of the epithelial 
compartment of the hair follicle causing the cessation of hair shaft production and leaving behind 
an epithelial strand. This stage lasts approximately two weeks in humans. The dermal papilla rests 
next to the bulge region (epithelial stem cell niche) in the telogen phase (yellow) of the hair cycle 
and a club hair formed. Shedding of the hair is described as exogen, but is a side path off the cycle 
stages. After approx. 2-4 months in humans, stem cells are activated and the anagen phase 
commences (green). This involves the total regeneration of the lower two-thirds of the hair follicle 
as rapid proliferation and differentiation occurs. Anagen involves the production of a new hair and 
lasts 2-7 years on the human scalp. DP = dermal (follicular) papilla, HS = hair shaft, ORS = outer 
root sheath, SG = sebaceous gland. Adapted after Schneider et al, 2009. The Hair Follicle as a 
Dynamic Miniorgan. Current Biology 19:R132-R142 
 
be attributed to changes in normal HF cycling dynamics, most notably to 
abnormalities in the anagen-catagen transformation (Cotsarelis and Millar 
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2001; Paus 2006). Unfortunately, none of the currently FDA-approved major 
anti-hair loss drugs (e.g. finasteride, minoxidil) counteract undesired anagen 
shortening at a satisfactory level of efficacy and reliability. Therefore, more 
effective “hair drugs” that target key components of the human hair cycle are 
urgently needed. 
 There is growing consensus that the regulatory mechanisms governing 
the human hair cycle are based on an autonomous, intra-follicular oscillator 
system (Al-Nuaimi et al., 2010, Robinson et al., 1997, Paus and Foitzik, 2004, 
Kwon et al., 2006). Here, we hypothesise that clock genes, responsible for the 
autonomous oscillatory timing system, that is the circadian rhythm, are core 
molecular elements of human hair cycle regulation. 
 Clock genes represent a crucial chronobiological system for the 
organisation of cyclic changes in the activities of cells, tissues, and organisms 
(Miller et al., 2007, Lowrey and Takahashi, 2004, Dunlap et al., 2004). The 
circadian rhythm is brought about by a self-autonomous process driven by 
transcriptional and translational feedback loops and post-translational 
processes (Figure 7.2). The result is a timing of approximately 24 hours. The 
central clock is governed by a central pacemaker (“master clock”) in the 
suprachiasmatic nucleus (SCN) (Dunlap et al., 2004, Dardente and Cermakian, 
2007, Langmesser et al., 2008, Shearman et al., 2000, Kume et al., 1999). The 
molecular components of the core clock mechanism are the PAS (PER-ARNT-
SIM) domain transcription factors including Clock, Bmal1,Npas2 and Cry1, Cry2, 
Period1, Period2 and Period3 (Lowrey and Takahashi, 2004). CLOCK and 
BMAL1 transcription factors form a heterodimer which bind to the E-box 
response element for Pers and Crys and induce their transcription making up 
the positive limb of the feedback process. Translated PER and CRY proteins 
heterodimerise in the cytoplasm and enter the nucleus to inhibit CLOCK-BMAL1 
heterodimerisation via interaction with the PAS domain of CLOCK-BMAL1 
forming a negative feedback loop and repress their own transcription (Dardente 
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and Cermakian, 2007, Langmesser et al., 2008, Shearman et al., 2000, Reppert 
and Weaver, 2002, Gekakis et al., 1998, Duffield, 2003, Takahashi et al., 2008). 
 
Figure 7.2: Basic core clock mechanism with regulatory inputs and outputs 
The mechanism governing the circadian system involves self-sustaining endogenous oscillators 
which consist of interlocking transcriptional feedback loops synchronised via a central pacemaker 
(“master clock”) in the suprachiasmatic nucleus (SCN) (Dardente and Cermakian, 2007, 
Langmesser et al., 2008, Shearman et al., 2000, Dunlap et al., 2004, Kume et al., 1999). The 
molecular components of this core clock mechanism (components within the blue circle represent 
this at a very simplified level) involve auto-regulated expression of a class of PAS (PER-ARNT-SIM) 
domain transcription factors including Clock, Bmal1, two Cryptochrome genes (Cry1 and Cry2) and 
three Period genes Period1, Period2 and Period3 (Lowrey and Takahashi, 2004). CLOCK and 
BMAL1 proteins form a heterodimer (positive loop, green arrows) which bind to the E-box response 
element for Per and Cry and induce their transcription. The translated PER and CRY proteins 
(negative loop, red dashed line) in turn inhibit CLOCK-BMAL1 heterodimerisation via interaction 
with the PAS domain of CLOCK-BMAL1 (Dardente and Cermakian, 2007, Langmesser et al., 2008, 
Shearman et al., 2000, Reppert and Weaver, 2002, Gekakis et al., 1998, Duffield, 2003). Other genes 
that are not involved in the clock mechanism, CCGs, such as D-box binding protein (Dbp), are 
regulated directly by the CLOCK-BMAL1 heterodimer. These CCGs have been found to be involved in 
physiological processes with 10% of genes within a tissue found to be CCGs. Importantly the 
expression of these genes have also shown tissue-specific expression (Duffield, 2003). The resulting 
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output of the clock mechanism is that mRNA and protein levels within this basic and extended 
system oscillate as seen in the graph. 
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A secondary loop exists comprising of orphan nuclear receptor NR1D1 
which associates with BMAL1. It is thought that this accessory feedback loop 
acts to improve the robustness of the circadian mechanism (Takahashi et al., 
2008). Recently, it has been shown that peripheral tissues also possess 
peripheral clocks responsible for implementing local physiology (Dardente and 
Cermakian, 2007). The core molecular components of both central and 
peripheral oscillators are preserved. A peripheral clock has been demonstrated 
in the murine skin (Tanioka et al., 2009). 
Other genes that are not involved in the clock mechanism; clock-
controlled genes (CCGs), such as c-Myc and Cdkn1a (also known as p21), are 
regulated directly by the CLOCK-BMAL1 heterodimer (Miller et al., 2007). CCGs 
have been found to be involved in physiological processes with 10% of genes 
within a tissue thought to be CCGs. Importantly the expression of these genes 
have also shown tissue-specific variability (Duffield, 2003). 
That clock genes and clock-controlled genes (CCGs) are evident 
candidates for an involvement in the human hair cycle (Geyfman and Andersen, 
2010) is further supported by the fact that clock genes not only exhibit 
autonomous, self-regulated oscillations (Dardente and Cermakian, 2007, Dunlap 
et al., 2004, Dibner et al., 2010) but also impact on cell cycle and apoptosis 
control (Lee, 2005, Chen-Goodspeed and Lee, 2007, Fu et al., 2002, Matsuo et al., 
2003, Miller et al., 2007, Takahashi et al., 2008); two key processes occurring 
during HF cycling. Indeed, CCGs and their encoded proteins are involved in 
murine HF cycling in vivo by interacting with cell cycle control (Lin et al., 2009). 
Even though it could not be excluded that this reflected the central clock 
influences on HF cycling, this study suggested that circadian clock genes are 
involved in cutaneous processes that transcend a 24-hour periodicity (Geyfman 
and Andersen, 2010). Also, human HF cells from plucked hair shafts have been 
shown to exhibit circadian rhythmicity in clock genes and CCG expression 
(Akashi et al., 2010).  
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The localisation and function of clock genes and proteins in the human 
HF remain to be characterised, and their impact on human HF cycling awaits 
clarification. More importantly, previous studies (Lin et al. 2009, Akashi et al. 
2010) were not able to distinguish between the central and the peripheral clock 
in the HF. On this basis, we have addressed the following specific questions: 
1. Does the expression of clock genes and proteins in intact human scalp HFs 
show circadian and/or hair cycle-dependent variations? 
2. Does clock gene silencing affect human HF cycling, hair growth and/or 
pigmentation?  
3. Does follicular (i.e. peripheral) clock gene expression underlie 
neuroendocrine controls that are recognised for the central clock, namely by 
TRH? 
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7.3 MATERIALS AND METHODS  
7.3.1 Human skin and hair follicle sample collection 
Redundant human scalp skin was obtained from the temporal or occipital 
regions from females undergoing routine facelift surgery (total n=10, 54-71 
years) and scalp occipital hair follicular units from males undergoing hair 
transplantation surgery (total n=6, 28-66 years). Tissue was obtained following 
ethical approval (Faculty of Medicine, Ethics Committee, University of Lübeck 
and Translational Medicine, University of Manchester) and informed patient 
consent. For whole skin analysis, skin was cut into small blocks and either fixed 
in 10% phosphate buffered formalin and snap frozen in liquid nitrogen or first 
embedded in Shandon Cryomatrix (Fisher Scientific) prior to snap freezing. For 
isolated HF analyses, these were isolated by microdissection and then used in 
HF organ culture experiments or embedded in Shandon Cryomatrix and snap 
frozen in liquid nitrogen for immunohistochemistry experiments. 
7.3.2 Human hair follicle organ culture  
Anagen VI HFs were isolated from human scalp skin according to previously 
described methods (Philpott et al., 1990, Sanders et al., 1994). Using this well-
established model, human HFs are able to continue growing in standardised 
conditions whereby late anagen (anagen VI) HFs will continue to produce a hair 
shaft exhibiting elongation and eventually enter a catagen-like state 
spontaneously. The other stages of telogen and early anagen are not captured 
using this method. 
Isolated HFs were maintained in a 24-well plate; each well containing 
500 µl serum-free Williams’ E medium (Biochrom) supplemented with 2 
mmol/L L-glutamine (Invitrogen), 10 ng/ml hydrocortisone (Sigma-Aldrich), 10 
µg/ml insulin (Sigma-Aldrich) and 1% antibiotic/antimycotic mixture (100x, 
GibCo). The supplemented medium was changed every second day. 
 
 176 
 
7.3.3 Time series experiments for temporal gene profiling in anagen 
human hair follicles 
In order to establish the expression pattern of core clock genes and selected 
CCGs during the circadian cycle, human scalp occipital anagen VI HFs from two 
patients were obtained. The operations were performed during the time 
window of 09:30-13:00 GMT. Microdissection of the HFs was performed and the 
HFs maintained in culture media for 24 hours for two patients and 7 days in the 
third patient. Synchronisation of the HFs was then performed using 100nM 
dexamethasone for 30 minutes and whole HFs were harvested every 4 hours 
following synchronisation for a 24 hour period. The HFs were maintained in 
constant conditions in a 5% CO2 incubator at 37ºC. When harvested the HFs 
were stored in RNAlater and then processed for qPCR analysis (see below) to 
establish the expression pattern of Clock, Bmal1, Period1, Nr1d1, Cdkn1a, C-myc. 
A further experiment was performed without dexamethasone synchronisation 
as a comparison using 42 fronto-temporal anagen VI HFs (female, aged 64 
years). These HFs were maintained in the same conditions. Time points of 8:00, 
14:00 and 21:00 GMT were taken and the HFs snap frozen whole for qPCR 
analysis of Clock, Bmal1 and Period1. 
7.3.4 Hair follicle organ culture – “catagen culture” 
In order to investigate changes in clock genes and proteins in accordance with 
the hair cycle, organ cultured anagen VI human HFs were isolated and 
maintained in organ culture conditions as described. HFs were assessed daily 
using a Nikon Diaphot inverted binocular microscope to determine whether 
they appeared, macroscopically, to be in anagen or early, mid- and late catagen 
phases. Once identified to be in the correct stage (Kloepper et al., 2009, Müller-
Röver et al., 2001), HFs were immediately embedded in Shandon Cryomatrix 
and snap frozen in liquid nitrogen and 6µm thick cryosections cut by cryostat 
(Model CM 3050S, Leica) and stored at -80°C until required for 
immunohistochemistry analyses. HF stages (anagen versus catagen) were 
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assessed by applying carefully defined morphological and immunohistological 
staging criteria (Kloepper et al., 2009). For qPCR analyses anagen and catagen 
HFs were stored in RNAlater and then processed as described in the qPCR 
section (below and Chapter 6). This method was used for collecting HFs that 
were either maintained in anagen or had spontaneously entered catagen stages 
(early, mid and late catagen) and frozen for IF PERIOD1 and BMAL1. In addition, 
anagen and catagen HFs were obtained from one patient to check for any 
changes in expression between (non-synchronised) anagen and catagen HFs.  
7.3.5 Synchronised time series experiment of anagen and catagen hair 
follicles to determine clock gene expression 
Microdissected human scalp HFs were obtained from redundant hair 
transplantation surgery follicular units. Five patients were used for this 
experiment (Table 7.1). The first two patient samples for anagen were obtained 
as described for temporal profiling of anagen HFs. The last three patient 
samples were obtained after maintaining the HFs in organ culture as described. 
All HFs were assessed daily and staged according to macroscopic staging 
criteria (Kloepper et al., 2009). For patient C; once half the HFs had entered 
anagen and the other catagen, the samples were synchronised using 
dexamethasone and harvested into two groups anagen and catagen and the six 
time points for each group. For patients D and E, once all HFs were seen to be in 
catagen, the synchronisation and harvesting experiment over 24 hours was 
performed. This took between 7 and 14 days for the HFs to enter the correct 
stage. The HFs were maintained in RNAlater until processed for qPCR analysis 
to check the expression of Clock, Bmal1 and Period1.  
 
Table 7.1: Patient samples for 24 hour synchronised time series experiment 
Patient 
ID 
Age Gender Location Hair cycle stage when 
samples taken 
A 35 M Occipital Anagen 
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B 28 M Occipital Anagen 
C 40 M Occipital Anagen 
Catagen 
(Both stages harvested on the 
same day) 
D 40 M Occipital Catagen 
E 40 M Occipital Catagen 
 
7.3.6 Clock and Period1 knock-down in organ cultured human hair 
follicles  
Anagen VI HFs were isolated from human scalp skin as described (see above) 
(Philpott et al., 1990, Sanders et al., 1994). To inhibit the expression of Clock and 
Period1 genes in human HFs, HFs were transfected with Clock siRNA (Clock 
siRNA (h): sc-35074) and Period1 siRNA (Per1 siRNA (h): sc-38171) in separate 
organ culture experiments (see Table 7.2). All reagents were from Santa Cruz 
Biotechnology, Inc. and the transfections were performed according to 
manufacturer’s gene silencing protocol. HFs were incubated for 5 hours at 37ºC 
in an atmosphere of 5% CO2 and 95% air. siRNA Transfection medium was then 
removed and HFs incubated for either an additional 24 or 96 hours in 
supplemented William’s E Medium. Medium was changed every 48 hours. 
Control experiments were performed in parallel, using the same patient HFs, 
with random scrambled oligos (Control siRNA (FITC Conjugate)-A: sc-36869) 
(Santa Cruz). Whole HFs were collected from the siRNA transfected and control 
groups for qPCR or immunohistochemical analyses. PERIOD1 (PER1) protein 
staining, Masson Fontana and double staining for Ki-67/TUNEL were performed 
to decipher any effect on proliferation and apoptosis, melanin content and PER1 
protein production by siRNA treatment at either 24 hours or 96 hours. HFs 
were allocated into their correct hair cycle stage (either anagen or early, mid-, 
late catagen) using microscopic staging criteria on all cryosection pictures taken 
from IHC analyses after 96 hours culture. The results of each stain was analysed 
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by combining the data from the four patients for the siRNA Period1 data and the 
one patient for siRNA Clock data. Contingency table analysis (Fisher’s Exact test) 
was performed to test for significant differences in staged groups between the 
siRNA and control groups. Significant differences were taken as p<0.05. 
Table 7.2: siRNA transfection experiments – sample demographics and 
experimental plan 
 
7.3.7 TRH treatment of human hair follicles - 6 day organ culture 
To investigate the effect of TRH on human HFs in organ culture, isolated anagen 
VI HFs were maintained in a 24-well plate for 6 days. 5-100 ng/ml TRH was 
added to the culture medium every 48 hours as previously described (Gáspár et 
al., 2010). Once completed, HFs were either frozen whole (5 ng/ml and 100 
ng/ml concentrations) for qPCR analysis or embedded for subsequent 
cryosectioning and immunohistochemical staining (5 ng/ml and 10 ng/ml 
concentrations). All HFs were maintained in the same conditions in organ 
culture and all samples were harvested within the same time window (19:00-
22:00 h). 
 
Gene SiRNA probes 
used 
Patient Age No. of 
HFs 
Location Duration of 
knock-down 
Period1 Period1 siRNA 
(h): sc-38171 
and control 
siRNA 
69  yr, female 90 Scalp, 
occipital 
24 hrs 
53  yr, female 70 Scalp, 
temporal 
96 hrs 
47 yr, male 75 Scalp, 
occipital 
96 hrs 
48 yr, male 75 Scalp 96 hrs 
45 yr, male 83 Scalp 96 hrs 
Clock Clock siRNA 
(h): sc-35074, 
Control siRNA 
71 yr, female 95 Scalp, 
occipital 
24 hrs 
59  yr, female 92 Scalp, 
temporal 
96 hrs 
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7.3.8 Quantitative PCR – Method 1 
This method for qPCR was carried out for all experiments apart from those 
specified in the below section.  
Total RNA was extracted from whole HF samples using PureLink RNA Mini Kit 
(Invitrogen) following the manufacturer’s instructions.  Samples were all 
treated with Purelink DNase treatment Kit (Invitrogen) as directed by the 
instructions. RNA purity and concentrations were established by analysing the 
UV absorbance using the Nanodrop ND-1000 (Fisher Scientific, Loughborough, 
UK). Reverse transcription was carried out using the cloned AMV First Strand 
cDNA Synthesis Kit (Invitrogen, Paisley, UK) according to the manufacturer’s 
instructions. The volume of RNA added to the reaction mix was adjusted for 
each sample in each experiment to ensure the same concentration of RNA was 
loaded in the reverse transcription reactions for each sample set. This was to 
ensure that samples whose results were going to be compared by qPCR were 
subjected to the same conditions and to minimise any variation being due to 
different RNA amounts included in the reverse transcription reaction rather 
than true differences. Controls were included for each sample whereby the 
reverse transcription reaction was carried out without any reverse 
transcriptase. This was to test for any genomic DNA contamination present in 
the RNA samples during qPCR. Real time quantitative polymerase chain reaction 
(qPCR) was performed using human TaqMan® gene expression assays (Applied 
Biosystems, Warrington, UK) (Table 7.3). The TaqMan® gene expression assays 
are detailed in (Table 7.3). The StepOne Plus™ Real-Time PCR system was used 
(Applied Biosystems). Real-time quantification plots were collected and stored 
by the StepOne software. Relative expression was determined using the delta Ct 
and delta delta Ct methods against the housekeeper gene PPIA. Results were 
plotted and analysed using Graphpad prism and EXCEL (Microsoft®). Statistical 
analysis of paired or unpaired Student’s t-tests were performed or one way 
ANOVA when appropriate. Results were considered significant if p<0.05. 
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Table 7.3: Taqman® qPCR primers 
7.3.9 Quantitative PCR – Method 2 
The HF samples; 6 day TRH experiment, non-synchronised anagen and catagen 
samples, non-synchronised three time point samples and 24 hour knockdown 
with Period1 and clock confirmation were all performed in the Biro lab, 
Hungary. The following method was used: Total RNA was isolated using TRIzol 
(Invitrogen) and 1 μg of total RNA was reverse-transcribed into cDNA by using 
15 U of AMV reverse transcriptase (Promega) and 0.025 μg/μl random primers 
(Promega). Q-PCR was performed on an ABI Prism 7000 sequence detection 
system (Applied Biosystems) using the 5’ nuclease assay as detailed previously 
(Bodo et al., 2005, Tóth et al., 2009). PCR amplification was performed by using 
the TaqMan® primers and probes (Table 7.3) and the TaqMan® universal PCR 
master mix protocol (Applied Biosystems). The internal control gene used to 
normalise the data for all cases apart from TRH-treated HFs was peptidylprolyl 
isomerase A (PPIA). β-actin (ACTB) was used for the 6 day TRH treated-HFs. 
Gene GeneBank 
Accession No. 
TaqMan® assay 
ID 
Full gene name 
Clock NM_004898.2 Hs00231857_m1 clock homolog (mouse) 
Bmal1 NM_001178.4 Hs00154147_m1 
aryl hydrocarbon receptor 
nuclear translocator-like 
Period1 NM_002616.2 Hs00242988_m1 
period homolog 1 
(Drosophila) 
Cry1 NM_004075.3 Hs00172734_m1 
cryptochrome 1 (photolyase-
like) 
Cry2 
NM_021117.1, 
NM_01127457.1 
Hs00323654_m1 
cryptochrome 2 (photolyase-
like) 
Cdkn1a NM_000389.4 Hs00355782_m1 
cyclin-dependent kinase 
inhibitor 1A (p21, Cip1) 
c-Myc NM_002467.4 Hs00905030_m1 
v-myc myelocytomatosis viral 
oncogene homolog (avian) 
PPIA NM_021130.3 Hs99999904_m1 peptidylprolyl isomerase A 
ACTB NM_001101.3 Hs99999903_m1 actin, beta 
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Normalisation was carried out based on the delta Ct method. Experiments were 
performed in triplicates; the average relative expression levels were calculated 
and plotted using EXCEL (Microsoft®) or Graphpad prism. Statistical analyses 
were carried out with SPSS 9.0 statistical software (SPSS Inc.) using 
independent sample t-tests and one-way ANOVA. Pair-wise comparison was 
performed using both Dunnett and Bonferroni tests in order to compare the 
means of more than 2 samples. 
7.3.10 In situ hybridisation for clock mRNA 
For the in situ hybridization, digoxigenin (DIG) labeled Clock sense and 
antisense probes were generated as previously described (Eichberger et al., 
2004) (Table 7.4). In brief, 6m tissue sections were pre-hybridised in pre-hyb-
solution (4x saline sodium citrate (SSC), 1x Denhardt’s, 50% formamide, 500 
mg/ml tRNA and 500 mg/ml salmon testes DNA, denatured at 100 ºC for 10 min 
and placed on ice before adding to the mix) and incubated at 42 ºC for 3-4 
hours. Hybridisation was carried out using fresh pre-hyb-solution containing 
80-100ng labelled probe (denatured at 65 ºC for 5 min) at 42 ºC overnight. 
Sections were washed in 2x SSC for 5 min (two times) and in 2x SSC, 1x SSC, 0.5x 
SSC, each containing 50% formamide, at 45 ºC – 55 ºC and in 0.1x SSC 50% 
formamide at 50 ºC – 60 ºC for 20 min. A final wash was in 2x SSC and rinsed in 
DIG buffer 1 (100mM Tris-HCl, 150mM NaCl pH 7.5). Sections were blocked 
with 10% normal sheep serum (NSS) in DIG buffer 1 and incubated with an anti-
DIG alkaline phosphatase-conjugated antibody (Roche) diluted 1:400 in 1% NSS 
DIG buffer 1 for 2 hours, followed by washing in DIG buffer 1 (two times) and 
DIG buffer 2 (100 mM Tris-HCl pH 9.5, 100 mM NaCl, 50 mM MgCl2) for 10 min. 
The hybrids were visualised by incubating the section with BCIP/NBT (Sigma-
Aldrich) liquid substrate in dark at 4 ºC overnight. The colour reaction was 
stopped by immersing the sections in 10 mM Tris-HCl pH8 1 mM EDTA for 30 
min. The developed slides were mounted and examined under a light 
microscope. 
 183 
 
 
Table 7.4: Primer sequences for Clock mRNA in situ hybridisation 
 
7.3.11 Quantitative immunohistomorphometry 
Immunohistochemistry (IHC) staining for localisation and quantification of 
clock proteins was established and performed on whole human scalp skin 
cryosections (8 µm) and isolated human scalp HFs (6 µm). (Table 7.5 provides 
details of the individual IHC methodologies.) Primary antibodies were incubated 
overnight at 4°C. Sections were washed in either phosphate-buffered saline or 
TRIS-buffered saline between steps. Sections that were to be directly compared 
for quantification were processed at the same time to ensure that any variation 
in results were not due to different experimental conditions. IHC staining for 
Masson-Fontana and Ki-67/TUNEL double-immunofluorescence microscopy 
were carried out as previously described in (Ito et al., 2005b) and (van Beek et 
al., 2008), respectively. Immunolocalisation and intensity analyses were 
performed with the Biozero-8000 microscope (Keyence) and analysed using 
ImageJ software (National Institute of Health). Immunofluorescent images were 
taken using the same exposure time when using intensity of fluorescent stain 
for quantitative analyses. To compare staining intensity and positive cell 
numbers, the mean values from multiple cryosections was taken to allow for 
variation in sections. 
 
Primer  Forward (5’  3’) Reverse (3’  5’) Gene bank 
accession 
number 
Clock (h) AACAACTTCAGATGGT
CCATGGT 
GAGTTGTGCCAATGTGTCC
AGT 
NM_004898.2 
 
GAPDH 
(h) 
TCCCATCACCATCTTCC
A 
GTCCACCACCCTGTTGCT NM_002046.3 
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Table 7.5: Protocol summaries for clock protein immunofluorescence and 
immunohistochemistry experiments 
Protein  Primary 
Antibody  
Secondary antibody, 
detection system  
Negative control 
(besides omission 
of primary 
antibody) 
Positive 
control 
tissue 
References 
CLOCK Rabbit anti-
human Clock 
(Clock 
AB5418P, 
Chemicon) 
Horse anti-rabbit 
biotinylated (Vector 
Laboratories).  
ABC detection system  
 
 
HaCaT cell 
line 
(Zanello et 
al., 2000) 
BMAL1 Rabbit anti-
human 
MOP3, 1:40 
(MOP31-A, 
Alpha 
Diagnostics) 
Goat anti-rabbit 
fluorochrome 1:200 
(Jackson 
Immunoresearch) 
Primary antibody 
pre-incubated with 
blocking peptide  
(MOP31-P, Alpha 
Diagnostics) 
Human 
pineal 
gland 
(Ackermann 
et al., 2007) 
PER1 Rabbit anti-
human PER1, 
1:100 
(PER12-A, 
Alpha 
Diagnostics) 
Goat anti-rabbit 
fluorochrome 1:200 
(Jackson 
Immunoresearch) 
Primary antibody 
pre-incubated with 
blocking peptide  
(PER12-P,  Alpha 
Diagnostics) 
Human 
pineal 
gland & 
HaCaT cell 
line 
(Ackermann 
et al., 2007) 
(Zanello et 
al., 2000) 
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7.4 RESULTS 
7.4.1 Expression of the clock genes Clock, Bmal1, Period1 and clock-
controlled genes c-Myc, Nr1d1 and Cdkn1a exhibit a circadian 
rhythm in isolated human scalp anagen hair follicles 
In order to establish whether microdissected HFs exhibit a circadian expression 
pattern, qPCR was performed on isolated human scalp anagen VI HFs. Following 
dexamethasone synchronisation of clock gene activity, HFs were sampled 4 
hourly over a 24-hour period to determine whether Clock, Bmal1 and Period1 
were expressed. 
As shown in Figure 7.3, all three clock genes were expressed with circadian 
variation expression pattern displayed. The patients show similar expression 
patterns in terms of their phase distribution and mean overall relative 
expression values, however some variation was seen between patients (see 
Table 7.6). In the third patient, the expression patterns were noted to be 
different; in particular for Period1 expression (Figure 7.3c) Period1 mRNA was 
found to be undetermined in all samples apart from the 8 hours post 
synchronisation sample. The same patient samples did express Clock and Bmal1 
however (Figure 7.3c). This sample was taken after 7 days in culture, in contrast 
to the results in Figure 7.3a and 7.3b whose samples were harvested within 48 
hours of surgery. In the unsynchronised sample, variation in expression levels 
Bmal1 and Period1 mRNA was also seen over the three time points, although 
this was minimal (Figure 7.4). Human HFs also exhibited circadian rhythmicity 
of CCGs, Nr1d1, C-Myc and Cdkn1a (p21) in the patients A and B (Figure 7.5). 
Patient C was not tested for CCG expression. Subsequent to this analysis, all 
experiments not involving time series sampling were performed by harvesting 
HFs within the same time window (7-10 p.m.; see Methods) to control for these 
dynamic expression changes. 
 
 186 
 
 
 
 
Figure 7.3: Circadian expression profiles of clock transcripts Clock, Bmal1 and 
Period1 in isolated human hair follicles. 
Clock, Bmal1, Period1 mRNA was quantified using qPCR in whole hair follicles synchronised with 
dexamethasone and sampled at time points 4, 8, 12, 16, 20 and 24 hours post synchronisation. Data 
shown are the mean relative expression levels for each gene compared to housekeeping gene PPIA 
in individual patients (A), (B) and (C) (black dots). Fourth order polynomial graphs were fitted to 
the data to demonstrate the oscillatory pattern of expression over 24 hours (solid black line). 
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Table 7.6: Summary table of the pattern of clock mRNA expression in anagen hair 
follicles  
Clock, Bmal1, Period1 mRNA was quantified using qPCR in whole hair follicles synchronised with 
dexamethasone and sampled at time points 4, 8, 12, 16, 20 and 24 hours post synchronisation. Data 
shown are the mean relative expression levels for each gene over all time points compared to 
housekeeping gene PPIA in individual patients (A), (B) and (C). S.d = standard deviation. 
 
 Patient Amplitude Mean expression s.d. 
Clock A 0.007 0.007 0.003 
 B 0.003 0.003 0.001 
 C 0.027 0.012 0.009 
Bmal1 A 0.003 0.006 0.001 
 B 0.005 0.006 0.002 
 C 0.015 0.008 0.006 
Period1 A 0.043 0.035 0.017 
 B 0.027 0.037 0.011 
 C 0.012 0.002 0.005 
 
 
7.4.2 Clock proteins are expressed in normal human scalp hair follicles  
Next, we studied follicular clock gene protein expression and localisation in 
microdissected human anagen VI HFs. Immunohistochemistry demonstrated 
that expression of the clock proteins CLOCK, BMAL1 and PER1 was restricted 
mainly to the HF epithelium, and was most prominent in the human ORS (Figure 
7.6). However, BMAL1 immunoreactivity (IR) was also localised to the CTS and 
the DP of the HF, the key mesenchymal centres of HF biology. Expression of 
these proteins was confirmed in full-thickness human skin cryosections, using 
appropriate negative and positive controls (Figure 7.7 and Figure 7.8). These 
experiments show that human HFs express clock gene transcripts and proteins. 
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Figure 7.4: Unsynchronised time series of anagen hair follicles in organ culture. 
Variation is seen in Bmal1 and Period1. Expression values are relative PPIA expression 
(housekeeper) calculated by using the delta Ct values. One way ANOVA and Student’s t-tests did not 
find any significant differences between time points. Error bars are standard error of the mean 
(SEM). GMT = Greenwich Mean Time. 
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Figure 7.5: Clock controlled genes exhibit circadian expression in human hair 
follicles. 
Two patients (A) and (B) are shown individually. Data is plotted as the mean relative expression 
value for each time point with PPIA as the housekeeping gene. Fourth order polynomial graphs 
were fitted to the data to demonstrate the oscillatory pattern of expression over 24 hours (solid 
black line). 
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Table 7.7: Immunoreactivity patterns of CLOCK, BMAL1 and PERIOD1 proteins in 
human hair follicles and skin. 
CTS, connective tissue sheath; DP, dermal papilla; ORS, outer root sheath. 
Antigen Hair follicle IR pattern Skin IR pattern  Comments 
CLOCK Supra-basal cell layers of 
the infundibulum and ORS. 
Not detected in the matrix 
cells, proximal germinative 
epithelial cells, DP and 
CTS. 
 
Detected in the epidermis (nuclear 
and cytoplasmic in the basal cell 
layer). Dermis: fibroblasts, blood 
vessels, nerve fibres, eccrine 
sweat gland, sebaceous gland 
(suprabasal layers of the 
sebaceous duct and mature 
sebocytes) 
Figure 7.6a 
and 7.7 
BMAL1 ORS, hair matrix, DP and 
CTS 
Epidermis: all layers and dermis; 
individual fibroblasts and blood 
vessels. 
Figure 7.6 
PER1 Whole length of the ORS, 
matrix keratinocytes 
(cytoplasm and nucleus). 
HF mesenchyme (DP, CTS) 
negative 
Basal layer of the epidermis and 
the sebaceous glands 
Figure 7.6 
and 7.8 
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Figure 7.6: Clock, Bmal1 and Period1 expression in human hair follicles 
(A) Clock protein and mRNA expression in human hair follicles. RT-PCR gel showing Clock 
expression in normal human skin. IHC detected CLOCK protein in the hair follicle (ORS and supra-
basal cell layers of the infundibulum) and in the basal and supra-basal layers of the epidermis in 
skin. (B) Immunofluorescence human BMAL1 protein in isolated micro-dissected human hair 
follicles. BMAL1 localised to the ORS and CTS. Expression did not significantly change between 
anagen and catagen stages using quantitative immunohistochemistry analyses of staining 
intensity (C) PERIOD1 (PER1) protein expression in isolated human hair follicle cryosections. 
PER1 is localised to the nucleus and cytoplasm (green). Cell nuclei are counterstained with DAPI 
(blue). PER1 is found in the ORS and MKs of the hair follicle. 
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Figure 7.7: Clock mRNA and protein expression in human skin cryosections 
Clock mRNA localisation in the human skin and hair follicle was confirmed by in situ 
hybridisation (ISH) of whole human scalp skin cryosections (Red staining, left panel). 
Immunohistochemistry for CLOCK protein (red/bown staining, right panel) detected 
in the outer root sheath and supra-basal cell layers of the infundibulum in the hair 
follicle and in the basal and supra-basal layers of the epidermis in skin. 
 
7.4.3 Period1 and Clock expression increase in catagen hair follicles 
To further test our working hypothesis that clock genes are implicated in the 
regulation of human hair cycling, we assessed whether the transcription and 
protein expression of clock genes was altered during the anagen-to-catagen 
transformation of organ-cultured HFs. 
PER1 protein expression was found in the ORS and bulb MKs of anagen 
(A), early (EC), mid catagen (MC) and late (LC) catagen HFs Figure 7.9. In most 
analysed HFs, PER1 immunoreactivity was negative to minimal in the matrix 
during anagen, became increasingly positive during catagen stages, and was 
maximal in late catagen, as assessed by quantitative immunohistomorphometry 
(Figure 7.9). This expression difference in BMAL1 immunoreactivity between 
anagen and catagen HFs was not found (data not shown). 
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Figure 7.8: Immunofluorescent staining of BMAL1 and PER1 in positive control 
tissue and skin cryosections 
Top panel displays BMAL1 immunofluorescent staining (green) in positive control tissue pineal 
gland. The right side picture shows the use of blocking peptide as a negative control. 
PER1immunofluorescent staining (lower picture set, green fluorescence) is localised to the nucleus 
and cytoplasm. Cell nuclei are counterstained with DAPI (blue). Basal cell expression of PER1 is 
found in the epidermis of whole human skin and in nuclei and cytoplasm of positive control tissues 
HaCaT cells and human pineal gland. 
 
The protein expression data was also followed up on the transcriptional 
level (Figure 7.10). Synchronised samples comparing the expression of Clock, 
Bmal1 and Period1 in anagen and catagen HFs over 24 hours was obtained 
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(Figure 7.10). It was found that Clock exhibited a significantly higher mean 
expression in anagen when compared to catagen (mean anagen 0.007 (SEM 
0.001), mean catagen 0.004 (SEM 0.0005) unpaired Student’s t-test, p=0.046). 
There was no significant difference in mean expression values between anagen 
and catagen samples for both Bmal1 and Period1. On qualitative assessment of 
the data: the wave form appeared to be different between the two cycle stages 
in all three genes (Figure 7.10) therefore, amplitude of expression was 
calculated by subtracting the minimum expression level for each gene in each 
state from its maximum (Figure 7.11). Compared to anagen VI there was a 
significantly increased amplitude of Period1 mRNA expression in the catagen 
HFs (unpaired Student’s t-test; p<0.05) (Figure 7.11). No phase shift effect was 
noted in the Clock and Bmal1 samples between the anagen and catagen samples. 
In the Period1 sample, there appeared to be some phase shifting, but the main 
difference noted in the amplitude of expression in catagen compared to anagen 
here.  
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Figure 7.9: Differential expression of Period1 in human organ cultured hair 
follicles during anagen and catagen 
PER1 immunofluorescence on human anagen and catagen HFs. The HFs had been assigned to 
defined hair cycle stages on the basis of morphological criteria (Kloepper et al., 2009). As HFs were 
maintained in organ culture and a proportion spontaneously entered catagen. The time for this to 
occur varied between patients and is usually 4-9 days. PER1expression increased from anagen to 
late catagen with greatest expression in late catagen. Fluorescent images were analysed using 
ImageJ software. Intensity of fluorescent staining (FITC) was measured in reference area of 
interest (only the epithelial hair follicle) and average intensity in the reference area recorded. 
Intensity/area was calculated and results tested for statistical significance using Mann-Whitney U 
tests to compare two groups and p values were corrected for multiple testing using the Holm-
Bonferroni test (*p <0.05,***p<0.001). Abbreviations: CTS, connective tissue sheath; ORS, outer root 
sheath; IRS, ORS, outer root sheath; DP, dermal papilla; MK, matrix keratinocytes. 
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Figure 7.10: Time series expression of clock mRNA in anagen and catagen human 
hair follicles 
The average relative expression levels (from three patients in each group – anagen (green) and 
catagen (green)) (determined by the delta Ct method against housekeeping gene PPIA) for each 
time point are displayed in the graphs. Error bars shown are SEM. 
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Figure 7.11: Amplitudes of clock mRNA expression in anagen versus catagen hair 
follicles  
Difference in amplitude of expression was calculated by obtaining the maxima and minima 
expression levels for each gene (Figure 7.10). The plotted values show the means with SEM as error 
bars. Statistical significance was tested for using unpaired Student’s t-test. Period1 amplitude in 
catagen was significantly greater than the anagen sample with p<0.05. Error bars shown are SEM. 
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7.4.4 Period1 silencing in human hair follicles significantly prolongs 
anagen  
In light of these data, we went on to functionally investigate the possible role of 
Period1 and Clock in the anagen-to-catagen transition.  Given that Period1 
expression was low in anagen and sharply rose during catagen, we hypothesised 
that silencing of Period1 would prolong anagen duration. To test this hypothesis, 
human scalp HFs from four patients, were transfected with a Period1-specific 
siRNA probe. Success of the technique in human anagen HF organ culture was 
demonstrated on the mRNA and protein level (Figure 7.12). 
Human HFs transfected with Period1 siRNA showed a significantly 
greater proportion of anagen HFs (71.4%) than the control group (4.3%) 96 
hours following Period1 knock-down (p<0.05, Fisher’s exact test) (see Figure 
7.13 and (Table 7.8). In addition, the test group also showed a higher number of 
Ki-67 positive (i.e. proliferating) hair MKs compared to the scrambled 
oligonucleotide-treated HFs (three patients, total number of HFs in siRNA 
group= 10, control group = 12, non-significant) (Figure 7.14a). Since HF 
melanogenesis is tightly coupled to anagen (Tobin et al., 1999, Slominski et al., 
2005), HF pigmentation was assessed as another independent marker for 
anagen prolongation. As shown by quantitative histochemistry (Masson-
Fontana), 96 hours after Period1 knockdown, the melanin content of silenced 
HFs was higher than that of control HFs, but the difference did not reach 
statistical significance (three patients, total number of HFs in siRNA group= 12, 
control group = 10, Student’s t-test p=0.07)  (Figure 7.14b). 
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Figure 7.12: Period1 and Clock mRNA knock-down in human scalp hair follicles 
(A) Relative expression of Period1 mRNA in human hair follicles transfected with Period1 siRNA 
(n=24, mean 0.018) and corresponding control (n=24, mean 0.03). Housekeeping gene PPIA. 
Quantitative immunohistomorphometry of PER1 immunofluorescent staining 96 hours following 
Period1 knock-down compared to the control (random oligonucleotides). Hair follicles in the same 
hair cycle stage (mid catagen) were compared in the two groups to ensure that any differences in 
protein expression were not connected to the cycle stage differences in the two groups. (C) shows a 
box plot of the intensity of PER1 fluorescent staining in the matrix keratinocytes (reference area 
below Auber’s line). The hair follicles transfected with siRNA Period1 showed a statistically 
significant reduction in the expression of PER1 protein. Mann-Whitney U test, * p<0.05 (B) Relative 
expression of Clock mRNA following Clock knock-down (n=26, mean expression 0.0003) and 
corresponding control (n=25, mean expression 0.007). Housekeeping gene PPIA. The difference 
between knock-down and control groups for each knock-down experiment was tested statistically 
using Student’s t-test. ** p<0.01, ***p<0.001. 
 
 
 200 
 
 
Figure 7.13: Hair cycle stages in Period1 knock-down hair follicles and controls 
Graph displays the number of hair follicles found to be in each hair cycle stage 96 hours post-
Period1 knock-down. This graph combines the staging results from 4 Period1 knock-down 
experiments performed for 96 hours on separate patients. 40 hair follicles were still in anagen in 
the Period1 knock-down group compared to only 2 hair follicles in the control group (treated with 
scrambled oligonucleotides). (p<0.05, Fisher’s exact test). 
 
7.4.5 Period1 inhibits human HF melanogenesis 
In order to check whether Period1 has a hair cycle-independent effect on human 
HF pigmentation, only anagen VI HFs were compared between silenced and 
control groups in one patient. The melanin content of Period1-silenced anagen 
HFs was significantly increased (p=0.034, Figure 7.15).  
 
Table 7.8: Hair cycle stages in Period1 knockdown hair follicles and control 
 
 Anagen  
n (%)  
Catagen  
n (%)  
Total 
siRNA Period1  40 (74.1)  14 (25.9)  54 (100)  
Control  2 (4.3)  45 (95.7)  47 (100)  
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Figure 7.14: Period1 knockdown in human hair follicles - effect on proliferation, 
apoptosis and melanin content 
In the 3 patients, 96 hours following Period1 knock-down, there was increased ki-67 positive cells 
and a decrease in TUNEL positive cells in the Period1 knockdown group These differences were not 
statistically significant. (B) An increased melanin content was also observed. (three patients, total 
number of HFs in siRNA group n= 12, control group n= 10, Student’s t-test p=0.07). Error bars 
shown are SEM. 
 
7.4.6 Clock knock-down prolongs anagen and increases both melanin 
content and hair matrix keratinocyte proliferation 
We assessed whether Clock silencing also prolonged anagen. In the Clock knock-
down group, 21.1% of HFs remained in anagen compared to 5.4% in the control 
group (Figure 7.16a). In addition, keratinocyte proliferation in the hair matrix 
was significantly increased after Clock silencing (p=0.017) (Figure 7.16b). As 
shown by quantitative histochemistry, when only anagen VI HFs were 
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compared between silenced and control groups, the melanin content of Clock-
silenced anagen HF was significantly increased (Figure 7.16c). 
 
 
Figure 7.15: Modulation of melanin content in anagen hair follicles following 
Period1 knockdown 
A. Period1 knock-down increases melanin content in human anagen scalp hair follicles 24 hours 
following transfection. Images show Masson Fontana staining (Mann-Whitney U test, p=0.016). 
Average intensities were obtained over multiple cryosections to ensure un-biased quantification of 
sections. (B) Period1 knock-down in human hair follicles resulted in an increase in proliferation of 
human HFs 24 hours following transfection. Double immune-staining for Ki-67/TUNEL was 
performed on hair follicles following Period1 knock-down and the control group. An increased 
percentage of Ki-67 positive matrix keratinocytes were found in Period1 knock-down hair follicles 
(46.7%) when compared to control group (36.0%) (transfected with random oligos). This 
difference was found to be non-significant (Mann-Whitney U test, p=0.2). Error bars are SEM. 
A 
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7.4.7 Period1 may regulate anagen to catagen transition via CCGs genes 
some of which are already implicated in the hair cycle control 
As a first attempt towards exploring the unknown mechanism by which clock 
genes may impact on human HF biology, we assessed by qPCR how Period1 
silencing affects the transcription of selected clock-controlled gene (CCG) 
expression, with emphasis on classical CCGs that are recognised as regulators of 
cell cycling and the apoptotic machinery. This revealed that Period1 knock-
down down-regulated the expression of c-Myc and p21(CDKN1A), although this 
is the result of a preliminary study (Figure 7.17). 
 
7.4.8 TRH may regulate the intrafollicular expression of clock-related 
transcripts 
We wanted to determine whether TRH may regulate clock genes in the human 
HF. By qPCR we show that, compared to vehicle control HFs, TRH-treatment 
significantly up-regulated the transcription of Clock and Bmal1, while it 
significantly down-regulated Period1 expression (at the lower concentration of 
TRH) (Figure 7.18). Moreover, by quantitative immunohistomorphometry, 
PER1 protein expression was down-regulated by TRH, when only anagen VI 
TRH-treated and control HFs were compared. 
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Figure 7.16: Clock knock-down in human hair follicles resulted in increased 
number of anagen hair follicles, melanin content and proliferation in human scalp 
hair follicles. 
(A) 96 hours Clock knock-down, 21.1% of hair follicles were found to still be in anagen as 
compared to 5.4% of hair follicles in the control group (using scrambled oligonucleotides). (B) 
Significantly increased melanin content was found in human hair follicles after Clock knockdown 
compared to the control (p=0.034). Average intensities were obtained over multiple cryosections to 
ensure un-biased quantification of sections. The intensity of the stains were measured in the 
reference areas as shown in B. (C) Double staining for Ki-67/TUNEL following Clock knock-down 
and the control group. The number of DAPI, Ki-67 (C) and TUNEL positive cells were counted 
within the reference area (C shows the reference area; this was the region bound by the epithelial 
hair follicle and below Auber’s line (red line)). The percentage of Ki-67 positive and TUNEL positive 
cells was calculating using the number of DAPI positive cells as the total number of cells. Mann-
Whitney U test compared Clock knockdown and control for differences. Clock knockdown resulted 
in a significant increase in the percentage of Ki-67 positive cells (p=0.017) after 
immunohistochemistry double staining for Ki-67 and TUNEL. The percentage of TUNEL positive 
cells also increased but this was not statistically significant. * p<0.05. Error bars shown are SEM. 
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Figure 7.17: Expression of clock-controlled genes c-Myc and Cdkn1a following 
Period1 knockdown 
 qPCR was performed on one patient sample and relative expression levels determined of target 
genes against housekeeper gene PPIA. Both CCGs are down-regulated in the knock-down group. 
Statistical analysis was not performed as a greater patient number is awaited. Error bars shown 
are SEM. 
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Figure 7.18: Thyrotropin-releasing hormone treatment - modulation of clock gene 
expression and PER1 protein expression.  
PER1 protein expression decreases in intensity with thyrotropin-releasing hormone treatment. (B) 
Clock, Bmal1, Cry1 and Cry2 mRNA expression increases in a dose-dependent manner with 
thyrotropin-releasing hormone treatment. Expression was determined relative to housekeeper 
ACTB. The effect of TRH on CLOCK expression was significant at p<0.01 at 5ng/ml and p<0.001 at 
concentration 100ng/ml. The effect of TRH on Bmal1 was significant at higher TRH concentration 
when compared to control HFs (p<0.001). Cry1 expression was found to be significantly higher 
(p<0.001) in hair follicles treated with 100ng/ml of TRH compared to the control group. Period1 
gene expression decreased compared to control hair follicles, but the trend was not dose-
dependent. Period1 transcription was highest in the control group, lowest in the group treated 
with 5ng/ml of TRH (p<0.05) and increased in the 100ng/ml TRH treated group. Hair follicles in 
the same stage were compared to each other. Error bars shown are SEM. 
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7.5 DISCUSSION 
The molecular control mechanisms that coordinate the human hair cycle have 
not been identified (Stenn and Paus, 2001, Paus and Foitzik, 2004, Paus et al., 
1999a). In this study the role of clock genes and proteins, as potential 
candidates in controlling the human hair cycle, have been investigated. This 
study implicates circadian clock genes as regulators of infradian tissue 
remodelling events i.e. the human hair cycle. Importantly, we show that 
peripheral clock genes are not only expressed in a circadian and hair cycle 
dependent manner, but also actively modulate human anagen-to-catagen 
transition in the absence of influences from the central clock. Specifically, we 
identify Period1 and Clock as functionally important anagen-terminating signals 
in the human HF. Although not established here, we present preliminary work 
that suggests that the mechanism may be via modulating the activity of cell- and 
hair cycle modulatory CCGs such as p21 or c-Myc. In addition, we report the 
novel finding that Period1 and Clock modulate HF pigmentation in situ. Finally, 
we explore the possibility that intra-follicular activity of clock gene activity in 
human HFs may be modulated by the neuroendocrine hormone TRH. 
Evidence of a functional peripheral circadian clock is demonstrated in 
both anagen and catagen isolated human HFs. Both core clock and clock-
controlled mRNAs were found to be expressed in a circadian manner (clock-
controlled mRNA expression was investigated in anagen HFs only). The 
experimental assay of healthy micro-dissected human scalp HFs was used so as 
to eliminate any extra-follicular inputs on HF cycling (including central clock 
influences). Therefore, from our results, organ-cultured human scalp HFs seem 
to exhibit a functional circadian clock when removed from any central clock 
influences. 
These results are in line with previous work on mammalian skin and cultured 
skin cell populations that show circadian expression of clock genes in these 
samples (Bjarnson et al., 2001, Balsalobre, 2002, Gachon et al., 2004, Lee, 2006, 
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Gréchez-Cassiau et al., 2008, Duguay and Cermakian, 2009, Lin et al., 2009, 
Akashi et al., 2010, Spörl et al., 2011). 
We also demonstrate that human scalp HFs differentially transcribe the 
core clock mRNA (Period1) and its protein product (PER1) in a hair cycle-
dependent manner; with up-regulation in catagen. In addition, knock-down of 
Period1 significantly promoted anagen maintenance. Interestingly, we saw that 
in Patient C, the anagen HFs exhibited very minimal Period1 mRNA expression 
(Figure 7.3c). The HFs had been maintained in organ culture for 7 days and both 
anagen and catagen HFs were harvested on the same day. Although, this was 
only reported in one patient, this fits into the hypothesis that Period1 promotes 
catagen. The anagen HFs may have remained in anagen as they had a “Period1 
repression” (or knock-down) status. Of course, this can be confirmed or refuted 
by repeating the experiment for greater patient numbers in the future. 
Our data also suggests that Clock promotes catagen, with knock-down 
promoting the anagen state. Our human data complements the previously 
documented role for Clock in the HF switch from telogen to anagen in mice in 
vivo with knock-out mice exhibiting delayed anagen entry (unfortunately, this 
switch cannot yet be studied in human HF organ culture as HFs do not enter 
telogen from catagen in organ culture) (Lin et al., 2009). Also, the Period1 
protein and mRNA expression differences between anagen and catagen 
reported here are mirrored in the murine hair cycle: Period1 mRNA expression 
in mouse skin increased during the anagen-catagen transformation of the HF 
(Lin et al., 2009), though less dramatically than seen during the human anagen-
catagen transformation here. While this murine in vivo study could not exclude a 
major influence of the central clock on HF cycling, our current study excludes 
the central clock from playing a role in our isolated human HFs and therefore 
suggests that the peripheral clock is important for HF cycling, at least in the 
human system. This would need to be further examined in future experimental 
work. 
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While clock gene expression has already been reported in isolated, 
cultured human melanocytes (Zanello et al. 2000), we demonstrate here that 
Period1 and Clock may be novel, endogenous inhibitors of human HF 
pigmentation, namely in the HF pigmentary unit (Tobin, 2011). This makes 
Period1 and Clock the first clock genes to be potentially important modulators of 
normal human pigmentation in situ.  Therefore, the current study extends upon 
previously published work by demonstrating circadian and hair cycle-
dependent clock gene activity in intact human HFs (not just hair shafts (Akashi 
et al., 2010)) in the absence of central clock influences, and by demonstrating 
that clock gene silencing impacts human HF cycling and pigmentation. 
The major hair growth- and proliferation-modulatory effects of clock 
gene silencing seen here are in line with the established concept that clock gene 
and CCGs directly control cell cycling (Lowrey and Takahashi, 2004, Miller et al., 
2007). In fact, we demonstrate, in preliminary data performed on one patient, 
that selected genes involved in cell cycling are modulated by a knock-down of 
Period1. For example, the effect of Period1 on the anagen-catagen 
transformation of human HFs may be via CCGs. The crucial cell cycle regulator 
and CCG, C-Myc, which is under direct circadian regulation (Lee, 2006, Fu et al., 
2002) and also controls murine HF cycling (Bull et al., 2005), is affected by 
Period1 knock-down. Thus, Period1 may regulate the human hair cycle via 
modulating the cell cycle machinery of HF keratinocytes, very similar to the 
CCGs investigated in the murine hair cycle study by Lin et al. 2009 (Lin et al., 
2009).  
Namely, we show that the cell cycle regulator, p21 (CDKN1A), acts as a 
CCG in isolated human HF and that Period1 knock-down reduces p21 
expression. This fits nicely to the findings of Lin et al. who have shown an up-
regulation of p21 in the secondary hair germ of Bmal1 knockout mice  which 
display delayed anagen induction (Lin et al., 2009). Intriguingly, Period1 is 
implicated in tumour suppression: Per1 and Per2 knockout mice exhibit 
neoplastic and hyperproliferative phenotypes, and deregulation of cell cycle 
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genes such as c-Myc and Cyclin D1 are found in mPer2 mutants (Lee, 2005, Lee, 
2006). Therefore, it is reasonable to propose that Period1 controls the anagen-
catagen transformation of human HFs by balancing apoptosis and proliferation 
in the hair matrix via CCG pathways as a hypothesis for future work. Among 
these classical Period1 target genes, c-Myc and p21 are recognised as important 
hair cycle-regulatory genes (Bull et al., 2005, Bull et al., 2001, Mitsui et al., 2001, 
Ohtani et al., 2007). Therefore, while this remains to be demonstrated, it is 
conceivable that Period1 regulates the anagen-to-catagen transition via its 
impact on CCGs genes that subsequent execute this HF transformation. 
It has been the experience in some laboratories that siRNA transfection 
induces apoptosis in human hair follicles in organ culture. To further delineate 
the role of Period1 and Clock in the human hair follicle, it would be prudent to 
check the hair growth, hair cycle, melanin content, proliferation and apoptosis 
effect of siRNA transfection compared to untransfected HF controls also. This 
would indicate whether the changes seen in the Period1 and Clock knock-down 
groups compared to the scrambled oligonucleotides controls was an effect that 
was over and above performing no transfection at all. This shall be performed in 
future experiments.  
Since our organ-cultured human HFs did not contain the bulge region 
and its epithelial and melanocyte stem cells (Philpott et al., 1994a, Ito et al., 
2004), the observed catagen inhibition and stimulation of HF pigmentation 
must have occurred independent of bulge epithelial and melanocyte stem cells. 
Using a recently developed model of keratin 15-promoter-driven GFP 
expression in human HF epithelial progenitor cells (Tiede et al., 2009), we hope 
to dissect, next,  how Period1 or Clock silencing impact on adult human 
epithelial stem cell biology in situ. A future question is therefore: How did clock 
genes and related CCGs impact on the progeny of these stem cells (i.e. transit 
amplifying cells) that constitute the hair bulb cells that have been studied in the 
current human HF organ culture assay? 
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The impact of thyrotropin-releasing hormone (TRH), a hypothalamic 
clock gene regulator (Gary et al., 1996, Gary et al., 2003) on human HF clock 
gene and PER1 protein expression was assessed here. This was particularly 
interesting in the current context, since it has been shown that TRH is expressed 
in human HFs and promotes human hair shaft growth and prolongs anagen 
duration in vitro (Gáspár et al., 2010). We found that TRH stimulated Clock, 
Bmal1, Cry1 and Cry2 mRNA expression, while its effect on Period1 mRNA was 
variable according to dose, but decreased PER1 protein expression in human 
HFs. This suggests that TRH may modulate clock gene activity within the human 
HF. It is not clear, however, whether these differences may be secondary to 
phase shifting effects. We are currently performing further experiments to 
confirm these results following acute treatment with TRH. Human HFs have 
recently been recognised as an extra-hypothalamic site of TRH expression on 
the gene and protein level. In addition, TRH has been shown to inhibit catagen 
and stimulates hair MK proliferation (Gáspár et al., 2010). Therefore, TRH may 
serve as an intra-follicular neuroendocrine input signal for the regulation of 
human hair cycling. This is in line with the recognition that TRH centrally 
modulates clock-related biological rhythms (Gary et al., 2003). Therefore, 
regulatory feedback loops between TRH expression and clock gene activity can 
be envisioned and this will require further analyses.  
This study extends upon previously published work by demonstrating 
circadian and hair cycle-dependent clock gene activity in intact human HFs in 
the absence of central clock influence. In addition, we demonstrate functional 
effects of clock gene silencing on human HF growth, cycling and pigmentation. 
Moreover, our data support the working hypothesis that spontaneous or 
neuroendocrinologically induced fluctuations in intra-follicular clock gene 
activity are an integral component of the proposed human “HCC” (Paus & 
Foitzik 2004). This begs the question of how the molecular machinery that 
governs circadian events (i.e. a 24 hour rhythm) may also be responsible for co-
coordinating infradian processes such as the human hair cycle (which lasts 
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several months to years). Our findings are in line with a growing body of 
evidence that circadian clock genes regulate multiple physiological processes 
including infradian rhythms, such as the cell cycle (Khapre et al., 2010, Matsuo 
et al., 2003), tumour suppression (Fu et al., 2002, Yang et al., 2009, Chen-
Goodspeed and Lee, 2007), seasonal rhythms (Hazlerigg and Loudon, 2008), 
breeding patterns (Miller et al., 2004), and the reproductive cycle. The control of 
infradian events by “circadian” clock genes may even extend to disease states 
such as diabetes and depression (Takahashi et al., 2008, Ando et al., 2009). 
Therefore, the concept that clock genes are part of the autonomous oscillator 
system that drives infradian HF cycling is in line with an evolving paradigm shift 
in our understanding of so-called “circadian” clock functions (Geyfman and 
Andersen, 2010). 
The activity of two core clock genes (Period1, Clock) modulate human HF 
growth, cycling and pigmentation. Our findings suggest a new mechanism for 
how human HF cycling may be autonomously and rhythmically controlled. 
Therefore Period1 activity is particularly highlighted here as a promising novel 
target for therapeutic hair growth modulation. Antagonising the activity of 
Period1, Clock and selected down-stream CCGs may serve to counteract various 
forms of hair loss characterised by premature catagen induction and 
subsequent telogen effluvium. Promotion of these targets may be exploited for 
treating unwanted hair growth (hirsutism) (Cotsarelis and Millar, 2001, Paus, 
2006). Furthermore, the novel inhibitory role of Period1 and Clock in human 
hair pigmentation identified here invites the speculative question whether 
excessive Period1 and Clock activity may in any way be related to hair greying.  
In summary, we show that the human HF offers a clinically relevant 
model for studying how two distinct chronobiological systems, i.e. “circadian” 
system and the oscillator system that drives non-diurnal, cyclic organ 
transformation intersect (Schneider et al., 2009, Plikus et al., 2008). Finally, 
human HF organ culture may facilitate dissection of the role of peripheral clock 
genes in peripheral human tissue physiology and remodelling.   
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8 CHAPTER 8: TOWARDS DEFINING A 
MOLECULAR SIGNATURE OF HUMAN ANAGEN 
AND CATAGEN BY TRANSCRIPTOME PROFILING 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter under preparation for submission as “Patterns of Expression” article to 
Experimental Dermatology 
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8.1 CHAPTER SUMMARY 
In the previous chapters, we presented two hypothesis-driven modes to 
investigate the human hair cycle (in particularly the controls that drive the 
anagen-to-catagen transition) from a systems biology perspective. The first 
approach used mathematical modelling to address the nature of the human hair 
cycle rhythm, and the second explored a chronobiological hypothesis regarding 
the role of circadian transcription factors as potential regulators of the anagen-
to-catagen transition.  
In the current chapter, these research strategies are complemented with a 
third “unbiased” experimental approach by exploring the global gene 
expression (transcriptome) profile of the human anagen and catagen states. 
This final component of the thesis was intended as an important step towards 
defining the molecular signature of human HF cycling, namely towards 
establishing an extended data base for future systems biology research into 
important genes and signalling pathways that participate in regulating the 
anagen-catagen transformation of human HFs.   
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8.2 ABSTRACT 
The human hair cycle represents a complex, dynamic systems process that 
is based on interconnected networks of molecules and signalling 
pathways. These are recruited to drive the hair follicle (HF) through its 
cyclic transformations from organ growth (anagen) via organ regression 
(catagen) to resting (telogen). Despite great advances in our 
understanding of the hair cycling process, for example with the use of 
mouse mutants, there are large gaps in the knowledge of how these 
candidates are expressed in the human hair follicle, and their impact on 
human HF cycling. Therefore, the global gene expression (transcriptome) 
profile of the human anagen and catagen states was explored by 
microarray and qPCR analysis of microdissected, organ-cultured anagen 
and catagen HFs from three female patients. Fold changes were calculated 
using anagen as the baseline sample. This gene profiling approach 
revealed that similar genes and pathways that had been shown to control 
the murine hair cycle in vivo, such as Sgk3, Msx2 and the BMP pathway, are 
also differentially regulated during the anagen-catagen transformation of 
human hair follicles. In addition, novel genes including AKR1C2 and Dsg4 
were found to be significantly up-regulated in catagen and anagen 
respectively. This study contributes to the identification of important key 
and novel genes in human hair cycle control and suggests targets for 
therapeutic hair growth regulation. In addition, this anagen-catagen 
transcriptome analysis allows future refinements of mathematical hair 
cycle models by integrating concrete molecular candidates into these 
models. 
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8.3 INTRODUCTION 
The HF undergoes dramatic structural and molecular changes in a cyclical 
manner during the hair cycle. This process represents dynamic, spatio-temporal 
changes at multiple scales. It has been suggested that changes in local signalling 
cause the transition from one cycle to the next (Stenn and Paus, 2001, 
Botchkarev and Kishimoto, 2003, Schneider et al., 2009). However, much of the 
data we have on the hair cycle relies on murine data. Previous studies have not 
looked at hair cycle associated gene profile changes in the human system.  
Hair cycle dependent changes in the transcription of individual genes 
and gene products during selected hair cycle stages has been identified, mostly 
in mice (see (Schneider et al., 2009, Stenn and Paus, 2001, Paus and Foitzik, 
2004)). Schlake et al published one of the first investigations of global hair cycle 
expression profiles using microarray analysis. The authors used murine dorsal 
skin, therefore, the HFs were synchronised in the murine hair cycle (Schlake et 
al., 2004). The work was limited by the fact that the HF itself was not extracted 
from the skin, thus results were confounded by hair cycle-associated 
transcriptional changes in peri- and inter-follicular skin cell populations. A 
similar temporal expression experiment on RNA extract from total skin was 
performed on the murine hair cycle by Lin et al (Lin et al., 2004). Again, 
synchronised hair cycling in the neonatal and juvenile mice was utilised in the 
microarray analyses. Unfortunately, the “first hair cycle” investigated in this 
analysis actually represented the end of postnatal HF morphogenesis. 
Therefore, this study did not allow one to distinguish clearly between 
morphogenesis and hair cycle associated transcriptional changes. 
To-date there is no published microarray analysis that has compared 
human anagen VI HFs and catagen HFs from the same patient. Previous global 
expression analyses of microdissected human HFs has focussed on identifying 
gene expression profile changes in human anagen VI HFs in response to defined 
test agents, such as hormones, polyamines or chemotherapy (Bodo et al., 2007, 
Langan et al., 2010, Gáspár et al., 2010, Ramot et al., 2010, Ramot et al., 2011). 
Another study has compared the transcriptome expression profiles between 
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white and grey human HFs (Choi et al., 2011). In addition, previous studies have 
investigated extracted human HF compartments, which also allow site specific 
expression profiles to be identified, such as human HF DP cells (Park et al., 
2007, Iino et al., 2007) and the CTS (de Schellenberger et al., 2011).  
Establishing changes in the global gene expression profile between 
human anagen and catagen states may provide important indications as to 
which genes: a) may be involved in regulating the human anagen to catagen 
transformation, and b) may serve as specific molecular markers of human 
anagen VI versus catagen.  
As argued before, understanding the complex systems changes that occur 
in the human HF in the normal anagen and catagen stages may aid in tackling 
the disease process (Al-Nuaimi et al., 2010, Paus, 2006, Paus and Foitzik, 2004). 
Human HFs, although possessing many similarities with murine hair, also 
exhibit important differences in their temporal and spatial cycling properties 
(Al-Nuaimi et al., 2010, Plikus et al., 2011). Moreover, definition of the human 
anagen-catagen transcriptome may facilitate future refinements of 
mathematical hair cycle models, since this could allow one to by integrate key 
molecular players into such models. 
In this pilot study, we aim to explore the human anagen and catagen 
states using microarray analysis and to establish whether important hair cycle-
regulatory candidate genes known from the murine hair cycle also are 
differentially regulated during the human anagen-catagen transformation. 
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8.4 METHODS 
8.4.1 Hair follicle isolation and culture for microarray analysis 
Redundant human scalp skin was obtained from the scalp of three patients (all 
females, ages 48, 54 and 68) undergoing facelift surgery following informed 
consent (Table 8.1). Individual HFs were isolated by micro-dissection as 
previously described (Philpott et al., 1990, Sanders et al., 1994).  
The HFs were assessed under the dissection microscope to ensure they had not 
been damaged during isolation and that they appeared to be in anagen VI 
(Kloepper et al., 2010).  Isolated, exemplary reference HFs were examined 
histologically, following published hair cycle staging criteria (Kloepper et al., 
2010) and using the hair staging accuracy investigation (Chapter 6.7) as 
validations for whether the “macroscopic” hair cycle staging had been accurate. 
The investigation presented in Chapter 6.7 and previous comparisons in the 
Paus lab (University of Luebeck), revealed a reasonable congruence between 
“macroscopic” and histomorphometric human hair cycle staging results. The 
HFs were assessed to ensure they had not been damaged during isolation and 
that, macroscopically, they appeared to be in anagen VI (Kloepper et al., 2009).  
Anagen VI HFs for each patient were maintained in a 24-well plate; each 
well contained 500µls serum-free Williams’ E medium (Biochrom, Cambridge, 
UK) supplemented with 2mmol/L L-glutamine (Invitrogen, Paisley, UK), 
10ng/ml hydrocortisone (Sigma-Aldrich, Taufkirchen, Germany), 10µg/ml 
insulin (Sigma-Aldrich) and 1% antibiotic/antimycotic mixture (100x, Gibco, 
Germany, Karlsruhe). The supplemented media was changed every two days. 
HFs were placed in an incubator at 37°C with 5% CO2 level, maintained in 
culture and assessed daily using light microscopy to determine whether they 
appeared, macroscopically, to be in anagen or late catagen phases. Once HFs 
were seen to have entered the appropriate stage for experimentation, HFs were 
immediately snap frozen in liquid nitrogen. Anagen and late catagen samples 
were taken for microarray analysis to determine gene expression pattern 
differences between these two distinct cycle points. 
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8.4.2 RNA extraction for microarray analyses 
Anagen VI and late catagen HF samples for three female patients were taken for 
total RNA extraction (Table 8.1). The extractions were performed together in 
one run to ensure consistent experimental conditions and subsequent 
microarray analyses. Total RNA was extracted following the manufacturer’s 
protocols using TRIzol® and the PurelinkTM RNA Mini Kit (Invitrogen, UK) 
(homogenisation was performed by adding 800μl TRIzol® to each sample and 
using a pestle and mortar for 1 minute followed by 30 seconds with a 
homogeniser). The quantity and quality of the extracted total RNA was assessed 
using a BioAnalyzer 2100 (Agilent technologies Ltd., UK). 
 
Table 8.1: Summary of the patient samples used for microarray and qPCR 
experiments 
Patient Gender Location Stage Samples Microarray qPCR 
1 
 
Female Fronto-
temporal 
Anagen 30HFs   
  Late 
catagen 
10 HFs   
2 Female Fronto-
temporal 
Anagen 28 Hfs   
  Late 
catagen 
28 Hfs   
3 Female Fronto-
temporal 
Anagen 20HFs    
  Late 
catagen 
20 HFs    
4 
 
Male Occipital Anagen 30 HFs   
  Late 
catagen 
30 HFs    
5 Male Occipital Anagen 25 HFs   
  Late 
catagen 
37 HFs   
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8.4.3 Microarray analysis 
Human genome U133A oligonucleotide microarrays were performed by the 
University of Manchester Genomic Technologies Core Facility following the 
manufacturer’s instructions (Affymetrix®, UK). Technical quality control was 
performed using dChip (Li and Wong, 2004) followed by background correction, 
normalisation and expression using the GC-RMA method (Wu et al., 2004). 
Anagen state was taken as the baseline and fold changes were calculated as the 
expression in catagen compared to anagen for each patient. Differential 
expression between anagen and catagen samples was tested using paired 
Student’s t-tests. The data was filtered by creating a subset of probes whereby 
up or down-regulation was greater or less than 1.5 fold change in all three 
patients. Genes were subsequently analysed for over represented gene 
ontologies (GO) using the online tool Database for Annotation, Visualisation and 
Integrated Discovery version 6.7 (DAVID 6.7) (Huang et al., 2009, Dennis et al., 
2003). 
 
8.4.4 Additional hair follicle cultures for validation by real-time qPCR 
Two additional HF cultures were performed in exactly the same way as 
described above (see Table 8.1), however, in these samples the HFs were 
harvested on the same day when half the HFs in culture were in anagen and the 
other half were in catagen.  
 
8.4.5 Real-time qPCR 
In order to validate the results from the microarray experiment, total RNA 
extracted from three patients (Table 8.1) was used to perform qPCR on a sub-
selection of genes identified from the microarray. Total RNA isolations, reverse 
transcriptions and qPCR experiments were performed by University of 
Debrecen Physiology Department, Biro lab, Hungary. Taqman® (Applied 
Biosystems) gene expression assays were obtained for msh homeobox 2 
((Msx2) Assay ID Hs00741177_m1, RefSeq: NM_002449.4, Amplicon length 
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130bp), serum/glucocorticoid regulated kinase family, member 3 ((Sgk3) Assay 
ID Hs00179430_m1, RefSeq: NM_013257.4,  Amplicon length 88 bp), bone 
morphogenetic protein 2 ((Bmp2), Assay ID Hs00154192_m1, RefSeq : 
NM_001200.2,  Amplicon length  60 bp), bone morphogenetic protein 4 
((Bmp4), Assay ID Hs00370078_m1, RefSeq: NM_130850.2,  Amplicon length  
58 bp), secreted phosphoprotein 1 ((Spp1), Assay ID Hs00959010_m1, RefSeq: 
NM_001040058.1, Amplicon length 84 bp), frizzled homolog 10 (Drosophila) 
((Fzd10, Assay ID Hs00273077_s1, RefSeq: NM_007197.3, Amplicon length 
116bp), desmoglein 4 ((Dsg4), Assay ID Hs00698286_m1, RefSeq: 
NM_177986.3, Amplicon length 154 bp), FK506 binding like protein (FKBPL, 
Assay ID Hs00276690_g1, RefSeq NM_022110.3, Amplicon length 75 bp), BMP 
and activin membrane-bound inhibitor homolog (Xenopus laevis) ((Bambi), 
Assay ID Hs03044164_m1, RefSeq: NM_012342.2, Amplicon length 52 bp). The 
relative expression was obtained against the endogenous control peptidylprolyl 
isomerase A (cyclophilin A) ((PPIA), Assay ID Hs99999904_m1, RefSeq: 
NM_021130.3, Amplicon length 98 bp) ), because previous analysis in the Biró 
lab had shown this housekeeping gene to undergo only minimal hair cycle-
dependent expression changes during the human anagen-catagen 
transformation (data not shown).  
Total RNA was isolated using TRIzol (Invitrogen) and then 1 μg of total 
RNA was reverse-transcribed into cDNA by using 15 U of AMV reverse 
transcriptase (Promega; Madison, WI, USA) and 0.025 μg/μl random primers 
(Promega). Quantitative PCR was performed on an ABI Prism 7000 sequence 
detection system (Applied Biosystems; Foster City, CA, USA) using the 5’ 
nuclease assay as detailed in our previous reports (Tóth et al., 2009, Bodo et al., 
2005) and the TaqMan® universal PCR master mix protocol (Applied 
Biosystems). Experiments were performed in triplicates; the average relative 
expression levels were calculated using delta Ct method and relative fold change 
in catagen compared to anagen was calculated using the delta delta Ct method. 
The normalised relative expressions obtained via delta Ct method for anagen 
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and catagen was tested statistically using the paired Student’s t-test. Statistical 
analysis was performed using GraphPad prism 5. 
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8.5 RESULTS 
8.5.1 Microarray results 
Of the 54613 probe sets arrayed, 29244 (53.55%) were up-regulated and 25269 
(46.27%) down-regulated in catagen compared to anagen (Table 8.2 and Figure 
8.1). This global result represents the average expression of each probe set 
across the three patients. However, in order to establish the “transcriptional 
signature” in anagen, we selected genes that were down-regulated by a fold 
change of ≤1.5 in all three patients as an “anagen signature” subset. Likewise 
genes up-regulated with ≥1.5 fold change in all three patients were considered 
to provide the “catagen signature” (Figure 8.2). Each of these signature groups 
reassuringly contained genes associated with each state. For example, multiple 
hair keratins were seen to be differentially expressed in the anagen subset and 
several extracellular matrix genes in the catagen subset. Comprehensive lists of 
the genes in each subset can be found in Table 8.3 and 8.4. Of these subset 
genes, very few genes were up- or down-regulated by greater than 2 fold in all 
three patients. Twenty-four genes were down-regulated (by a fold change of <2 
in all three patients) in catagen compared to anagen (Table 8.3). Only three 
genes were up-regulated by >2x in all three patients in catagen compared to 
anagen (Table 8.4). These were secreted phosphoprotein 1, disabled homolog 1 
and aldo-ketoreductase family 1, member C2. 
 
 
Table 8.2: Table detailing the numbers of genes in each subset selected for further 
analysis (corresponds to red data values in Figure 8.2) 
 Probe sets Genes 
Total number of probe sets on the microarray 54613 - 
Up-regulated in catagen 29244 - 
Down-regulated in catagen 25269 - 
≥1.5 in all three patients (catagen signature) 26 20 
≤-1.5 in all three patients (anagen signature) 118 100 
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Figure 8.1: Scatter plot of the microarray results  
Fold change values of catagen samples compared to the anagen samples and the p-values obtained 
from paired Student’s t-test. 
 
Figure 8.2: 3D scatter plot of the fold change values for each probe set in three 
patients.  
Red indicates the subsets taken for further analyses. 
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Table 8.3: Genes selected as “anagen signature”  
Average fold change across three patients is displayed ordered by the greatest fold change. Bold 
indicates those that were significant - paired Student’s t-test (p<0.05). The gene names presented 
in bold were those taken for verification with qPCR 
Genes Average Fold 
change  
p value Genes Average Fold 
change  
p value 
KRT33A -13.3 0.20 MSX2 -2.7 0.17 
KRT81 -11.0 0.16 RARRES1 -2.7 0.12 
GPRC5D -10.3 0.27 WNT3 -2.7 0.09 
KRTAP4-5 -8.8 0.17 MSX1 -2.6 0.07 
KRTAP4-3 -8.5 0.10 KIF26A -2.6 0.06 
KRTAP4-4 -6.8 0.13 SHROOM3 -2.5 0.01 
KRT34 -6.6 0.08 GPR37 -2.5 0.01 
LY6G6D -6.5 0.01 NALCN -2.5 0.01 
KRTAP1-3  -6.4 0.11 PPM1H -2.4 0.05 
KRTAP2-4 -6.3 0.04 CYP26B1 -2.4 0.15 
KRTAP2-1 -5.9 0.08 PSORS1C2 -2.4 0.15 
DSG4 -5.8 0.08 NPR3 -2.4 0.04 
KRTAP1-1  -5.8 0.08 CAMK2N1 -2.3 0.06 
KRTAP9-4/ 9-9 -5.7 0.09 LONRF2 -2.3 0.01 
KRTAP2-2 -5.6 0.07 HHIP -2.3 0.03 
KRTAP2-4 -5.4 0.09 H2AFJ -2.3 0.10 
KRTAP4-2 -5.3 0.10 XK -2.2 0.11 
KRTAP3-1 -4.9 0.11 MT4 -2.2 0.01 
KRTAP4-6 -4.8 0.06 CKMT1A/B  -2.2 0.07 
KRTAP4-9 -4.7 0.08 IFRD1 -2.2 0.08 
KRTAP4-7 -4.7 0.05 ILVBL -2.2 0.04 
RNF182 -4.6 0.12 DLX1 -2.2 0.07 
SELENBP1 -4.5 0.02 TC2N -2.2 0.02 
CRNN -4.3 0.06 PCYOX1 -2.2 0.03 
KRT31 -4.2 0.19 QPCT -2.2 0.005 
KRTAP3-3  -4.2 0.03 GPR37 -2.1 0.05 
FAM126B -4.1 0.10 SMAD6 -2.1 0.04 
FZD10 -4.0 0.04 GAS2L3 -2.1 0.06 
BAMBI -3.9 0.03 DLX3 -2.1 0.04 
KRT73 -3.9 0.04 KRT73 -2.1 0.09 
C8orf44/ SGK3 -3.8 0.08 TDH -2.1 0.06 
DLX2 -3.7 0.06 LOC100131317 -2.1 0.03 
KRT86  -3.7 0.07 SAMD8 -2.0 0.03 
P2RY5 -3.6 0.05 OCA2 -2.0 0.05 
LONRF2 -3.6 0.04 KCNK7 -2.0 0.04 
KRTAP3-2  -3.5 0.07 SNHG3 -2.0 0.04 
MUC15 -3.4 0.06 AXIN2 -1.9 0.03 
KIF5C -3.4 0.05 MUCL1 -1.9 0.02 
DYNC1I1 -3.4 0.05 FBXO8 -1.9 0.03 
LOC100131317 -3.3 0.05 PAG1 -1.9 0.03 
MYCN -3.3 0.10 VPS8 -1.8 0.05 
MSX2 -3.2 0.02 EFHD1 -1.8 0.01 
PPP2R1B -3.2 0.06 MAP3K7IP3 -1.8 0.005 
KIF5C -3.2 0.06 ID3 -1.8 0.01 
MYB -3.2 0.03 EEA1 -1.7 0.01 
GAS2L3 -3.1 0.06 FKBPL -1.7 0.04 
NCRNA00084 -3.0 0.08 DPY30 -1.7 0.004 
SGK3 -2.9 0.06 TTC9 -1.6 0.01 
PPP2R1B -2.9 0.10 NAV2 -1.6 0.001 
FAM49A -2.8 0.08 PRKAG2 -1.6 0.005 
KRT37 -2.8 0.08 RNF149 -1.6 0.02 
NCRNA00084 -2.8 0.07 SLC6A15 -1.6 0.01 
KRT85 -2.8 0.03 ARHGAP29 -1.5 0.001 
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Table 8.4: Genes selected as “catagen signature”  
Fold change >1.5 in all three patients. Here the average fold changes across the three patients is 
provided and ordered by the greatest fold change. Bold indicates probes that were significant by 
paired Student’s t-test p<0.05. The gene names presented in boldwere those taken for verification 
with qPCR 
Gene Fold 
change  
p value 
SPP1 3.7 0.07 
TNFAIP6 3.1 0.11 
COL14A1 2.7 0.10 
DAB1 2.7 0.002 
AKR1C2 2.6 0.02 
CCDC3 2.5 0.05 
MMP16 2.5 0.05 
NEFL 2.4 0.07 
COL27A1 2.1 0.02 
FHL1 2.0 0.04 
C18orf1 2.0 0.03 
AKR1C1 2.0 0.05 
NFATC1 2.0 0.04 
KCND3 1.8 0.04 
LOC143381 1.8 0.05 
PARD6G 1.7 0.01 
LOC100130097 1.7 0.01 
PARVA 1.7 0.01 
TANC2 1.6 0.01 
ANKRD6 1.6 0.01 
 
Using the DAVID online tool (Dennis et al., 2003), over-represented gene 
ontology (GO) categories were identified in the two subsets of anagen signature 
and catagen signature. The functional categories are provided in Figure 8.3 and 
8.4 and Table 8.5. The significantly over-represented groups in the catagen 
group were found to be: cell adhesion, steroid dehydrogenase activity, 
regulation of cellular component size, collagen, cell projection and cell division. 
In anagen the significantly over-represented categories were: keratin filament, 
pattern specification process, skeletal system development, cell fate 
commitment, embryonic morphogenesis, response to protein stimulus, 
serine/threonine kinase signalling pathway, neuron differentiation and BMP 
signalling pathway. These are considered key biological processes that 
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significantly distinguish anagen and catagen states in these three patients. The 
full lists of functional categories are found in Appendices D and E.  
 
Figure 8.3: GO functional categories for the anagen signature  
(Genes down-regulated in catagen compared to anagen) *indicates significant increase in 
biological representation when compared to the background genome expression (this is provided 
by DAVID). 
 
 
Figure 8.4: GO functional categories of genes up-regulated in catagen  
(compared to anagen) *indicates significant increase in representation over the background 
genome expression.   
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Table 8.5: Significantly overrepresented functional categories in anagen and 
catagen states 
Functional categories determined by DAVID analysis to be significantly over-represented compared 
to background genome expression. Gene abbreviations are according to the NCBI listings. 
*indicates genes that have been previously shown to be involved in hair growth, development, 
cycling or hair disorders. 
 
Table 8.6: Microarray results for BMP2 and BMP4 in anagen and catagen hair 
follicles 
Gene Patient 1 Patient 2 Patient 3 Average p value 
Bmp2 -5.1 -1.9 -1.1 -2.7 0.22 
Bmp4 -1.50138 -1.0495 -1.01651 -1.2 0.34 
 
8.5.2 Quantitative PCR verification results 
To verify the microarray findings, qPCR was performed on nine genes selected 
from the anagen and catagen subsets. In addition, due to the DAVID gene 
Functional category Catagen Anagen 
Cell adhesion 
SPP1*,  COL27A1  
COL14A1*,  TNFAIP6 
(*TNFalpha) 
 
Steroid dehydrogenase 
activity 
AKR1C2, AKR1C1  
Regulation of cellular 
component size 
SPP1*, FHL1, NEFL  
Collagen COL27A1, COL14A1*  
Cell projection 
SPP1*, KCND3, NEFL, 
PARVA 
 
Cell division PARD6G  
Keratin filament  
KRTAP2-2, KRTAP1-3, KRT85*, KRTAP3-2*, 
KRT86*, KRTAP4-7, KRTAP4-9, KRTAP4-3, 
KRTAP3-1, KRTAP2-4, KRTAP4-6, KRT73, 
KRTAP4-5, KRTAP4-2, KRTAP3-3, KRT81*, 
KRTAP1-1*, KRTAP9-4/9-9, KRTAP4-4, 
KRTAP2-1 
Pattern specification process  
AXIN2, SMAD6, DLX1*, WNT3*, HHIP, 
SHROOM3, DLX2*, CYP26B1 
Cell fate commitment  DLX1*, WNT3*, IFRD1, DLX2*, CYP26B1 
Skeletal system development  MSX2*, AXIN2, DLX1*, MSX1*, NPR3, DLX2 
Neuron differentiation  KIF5C, EFHD1, DLX1*, ID3*, DLX2* 
Serine/threonine kinase 
signaling pathway 
 MSX2*, SMAD6, BAMBI, MSX1* 
Response to protein stimulus  MSX2*, ID3*, MSX1*, LY6G6D 
Embryonic morphogenesis  
WNT3*, MSX2*, SHROOM3, MSX1*, DLX2*, 
CYP26B1  
BMP signalling pathway  MSX2*, SMAD6, MSX1* 
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ontology analyses finding BMP signalling as a significant biological process, 
Bmps 2 and 4 were also included in the qPCR analysis, even though the genes 
Bmp2 and Bmp4 were not identified from the microarray analyses as being 
differentially expressed (Table 8.6). 
The qPCR results revealed large differences in average relative 
expressions of the target genes between the anagen and catagen samples (Table 
8.7, Figure 8.5 and Figure 8.6). The differences were, however, not significant at 
the 0.05 level.  
Statistically significant differences were found on comparing the anagen 
and catagen relative expression levels for each gene by individual patients 
(Figures 8.7 and 8.8). Spp1 was not up-regulated in catagen compared to anagen 
apart from in the individual patient 2 (Figure 8.8) and therefore, the trend and 
fold change difference were not confirmed in this transcript.  
 
Figure 8.5: qPCR results from three patients’ anagen and catagen samples.  
Relative expressions of candidate gene targets are provided and obtained from the delta Ct 
normalisation method. Large fold change differences are seen, however none are statistically 
significant on p<0.05 level. 
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Figure 8.6: Validations of microarray results using the nine selected target genes in 
qPCR. 
 The average fold change in expression in catagen compared to anagen is shown here and was 
obtained using the delta delta Ct normalisation method (n=3, Error bars: SEM). 
 
Table 8.7: Fold changes in candidates mRNA in catagen compared to anagen 
determined by qPCR 
Performed on anagen and catagen for three patients. Fold changes were obtained using the delta 
delta Ct method. 
 Fold change (Catagen compared to Anagen) 
Patient Msx2 Sgk3 Bmp2 Bmp4 Fzd10 Dsg4 Bambi Fkbpl Spp1 
2 -6.3 -1.1 -5.7 -4.8 0 -4.3 -5.7 -3.0 1.0 
4 -4.9 -1.7 -2.7 -1.9 0.7 -3.3 -15.1 -6.6 -1.3 
5 -10.2 -14.1 -10.7 -10.5 -12.9 -14.7 -9.8 -10.9 -5.2 
Average -7.1 -5.6 -6.3 -5.8 -4.1 -7.4 -10.2 -6.9 -1.8 
 
8.6 DISCUSSION 
In this pilot study, we report the transcriptome profile of the human anagen and 
catagen state in microdissected, organ-cultured anagen and catagen HFs from 
three female patients. This gene profiling approach revealed that similar genes 
and pathways that had been shown to control the murine hair cycle in vivo, such 
as Sgk3, Msx2 and the BMP pathway, are also differentially regulated during the 
anagen-catagen transformation of human hair follicles.  
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Although this transcriptome analysis of the human anagen-catagen 
transformation needs to be extended to additional individuals before definitive 
conclusions can be drawn, it already points to both recognised and novel key 
players in human hair cycle control and suggests additional targets for 
therapeutic hair growth regulation. In addition, this anagen-catagen 
transcriptome analysis allows future refinements of mathematical hair cycle 
models by integrating concrete molecular players into these models. 
Bone morphogenetic protein (BMP) signalling was identified as having a 
significant representation in human anagen compared to catagen follicles. BMP 
signalling has been shown to be involved in murine HF biology and cycling 
regulation (Andl et al., 2004, Kulessa et al., 2000, Plikus et al., 2008, Botchkarev 
and Sharov, 2004, Botchkarev, 2003, Guha et al., 2004, Kobielak et al., 2007, 
Kwan et al., 2004, O’Shaughnessy et al., 2004, Rendl et al., 2008, Sharov et al., 
2006, Zhang et al., 2006).  
Here, we show, for the first time, that the BMP pathway is significantly 
over-represented in human anagen HFs, in particular genes that have been 
intimately associated with BMP signalling, such as Msx1 and Msx2, Bambi and 
Smad6 were significantly up-regulated in this microarray investigation. The 
results from the microarray for Bambi and Msx2 were verified by qPCR and we 
additionally checked the expressions of Bmp2 and Bmp4 in the qPCR 
experiments and these were significantly up-regulated in anagen compared to 
catagen. Additionally, we found that there was an anagen-associated expression 
of Bambi, a BMP pathway inhibitor. This was verified by qPCR. These results are 
complimented by a microarray analysis on depilation-induced hair cycling in 
rats whereby Bambi was identified as being up-regulated during the hair cycle 
(Umeda-Ikawa et al., 2009). In addition, miRNA-3 has been shown to regulate 
Bambi in the murine HF (Mardaryev et al., 2010). In addition, we found that the 
gene ID3 is significantly up-regulated in anagen. This gene has also been shown 
to be controlled by BMP in murine HFs (O’Shaughnessy et al., 2004). Therefore, 
in light of the evidence, BMP functioning is an important anagen process in the 
human HF.  
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Figure 8.7: qPCR results for Msx2, Sgk3, Bmp2, Bmp4 and Fzd10 in anagen and catagen hair follicles in each individual patient.  
* p<0.05, ** p<0.01, p<0.001. Error bars shown are SEM.
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Figure 8.8: qPCR results for the expression of Dsg4, Bambi, Fkbpl and Spp1 in anagen and catagen hair follicles for three  individual patients 
 * p<0.05, ** p<0.01, *** p<0.001. All results were significant apart from Spp1 where we see conflicting results. Patients 2 and 4 have similar change between anagen and 
catagen whereas patient 5 shows that there is actually a decrease in Spp1 in catagen compared to anagen. Error bars shown are SEM. 
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This study has also identified possible novel genes in the physiology of the 
anagen and catagen state. Interestingly, the genes AKR1C2 and AKR1C1 were 
significantly up-regulated in catagen compared to anagen. These genes are 
members of the aldo-keto reductase (AKR) superfamily and code for enzymes 
responsible for steroid metabolism (Arthur and Reichardt, 2010, Penning et al., 
2004). AKR1C1 and AKR1C2 encode for the proteins; 20α-HSD and Type 3α-HSD 
respectively. 20α-HSD eliminates progesterone and Type 3α-HSD eliminates 5α-
dihydrotestosterone (Jin and Penning, 2007). These enzymes not only 
metabolise steroids but also regulate androgen receptors (Penning et al., 2004) 
and AKR1C1 is involved in the metabolism of prostaglandin (Colombe et al., 
2007).  
Skin and the HF are known to metabolise and produce steroids 
(Hoffmann, 2003, Ito et al., 2005a) and androgens play a key role in the 
pathogenesis of hair disorders such as androgenetic alopecia and hirsutism 
(Eicheler et al., 1998, Chen et al., 2002, Steiner et al., 2008, Riedel-Baima and 
Riedel, 2008, Naito et al., 2008). However, there is comparatively little research 
specifically concerning the AKR superfamily in the physiology of skin and 
particularly HF function (Hoffmann, 2003). One study has shown that AKR1C2 is 
implicated in hirsutism (Steiner et al., 2008). Here we show that these genes are 
also important as catagen markers, which has not been reported previously 
(Zouboulis et al., 2007). 
In addition, a previous study has shown that increased AKR1C1 and 
AKR1C2 expression occurs following UV treatment of human skin with 
concomitant expression of apoptosis markers (Marίn et al., 2009). These authors 
suggest a role in keratinocyte survival and protection of keratinocytes from 
apoptosis. This is highly interesting as this information and our findings that 
these two genes are significantly up-regulated in catagen (a hair cycle stage 
heralded by apoptosis), provides a novel hypothesis that they are important in 
HF cycling and function and may even be the important factors in the 
pathogenesis of hormone related hair disorders, namely androgenetic alopecia. 
Another gene identified as differentially expressed in catagen was Spp1 
(secreted phosphoprotein 1) commonly known as osteopontin (OPN)). It is 
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known to be expressed in human DP cells (Chermnykh et al., 2010), however, 
there are limited reports on osteopontin and its role in the HF.  
In the skin, osteopontin has been implicated in psoriasis, skin cancer 
(Chang et al., 2008) and has been shown to have anti-apoptotic effects (Buback et 
al., 2009). Spp1 has been shown to protect cells from environmental insults 
(Wang and Denhardt, 2008, Denhardt et al., 2001) and may function to protect 
surviving HF cells during catagen. One report in rat HFs shows that osteopontin 
is expressed specifically in catagen (Yu et al., 2001). Yu et al showed that the 
expression of osteopontin was specific to the DP and the catagen stage in rat DP 
cells (Yu et al., 2001). Our study shows inconclusive results regarding the 
expression of Spp1 as the qPCR validations did not show up-regulation in 
catagen. The report in rat DP cells supports our microarray finding that Spp1 is a 
catagen-specific gene in human HFs, but the exact expression profile will need to 
be clarified further. 
Desmoglein 4 (Dsg4) mutations lead to hypotrichosis (Kljuic et al., 2003, 
Meyer et al., 2004, Schaffer et al., 2006, Bazzi et al., 2009). Here this was 
identified as an anagen associated transcript via microarray and qPCR analyses. 
Dsg4 is specifically expressed in the HF (Bazzi et al., 2006) and therefore may be 
a suitable anagen marker.  
Loss of muscle segment homeobox 2 (Msx2) causes major defects in hair 
cycling and hair shaft differentiation resulting in “cyclic alopecia” in mutant mice 
(Ma et al., 2003). Here, Msx2 was significantly up-regulated in human anagen HFs 
compared to catagen. Msx2 has been reported, to be expressed in human skin 
(Stelnicki et al., 1997). The microarray and qPCR results presented here are the 
first human hair cycle-dependent findings concerning this gene. Msx2 is also 
linked to BMPs as a downstream target (Cai et al., 2009) and has functional 
connections to another anagen-to-catagen regulatory gene, i.e. Dlx2 (Distal less 
homeobox 2) as shown in gene ontology analyses. Interestingly Dlx3 has been 
postulated to play a role in normal HF cycling (Hwang et al., 2008). The current 
transcriptome analysis identifies Dlx2 and Dlx1, but not Dlx3, as candidates for 
maintaining anagen in human HFs. 
Another gene that has been prominently implicated in timing of the 
murine hair cycle was identified as a member of the human anagen transcript 
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profile here. Sgk3 is responsible for the fuzzy phenotype (Campagna et al., 2008, 
Alonso et al., 2005, Okada et al., 2006) (see Chapters 2 and 3 also). Again, there 
are no reports on Sgk3 expression in the human HF. Sgk3 has been shown to 
affect cell survival and beta catenin expression; which are also known to be 
important in hair cycling (McCormick et al., 2004). Therefore, this gene may play 
an important role in human hair cycling. 
Other candidate human hair cycle-regulatory genes identified via the 
current microarray analysis are Wnt3 and Smad6. Wnt3 has already been shown 
to affect murine HF morphogenesis and cycling (Millar et al., 1999, Charpentier 
et al., 2000). In addition, Wnt has been demonstrated to maintain the anagen-like 
expression properties of DP cells in vitro (Kishimoto et al., 2000). 
Frizzled 10 (Fzd10) is a cell surface receptor for Wnts and is known to be 
expressed in the matrix, ORS and DP of postnatal murine HFs (Reddy et al., 
2004). There is evidence that Bmp2 modulates several Wnts and Frizzled 
proteins including Fzd10 (Yang et al., 2006). The results of the microarray 
analysis here showed that there was up-regulation in anagen; however, this was 
not confirmed by the qPCR analysis. This is the first report of Fzd10 expression 
in the human HF. Since the results were conflicting between qPCR and the 
microarray, this is best followed-up in additional patients and on the protein 
level, before one reaches conclusions. 
Fkbpl (fk506) was chosen as an interesting new candidate to verify the 
microarray date with. This was chosen as Fkbpl (otherwise known as 
Tacrolimus) is important in treating many dermatological conditions. In 
addition, it has been shown to induce anagen (Iwabuchi et al., 1994). Fkbpl 
decreases the expression of VEGF and IGF-1 in human skin, while no hair growth 
effect was found (Wang et al., 2009). However, in mice, Fkbpl is a very potent 
anagen-inducing and catagen-suppressing agent (Maurer et al., 1997, Paus et al., 
1996). 
Since we used isolated human HFs maintained in organ culture, one must 
consider the possibility that the human HF in vitro does not utilise the same 
signals for controlling its cyclic anagen-catagen transformation as it does in vivo. 
This is thought to be unlikely, since the “HCC” is an intra-follicular mechanism 
and should be preserved even after HF microdissections, culture, and 
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transplantation (Paus and Foitzik, 2004). Another limitation of the work is that 
we present mainly microarray data, which could be followed-up only very 
selectively within the temporal confines of this thesis.  In order to fully 
investigate the current pilot observations further, we would now expect to 
systematically compare the transcriptome results on the translational level, 
namely by immunohistology. Indeed a thorough investigation of these processes 
should now include protein analyses as transcription changes may not be 
reflected on the protein level (White and Salamonsen, 2005). 
We attempt to explore these issues by establishing 
immunohistochemistry protocols for some of the most interesting gene products, 
namely MSX2 and SGK3. In addition, we also plan to perturb these genes and the 
BMP pathway by using RNA interference technology; using the simple, small-
interfering RNA silencing strategies that we had successfully employed for intra-
follicularly expressed circadian genes (see Chapter 6).  
To further dissect the complex interactions that exist in the HF, namely 
epithelial-mesenchymal interactions, future work should entail isolated cell 
compartments of the HF, such as by laser capture microdissection to obtain the 
expression profiles of these HF compartments  (Rogers and Koike, 2009). Also, 
we only investigated the proximal HF, thus excluding e.g. hair cycle-dependent 
gene expression changes in the HF’s epithelial stem cell compartment, the bulge. 
Thus future transcriptome analyses should explicitly include this region, using 
full-length scalp HFs, as they become available e.g. during routine hair transplant 
surgery. 
A major limitation of the study is the low number of patients that was 
available for transcriptome analysis. A larger patient set, which should also 
include HFs from male donors, would ensure that confidence can be placed on 
the dissected human anagen and catagen signature, and may reveal gender-
specific gene expression differences. Due to the severe limitation of available 
human skin and HFs, the microarray arrays were performed on female patients, 
while and the additional patients for qPCR validations (patients 4 and 5) were 
male. The majority of results agreed between the female patient in qPCR (patient 
2) and the male results (patients 4 and 5). 
 238 
 
While constitutive gender differences in the gene expression patterns of 
human HF have not yet been systematically studied, it is already known that 
there are substantial gender-dependent differences in the transcriptional 
response of male versus female scalp HFs when these are exposed to oestrogen 
(Ohnemus et al., 2006) or prolactin in HF organ culture (Langan et al., 2010). 
This makes the future search for gender-dependent differences in the human 
anagen and catagen gene expression profile both interesting and important. 
One study performed on plucked human HFs (Kim et al., 2006) aimed at 
to use HFs as a clinical diagnosis tool.  Therefore, the study design differed to the 
needs of our study. The limitations of that study were that only hair shafts were 
plucked and analyses were performed in ignorance of the exact hair cycle stage. 
Also, only a portion of the proximal epithelial HF would have been analysed, 
excluding much of the hair matrix and the entire HF mesenchyme (Botchkarev 
and Kishimoto, 2003).  
To conclude, previous studies have either looked at the transcriptome 
changes in RNA extracts from total skin between different murine hair cycle 
states or have investigated transcriptional changes in human anagen HFs in 
response to defined test agents. However, there are no previous publications 
which systematically compare the transcriptome of spontaneously developed 
human anagen and catagen HFs in organ culture. Therefore, despite its evident 
limitations, the current pilot study provides novel pointers to the transcriptional 
changes that may be functional important during the anagen-catagen 
transformation.  
This suggests important new molecular targets for therapeutic 
intervention in common human hair growth disorders. Working hypotheses 
generated on the basis of the current transcriptome analyses can be tested 
functionally in human HF organ culture, e.g. by antagonising signalling mediated 
by the identified target genes (such as Msx2). 
In addition, this work may be used to develop future mathematical 
models of the signalling pathways involved in human hair cycle control.  
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9 CHAPTER 9: SUMMARY OF THE THESIS AND 
FUTURE PERSPECTIVES 
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The human hair cycle has been investigated in this thesis using both theoretical 
and experimental approaches. This final chapter summarises the main  
conclusions drawn from the work presented in this thesis, and develops 
perspectives for future work on human hair cycle research from a systems 
biology viewpoint (for more extensive discussion and future perspectives of the 
individual results generated in this thesis, see the Discussion sub-chapters of 
Chapters 5 to 8). 
After introducing the general field of research (Chapter 1), the relevant 
literature regarding our current understanding of the molecular mechanisms 
that drive human HF cycling was reviewed (Chapter 2). This analysis 
established that the molecular nature of the “HCC”, both in man and in mice, is 
still unknown and that fully convincing theoretical models of HF cycling remain 
to be developed. 
In Chapter 3, the HF was presented as a complex, multilevel, systems 
biology problem, which deserves to be fully discovered as a unique and 
clinically relevant research model by mainstream system biology researchers. In 
addition, it was concluded that in order to understand the human hair cycle, 
systems biology approaches (i.e. integration of experimental data 
complemented by the construction of a mathematical model) should be 
employed. 
In Chapter 4 non-linear dynamics was introduced in the thesis with the 
principles and important terminologies explained. In Chapter 5, these general 
principles were then applied to the human hair cycle via the construction of a 
mathematical model that captures key features of human HF dynamics. In this 
model, the human hair cycle was portrayed as a multi-cellular dynamical 
system. It is argued that the hair cycle controls act on a tissue level which act to 
coordinate distinct cell populations through the cycle. To conclude, we have 
presented a simple mathematical model that captures the dynamics of the 
human HF. Using a dynamical systems approach we provide the first 
mathematically formulated theory of the intrinsic components of the “HCC”. Our 
prototypic two compartment model is based on the key cell populations 
responsible for hair growth; MKs with communication set up by a second 
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compartment; the DP. The key conclusion is that HF dynamics requires two 
essential features; a bistable switch and feedback inhibition. Importantly, this 
simple model not only captures normal cyclical behaviour of the HF, but other 
essential features of HF dynamics as seen in vivo and may be a future tool for 
experimental and treatment predictions. The model is a novel contribution to 
the field and accounts for both the dynamics of the normal cycling human HF 
and pathological states. This is an important feature of the model as its 
behaviour, depending upon parameter values and initial conditions, can account 
for both the normal cycling dynamics of the human HF and pathological 
behaviour. This is in line with the concept of “dynamical disease” in that disease 
is a pathological alteration of normal dynamics (Glass and Mackey, 1988).  
After detailing the experimental methodology employed in the current 
thesis (Chapter 6), Chapter 7 turns to another hypothesis-driven application of 
systems biology to studying the problem of human HF cycling. It is argued that 
clock and clock target genes represent a classical systems biology paradigm. 
These “circadian” genes control and coordinate very complex processes on both 
the cell and tissue level, while their own activities are also subject to multiple 
external controls. Specifically, we test in Chapter 7 the working hypothesis that 
selected clock and clock target genes are functionally important in the control of 
the anagen-catagen transformation.  
We show that circadian genes and proteins, responsible for 
autonomously coordinating the circadian rhythm, are involved in human HF 
cycling. In vitro, isolated human HFs exhibit both a circadian rhythm and hair 
cycle-dependent expression changes independently from central clock 
influences (such as from the suprachiasmic nucleus). By adopting siRNA 
technology for gene silencing purposes, Period1 and Clock are identified as 
modulators of the anagen-catagen transition in human scalp HFs in organ 
culture. Period1 and Clock also affect melanin content in anagen HFs, which 
produces new hypotheses regarding the role of these molecules in 
melanogenesis. 
This work is novel as circadian clock genes have not previously been 
implicated in human hair cycle control. This work establishes that the human 
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HF exhibits multiple chronobiological rhythms on several levels. The exact 
mechanisms by which the circadian clock system affects the infradian hair cycle 
remain to be elucidated. It is hypothesised firstly, that the effector mechanisms 
may be via clock-controlled genes such as c-Myc and Cdkn1a. Secondly, intra-
follicular clock gene activity may be under hormonal controls such as regulation 
by the intra-follicularly generated (hair growth and pigmentation modulating) 
neurohormone, TRH.   
In Chapter 8, the transcriptome profiles of isolated, organ-cultured 
human scalp anagen and catagen HFs is established. Significantly over-
represented gene functional categories in catagen were cell adhesion, steroid 
dehydrogenase activity, regulation of cell compartment size, collagen, cell 
projection and cell division. Anagen was characterised by the over-
representation of keratin filament, BMP signalling, patterning, development, 
differentiation, serine/theorine kinase signalling and morphogenesis genes 
compared to background genome expression. This unbiased human 
transcriptome analysis not only identifies  many genes that were known to be 
important in the control of murine HF cycling, but also demonstrates differential 
expression of novel candidate marker genes between anagen and catagen 
human HF. 
This pilot study suggests that anagen and catagen in human organ 
culture HFs have distinct gene expression profiles.  The identified marker genes 
could be used in the future to: verify human hair cycle staging, develop novel 
hair therapeutic targets and be factored into mathematical models of human HF 
cycling. The study remains to be complemented by additional systematic 
analyses on the protein level. 
In the experimental components of this thesis, anagen and catagen 
human scalp organ cultured HFs were utilised for study. The organ culture 
model is currently the best available assay for studying human HF cycling in 
vitro, however, this needs to be complemented on the in vivo level. Feasible 
future experiments include corresponding clinical trials, using e.g. the 
phototrichogram technique (Dhurat and Saraogi, 2009) and analysis of fresh 
samples of whole human skin. Unfortunately, this is severely limited by the fact 
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that usually only 5-10% of human scalp HFs are not in the anagen stage at one 
time. Therefore, such in vivo analyses will require many months or years to 
collect enough catagen and telogen human HFs for analyses. 
The distinct, but complementary research approaches employed in this 
thesis underscore that there is a challenge in dealing with the complexity in 
scales that one faces in hair biology i.e. both microscopic and macroscopic 
processes are involved in the hair cycle. A logical next step towards this 
challenge would be to integrate the novel molecular hair cycle control 
mechanisms (such as circadian clock genes or newly identified anagen/catagen 
marker genes) into the existing mathematical model of human HF cycling. The 
aim would be to then understand how such fast oscillators (circadian clock and 
cell cycle oscillators) may function together to regulate the slow human HF 
oscillator in a coordinated manner. This will require multi-scale modelling. 
Complementary experimental investigations would involve laser capture 
microdissection to gain compartmentalised expression of mRNA and proteins of 
interest. This will elegantly complement the compartmentalised mathematical 
model proposed here and thus build a spatio-temporal expression edifice of the 
anagen and catagen states. In addition, siRNA technologies may be implemented 
to further probe the functional role of candidate genes in human hair cycle 
control and to dissect the underlying mechanisms of action. 
To conclude, this thesis constitutes a first major step towards human 
hair research from a systems biology perspective. The thesis demonstrates that 
human HF cycling provides a most intriguing and clinically relevant systems 
biology problem.  The current work raises the hope that the application of 
classical tools of system biology to human hair research will improve our 
understanding of human hair biology and pathology. 
 
In summary, the key findings of the thesis are: 
a. The human hair follicle is a dynamic organ whose cyclical activity may be 
controlled at the tissue level in the form of an autonomous relaxation 
oscillator. The mechanism requires delayed feedback between two 
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compartments (the MKs and DP). This presents a new theory of the 
human ‘hair cycle clock’. 
b. Knock-down of core circadian clock components; Clock and Period1, 
prolongs anagen phase in isolated human hair follicles. 
c. Human isolated hair follicles in anagen and catagen have differential 
transcriptome signatures which may utilised to develop markers for 
human hair anagen and catagen states 
Finally, the thesis is presented in a graphical abstract below.  
 
 
Figure 9.1: Graphical abstract of the thesis 
Microarray chip image obtained from http://www.nchu.edu.tw/~ibms/ibms1/JJW/microarray%20lab%20index.htm 
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11 APPENDIX 
APPENDIX A FRONT PAGE REPRINT OF THE CYCLING HAIR FOLLICLE AS 
AN IDEAL SYSTEMS BIOLOGY RESEARCH MODEL 
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APPENDIX B REPRINT METHODS IN HAIR RESEARCH: HOW TO 
OBJECTIVELY DISTINGUISH BETWEEN ANAGEN AND CATAGEN IN HUMAN 
HAIR FOLLICLE ORGAN CULTURE 
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APPENDIX C  EFFICIENCY RESULTS FOR QPCR VALIDATION EXPERIMENT 
 
Appendix C provides all the efficiency plots (and the corresponding data) for all 
TaqMan® target genes against the housekeeping gene PPIA used in the thesis. 
This section corresponds to Chapter 6.18.3 in the thesis where the methodology 
can be found. Efficiency validations were performed prior to carrying out the 
qPCR experiments to ensure that the delta delta Ct method could be used to 
obtain relative expression level results for qPCR experiments performed. In this 
section each target gene is presented on its own individual page with the 
efficiency plots and the table containing the data plotted below. The results of 
the efficiency experiments were used to determine the range of concentrations 
of cDNA to use for qPCR experiments (A summary table is provided in Section 
6.18.3 or alternatively provided in the far right column of all the tables 
presented here).  
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Relative efficiency plot and table of results for Period1 and PPIA 
 
 
Input 
concentration 
cDNA (ng) 
PPIA 
Normaliser 
gene 
Average Ct  
Period1 
Target gene 
Average Ct 
ΔCt  
PPIA - Period1 
Acceptable 
dynamic range 
(ng) 
100 14.4 22.0 -7.6 
0.1 to 100 
10 17.8 25.5 -7.7 
1 21.7 29.7 -8.1 
0.1 25.4 32.7 -7.3 
0.01 29.5 36.0 -6.5 
0.001 33.9 40.0 -6.1 
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Relative efficiency plot and table of results for Bmal1 and PPIA 
 
 
Input 
concentration 
cDNA (ng) 
PPIA 
Normaliser 
gene 
Average Ct  
Bmal1  
Target gene 
Average Ct 
ΔCt  
PPIA - Bmal1 
Acceptable 
dynamic range 
(ng) 
100 14.9 22.3 -7.4 
0.1 to 100 
10 17.9 25.4 -7.4 
1 21.3 28.7 -7.4 
0.1 24.8 32.4 -7.6 
0.01 28.5 36.4 -7.9 
0.001 31.7 40.0 -8.3 
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Relative efficiency plot and table of results for Clock and PPIA 
 
 
Input 
concentration 
cDNA (ng) 
PPIA 
Normaliser 
gene 
Average Ct  
Clock  
Target gene 
Average Ct 
ΔCt  
PPIA - Clock 
Acceptable 
dynamic range 
(ng) 
100 14.9 24.3 -9.4 
0.1 to 100 
10 17.9 27.3 -9.4 
1 21.3 30.6 -9.3 
0.1 24.8 34.1 -9.3 
0.01 28.5 40.0 -11.5 
0.001 31.7 40.0 -8.3 
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Relative efficiency plot and table of results for Cry1 and PPIA 
 
 
Input 
concentration 
cDNA (ng) 
PPIA 
Normaliser 
gene 
Average Ct  
Cry1 
Target gene 
Average Ct 
ΔCt  
PPIA – Cry1 
Acceptable 
dynamic range 
(ng) 
100 14.9 21.5 -6.6 
0.1 to 100 
10 17.9 24.5 -6.6 
1 21.3 27.9 -6.6 
0.1 24.8 31.3 -6.5 
0.01 28.5 34.6 -6.1 
0.001 31.7 36.9 -5.2 
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Relative efficiency plot and table of results for Cry2 and PPIA 
 
Input 
concentration 
cDNA (ng) 
PPIA 
Normaliser 
gene 
Average Ct  
Cry2 
Target gene 
Average Ct 
ΔCt  
PPIA – Cry2 
Acceptable 
dynamic range 
(ng) 
100 14.9 24.2 -9.3 
0.1 to 100 
10 17.9 27.5 -9.6 
1 21.3 31.0 -9.7 
0.1 24.8 34.2 -9.4 
0.01 28.5 37.0 -8.5 
0.001 31.7 40.0 -8.3 
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Relative efficiency plot and table of results for Nr1d1 and PPIA
 
Input 
concentration 
cDNA (ng) 
PPIA 
Normaliser 
gene 
Average Ct  
Nr1d1 
Target gene 
Average Ct 
ΔCt  
PPIA – Nr1d1 
Acceptable 
dynamic range 
(ng) 
100 14.9 25.1 -10.2 
1 to 100 
10 17.9 28.5 -10.5 
1 21.3 31.5 -10.2 
0.1 24.8 35.8 -10.9 
0.01 28.5 36.7 -8.2 
0.001 31.7 36.7 -5.0 
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Relative efficiency plot and table of results for Cdkn1a and PPIA 
 
Input 
concentration 
cDNA (ng) 
PPIA 
Normaliser 
gene 
Average Ct  
Cdkn1a 
Target gene 
Average Ct 
ΔCt  
PPIA – Cdkn1a 
Acceptable 
dynamic range 
(ng) 
100 14.9 22.8 -7.9 
0.1 to 100 
10 17.9 25.9 -8.0 
1 21.3 29.2 -7.9 
0.1 24.8 32.6 -7.8 
0.01 28.5 35.9 -7.4 
0.001 31.7 40.0 -8.3 
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Relative efficiency plot and table of results for c-Myc and PPIA 
 
 
Input 
concentration 
cDNA (ng) 
PPIA 
Normaliser 
gene 
Average Ct  
c-Myc Target 
gene Average 
Ct 
ΔCt  
PPIA – c-Myc 
Acceptable 
dynamic range 
(ng) 
100 14.8 20.6 -5.7 
0.1 to 100 
10 18.0 23.0 -5.9 
1 21.3 27.3 -6.0 
0.1 24.8 30.6 -5.8 
0.01 28.1 34.3 -6.1 
0.001 31.6 34.4 -2.9 
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APPENDIX D ADDITIONAL MICROARRAY RESULT: GENE FUNCTIONAL 
CATEGORIES DOWN-REGULATED GENES IN CATAGEN 
 
Appendix D provides additional data arising from the work detailed in Chapter 
8. Human anagen and catagen hair follicle gene expression profiles were 
obtained via microarray experiments (see Chapters 6 and Chapter 8 for more 
methodologies and details). An anagen “signature” was defined as the probe set 
down-regulated in catagen by a fold change of >1.5 in all three patients. Here 
the functional categories of the genes in the anagen “signature” produced by 
performing DAVID bioinformatics analysis of this list is provided in the table. 
BP = Biological process, MF = molecular function, CC=cell compartment 
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 Term Genes 
CC 
intracellular non-
membrane-bounded 
organelle 
KIF5C, KRT31, KRT33A, KRT86, KRTAP3-2, KRT85, MYCN, KRTAP4-7, 
KRTAP4-6, KRTAP4-5, KRTAP3-3, KRT81, KRTAP2-4, CAMK2N1, 
KIF5C,KRTAP4-4, SHROOM3, KRTAP2-1, DYNC1I1, KIF26A, KRTAP2-2, 
KRTAP1-3, KRT37, H2AFJ, KRTAP4-9, KRTAP4-3, KRTAP3-1, KRT73, KRT34, 
KRTAP4-2, KRT73, KRTAP1-1, KRTAP9-4/9-9, NAV2 
CC Cytoskeleton 
KIF5C, KRT32, KRT33A, KRT85, KRTAP3-2, KRT86, KRTAP4-7, KRTAP4-6, 
KRTAP4-5, KRTAP3-3, KRT81, KRTAP2-4, CAMK2N1, KRTAP4-4, SHROOM3, 
KIF5C, KRTAP2-1, DYNC1I1, KIF26A, KRTAP2-2, KRTAP1-3, KRT37, KRTAP4-
9, KRTAP4-3, KRTAP3-1, KRT73, KRT34, KRTAP4-2, KRT73, KRTAP1-1, 
KRTAP9-4/9-9 
CC intermediate filament 
KRT33A, KRT31, KRT86, KRTAP3-2, KRT85, KRTAP4-7, KRTAP4-6, KRTAP4-5, 
KRTAP3-3, KRT81, KRTAP2-4, KRTAP4-4, KRTAP2-1, KRTAP2-2, KRTAP1-3, 
KRT37, KRTAP4-9, KRTAP4-3, KRTAP3-1, KRT73, KRT34, KRTAP4-2, KRT73, 
KRTAP1-1, KRTAP9-4/9-9 
CC keratin filament 
KRTAP2-2, KRTAP1-3, KRT85, KRTAP3-2, KRT86, KRTAP4-7, KRTAP4-9, 
KRTAP4-3, KRTAP3-1, KRTAP2-4, KRTAP4-6, KRT73, KRTAP4-5, KRTAP4-2, 
KRTAP3-, KRT73, KRT81, KRTAP1-1, KRTAP9-4/9-9, KRTAP4-4, KRTAP2-1 
MF structural molecule activity 
KRT33A, KRT31, KRTAP1-3, WNT3, KRTAP3-2, KRT86, KRT85, KRT37, 
KRTAP3-1, KRT73, KRT34, KRTAP3-3, KRT73, KRT81, KRTAP1-1 
MF transcription factor activity MSX2, SMAD6, DLX1, MYCN, POU4F1, MSX1, DLX2, DLX3 
BP 
pattern specification 
process 
AXIN2, SMAD6, DLX1, WNT3, HHIP, SHROOM3, DLX2, CYP26B1 
BP neuron differentiation KIF5C, EFHD1, DLX1, ID3, POU4F1, KIF5C, DLX2  
BP Regionalization AXIN2, SMAD6, DLX1,WNT3, HHIP, DLX2, CYP26B1 
BP 
skeletal system 
development 
MSX2, AXIN2, DLX1, MSX1, NPR3, DLX2 
BP cell fate commitment DLX1, WNT3, IFRD1,DLX2, CYP26B1 
BP embryonic morphogenesis MSX2, WNT3, SHROOM3, MSX1, DLX2, CYP26B1 
BP 
chordate embryonic 
development 
AXIN2, DLX1, SHROOM3, MSX1,DLX2 
BP 
negative regulation of 
apoptosis 
MSX2, SGK3, SMAD6, DLX1, MSX1 
BP 
protein serine/threonine 
kinase signaling pathway 
MSX2, SMAD6, BAMBI, MSX1 
BP 
response to protein 
stimulus 
MSX2, ID3, MSX1,LY6G6D 
BP epidermis development KRT31,KRT34, KRT85 
BP 
negative regulation of 
signal transduction 
AXIN2, SMAD6, HHIP,CYP26B1 
BP 
proximal/distal pattern 
formation 
Dlx1, Dlx2,  Cyp26b2 
BP BMP signaling pathway Msx2,Msx1, SMAD6 
BP cartilage development Msx1, Dlx2 
MF microtubule motor activity KIF5C, DYNC1I1, KIF26A, KIF5C 
BP appendage morphogenesis Msx2,Msx1, Cyp26b2 
BP 
forebrain neuron fate 
commitment 
Dlx1, Dlx2 
BP 
regulation of 
oligodendrocyte 
differentiation 
Dlx1, Dlx2 
MF 
structural constituent of 
epidermis 
Krtap1-3, Krtap1-1 
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APPENDIX E  ADDITIONAL MICROARRAY RESULT - FUNCTIONAL 
CATEGORIES UP-REGULATED GENES IN CATAGEN  
 
Appendix E provides additional data arising from the work detailed in Chapter 
8. Human anagen and catagen hair follicle gene expression profiles were 
obtained via microarray experiments (see Chapters 6 and Chapter 8 for more 
methodologies and details). The catagen “signature” was defined as the probe 
set up-regulated in the catagen samples when compared to the anagen samples. 
(fold change of >1.5 in all three patients). The catagen “signature” produced 
much less genes and functional categories as seen in the table below (compare 
to Appendix D – Anagen functional catgegories) 
BP = Biological process, MF = molecular function, CC=cell compartment 
 
 Term Genes 
BP Cell adhesion 
SPP1,  COL27A1  COL14A1,  TNFAIP6, 
PARVA, DAB1 
MF zinc ion binding KCND3, FHL1, MMP16 
CC Cell projection SPP1, KCND3, NEFL, PARVA 
CC extracellular region part SPP1, COL27A1, COL14A1, MMP16 
BP regulation of cellular component size SPP1, FHL1, NEFL 
BP Cell division PARD6G 
CC extracellular matrix COL27A1, COL14A1, MMP16 
MF steroid dehydrogenase activity AKR1C2 , AKR1C1 
CC Collagen COL27A1, COL14A1 
MF monocarboxylic acid binding AKR1C2 , AKR1C1 
BP regulation of axonogenesis SPP1, NEFL 
MF steroid binding AKR1C2 , AKR1C1 
BP response to toxin AKR1C1, NEFL 
BP 
regulation of neuron projection 
development 
SPP1, NEFL 
CC tight junction PARD6G 
BP 
regulation of cell morphogenesis 
involved in differentiation 
SPP1, NEFL 
 
